DIABETES & CANCER

1. A case of advanced cervical esophageal cancer with liver cirrhosis and diabetes mellitus showing a complete response by radiation therapy after the operation for …
2. A case of an elderly woman with concurrent pancreatic cancer and slowly progressive type 1 diabetes mellitus
3. A case of central diabetes insipidus caused by metastatic small cell lung cancer
4. A Case of Central diabetes Insipidus in Patient with Non-small Cell Lung cancer.
5. A case of diabetes mellitus accompanied by tumor-forming pancreatitis that was difficult to distinguish from pancreatic cancer
6. A case of effective weekly paclitaxel administration for advanced gastric cancer associated with diabetes mellitus-about the control of blood glucose when …
7. A Case of Fulminant Type 1 diabetes Mellitus and Diabetic Ketoacidosis Caused by Adjuvant Chemotherapy for Colon cancer
8. A case of lung cancer with pituitary metastases presented by diabetes insipidus
9. A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer
10. A Case of Pituitary Metastasis of Breast cancer Presenting as diabetes Insipidus and Panhypopituitarism.
11. A case of small cell lung cancer associated with diabetes insipidus and Cushing’s syndrome
12. A case of type 2 diabetes and metastatic liver cancer exhibiting hypercholesterolemia with abnormal lipoproteins
13. A Case of Ulcerative Colitis Combined with Follicular Thyroid cancer and Gestational diabetes Mellitus
14. A case-control study of diabetes mellitus and cancer risk
15. A Clinical Analysis of Endometrial cancer Accompanied by Hypertension and diabetes Mellitus
16. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes
17. A clinical prediction model to assess risk for pancreatic cancer among patients with pre-diabetes.
18. A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
19. A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus
20. A cohort study of the risk of cancer associated with type 2 diabetes
21. A COMPARISON OF SPIRITUAL DEVELOPMENT BETWEEN HEALTHY INDIVIDUALS AND PATIENTS SUFFERING FROM cancer AND diabetes
22. A Comprehensive Analysis of diabetes Self-Management among with Men with Prostate cancer in the United States: Evidence from the National Health and Nutrition …
23. A Connecting Switch Among Aging, diabetes and Tumor: Avenue Leading to cancer Therapeutics
24. A cross-sectional study of health-related quality of life deficits in individuals with comorbid diabetes and cancer
25. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan
26. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)—Potsdam Study cohort
27. A genetic link between type 2 diabetes and prostate cancer
28. A genetic relationship between diabetes and cancer
29. A high diet quality based on dietary recommendations is not associated with lower incidence of type 2 diabetes in the Malmö Diet and cancer Cohort
30. A high rate of undiagnosed diabetes in new uterine cancer patients
31. A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
32. A Hybrid Machine Learning Scheme to Analyze the Risk Factors of Breast cancer Outcome in Patients with diabetes Mellitus.
33. A meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer
34. A meta-analysis of diabetes mellitus and the risk of prostate cancer
35. A molecular rheostat at the interface of cancer and diabetes
36. A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time
37. A new approach for diagnosis of diabetes and prediction of cancer using ANFIS
38. A new ınsight ınto metformin action: diabetes, prostate cancer, and ıon channels
39. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose
40. A New Role for an Old Drug: Metformin Targets Micro RNA s in Treating diabetes and cancer
41. A noninvasive method to detect diabetes mellitus and lung cancer using the stacked sparse autoencoder
42. A novel approach for the diagnosis of diabetes and liver cancer using ANFIS and improved KNN
43. A NOVEL APPROACH IN COLORECTAL cancer AND diabetes MANAGEMENT: ROLE OF METFORMIN AND RAPAMYCIN
44. A novel design and analysis of high-sensitivity biosensor based on nano-cavity for detection of blood component, diabetes, cancer and glucose concentration
45. A novel mechanistic pathway linking diabetes to colorectal cancer: Role of AMPK and mTOR
46. A novel method for studying the temporal relationship between type 2 diabetes mellitus and cancer using the electronic medical record
47. A Novel Pathway Linking Oxidative Stress and Inflammation: Prevention of cancer, Sepsis, Asthma, diabetes and Uveitis by Aldose Reductase Inhibition.
48. A novel therapeutic approach to colorectal cancer in diabetes: role of metformin and rapamycin
49. A patient with diabetes and breast cancer in whom virilization was caused by a testosterone-producing mature cystic teratoma containing a brenner tumor
50. A pilot study evaluating steroid-induced diabetes after antiemetic dexamethasone therapy in chemotherapy-treated cancer patients
51. A population-based cohort study of all-cause and site-specific cancer incidence among patients with type 1 diabetes mellitus in Taiwan
52. A Potential Screening Strategy of Pancreatic cancer in New Onset diabetes Patients Using Serum CA19-9 in Combination With Age and BMI: 7
53. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 diabetes and Prostate cancer
54. A Progressive Stack Face-based Network for Detecting diabetes Mellitus and Breast cancer
55. A prospective study of the associations between treated diabetes and cancer outcomes
56. A Prospective Study of the Associations Between Treated diabetes Mellitus and cancer Outcomes
57. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer
58. A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk
59. A retrospective study of the impact of diabetes mellitus on survival in patients with lung cancer
60. A retrospective study of the impact of diabetes mellitus on survival in patients with tung cancer
61. A retrospective study on the role of diabetes and metformin in colorectal cancer disease progression.
62. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival
63. A retrospective-analysis of the correlation between diabetes mellitus and cancer
64. A review of cohort studies on the association between history of diabetes mellitus and occurrence of cancer
65. A review of current knowledge: Role of diabetes, cancer and cytochrome P450
66. A review of the etiology and biomarkers of pancreatic cancer, with emphasis on the role of diabetes
67. A Review of the Quality of Life of Hemodialysis, Breast cancer, and Type 2 diabetes Mellitus Patients
68. A risk stratification schema for predicting diabetes mellitus in cancer survivors.
69. A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study
70. A Study of the People’s Medicine Scheme in Mumbai and Thane region, India with reference to cancer and diabetes medicines
71. A study on implementation of national programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke in Udupi district, Karnataka
72. A study on utilization of diagnostic and therapeutic services of National Program for Prevention and Control of cancer, diabetes and Cardiovascular Diseases …
73. A SUCCESSFUL CASE OF GASTRIC cancer WITH diabetes MELLITUS IN 84 YEAR OLD MAN, TOTAL GASTRECTOMIZED WITH TRANSVERSE COLECTOMY
74. A SURVEY ON IMPROVING THE PERFORMANCE OF cancer AND diabetes DETECTION BY USING NOVEL TECHNIQUE OF MACHINE LEARNING
75. A Survey on The Roles of Life Style and Its Modification in The Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
76. A systematic review of cases of diabetes mellitus following immune checkpoint inhibitor therapy for cancer
77. A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
78. A systematic review study on the communication between diabetes and cancer: The serious risk of cancer in diabetic patients
79. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
80. A ubiquitous membrane fusion protein αSNAP: a potential therapeutic target for cancer, diabetes and neurological disorders?
81. Aberrant Expression of Sialidase in cancer and diabetes
82. Aberrant methylation of the Ras-related associated with diabetes gene in human primary esophageal cancer
83. Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering …
84. ABO blood group and diabetes mellitus influence the risk for pancreatic cancer in a population from China
85. ABO blood type, diabetes and risk of gastrointestinal cancer in northern China
86. ABO blood type, long-standing diabetes, and the risk of pancreatic cancer
87. Abolish cancer progenitor cells in a mouse model of diabetes associated hepatocellular carcinoma
88. Aboriginal and Torres Strait islander health: Accuracy of patient self‐report of screening for diabetes, high cholesterol and cervical cancer
89. Abstract A08: Human preadipocytes promote pancreatic cancer cellular growth in a diabetes-specific manner
90. Abstract A23: cancer outcomes in the diabetes prevention program outcomes study
91. Abstract A23: Metformin as a potent antiangiogenic factor: From diabetes to cancer angioprevention
92. Abstract A27: Association between diabetes pharmacotherapies and bladder cancer: A Medicare epidemiologic study
93. Abstract A58: Interaction of diabetes and obesity in postmenopausal breast cancer risk among black women
94. Abstract A76: diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
95. Abstract B026: Occurrence of comorbidities among diverse hospice cancer patients with and without diabetes
96. Abstract B17: Type 2 diabetes, metformin, and ovarian cancer survival: An analysis of tumor registry and electronic medical record data.
97. Abstract B43: Type 2 diabetes mellitus and colorectal cancer risk in Hispanics: A pilot case-control study
98. Abstract B45: Obesity, diabetes, other comorbidities and survival in a cohort of women with ovarian cancer
99. Abstract B94: Relationship of overweight and diabetes with prostate cancer stages in Mexican Americans: A population-based case-control study
100. Abstract C077: The association between diabetes, plasma fructosamine, and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white …
101. Abstract C28: An exploratory study of co-occurrence of breast cancer and diabetes in medically underserved Latinas
102. Abstract CT198: Efficacy of metfOrmin in PrevenTIng glucocorticoid-induced diabetes in Melanoma, breAst or Lung cancer patients with brain metastases: The phase …
103. Abstract GS2-09: diabetes risk reduction diet and survival following breast cancer
104. Abstract LB-18: Statins use prevents ovarian cancer recurrence in women with diabetes mellitus.
105. Abstract LB-190: Ethnic differences in the relationship between diabetes, adiposity measures and breast cancer-specific mortality
106. Abstract LB-278: Metformin exposure on survival in localized breast cancer patients with type II diabetes mellitus using electronic health records
107. Abstract LB-285: Glycemia is positively associated with prostate cancer mortality in white and black men without diabetes when better classifying hyper-and …
108. Abstract LB-296: Breast cancer metabolism in association with diabetes
109. Abstract LB-421: diabetes pharmacotherapy: A potential modifier of breast cancer prognosis
110. Abstract P1-08-05: Type 2 diabetes and survival outcomes among a multi-ethnic cohort of breast cancer patients
111. Abstract P1-10-02: Type II diabetes and subtype-specific breast cancer risk in medically underserved black and white women
112. Abstract P2-07-06: Obesity, dyslipidemia, and diabetes as risk factors for trastuzumab-related cardiotoxicity in breast cancer patients
113. Abstract P2-08-11: High prevalence and incidence of new onset diabetes in metastatic breast cancer
114. Abstract P2-11-09: Weight Change and Risk of Incident diabetes After Breast cancer
115. Abstract P3-02-10: The possible association among breast cancer, diabetes mellitus and GLP-1 receptor
116. Abstract P3-10-32: Breast cancer Patients with Type 2 diabetes Trend To Be Associated with Poor Prognosis
117. Abstract P344: Association of diabetes and cancer Mortality in American Indians: The Strong Heart Study
118. Abstract P4-12-07: diabetes Increases the Risk of Breast cancer
119. Abstract P4-13-08: diabetes, Related Factors and Breast cancer Risk
120. Abstract P5-12-04: Association of adjuvant endocrine therapy with diabetes among women with postmenopausal breast cancer in the Women’s Health Initiative (WHI)
121. Abstract P6-09-05: Insulin Resistance, diabetes Mellitus and Breast cancer Risk in Pre-and Postmenopausal Women: Modification Effect by Moderate Physical …
122. Abstract P6-10-03: The association between type-2 diabetes and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women from …
123. Abstract P6-10-12: Metformin increases survival in hormone receptor-positive, Her2-positive breast cancer patients with diabetes
124. Abstract PD11-05: diabetes decreases overall survival in women with breast cancer in the southern community cohort study
125. Abstract PD4-6: Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemias among breast cancer survivors
126. Abstract PL05-02: Current therapies for diabetes-will they reduce cancer risk?
127. Abstract PO-159: Mediation of black/white race disparity in triple-negative breast cancer: Effect of type 2 diabetes mellitus
128. Abstract PO-215: diabetes and the quality of adjuvant therapy in Medicaid-insured women with breast cancer
129. Abstract PO-237: Colorectal cancer screening in patients with type 2 diabetes mellitus
130. Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus
131. Abstract SY02-02: Shared risk factors for diabetes, cardiovascular disease, and cancer in a low-income population
132. Abstract SY02-04: Risk factors associated with cancer, type 2 diabetes, and cardiovascular disease in the multiethnic cohort: Comparisons across ethnic groups
133. Abstract# 2111: Effect of IGF gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
134. Abstract# 2938: Treatment for diabetes mellitus-2 could prevent pancreatic cancer cell growth
135. Acanthosis nigricans—decreased extracellular matrix viscosity: cancer, obesity, diabetes, corticosteroids, somatotrophin
136. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia
137. ACS/ADA/AHA issue core recommendations for preventing cancer, cardiovascular disease, and diabetes
138. Activation of cancer-related and mitogen-activated protein kinase signaling pathways in human mature osteoblasts isolated from patients with type 2 diabetes
139. Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
140. Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
141. ADA, ACS Spotlight diabetes–cancer Links
142. Adapted geometric semantic genetic programming for diabetes and breast cancer classification
143. Additional risk of diabetes exceeds the increased risk of cancer caused by radiation exposure after the Fukushima disaster
144. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
145. Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes
146. Addressing different biases in analysing drug use on cancer risk in diabetes in non‐clinical trial settings—what, why and how?
147. Adenosine monophosphate–activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection
148. Adherence to a healthy Nordic food index is associated with a lower risk of type-2 diabetes—The Danish diet, cancer and health cohort study
149. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010
150. Adherence to Dietary Indexes by diabetes and Hypertension Status among PLCO cancer Screening Trial Participants
151. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment
152. Adherence to the Danish food-based dietary guidelines and risk of type 2 diabetes: the Danish diet, cancer, and health cohort
153. Adiponectin as a potential key player in metabolic syndrome: Insights into atherosclerosis, diabetes and cancer
154. Adiposity and diabetes in breast and prostate cancer
155. Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the UK Biobank, and their modification by smoking
156. Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women
157. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer
158. Adopting Nrf2 and NF-κB from cancer: Is there any role of the duo in diabetes?
159. ADRB2 G–G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity
160. Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood
161. Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus
162. Advanced glycation end products in diabetes, cancer and phytochemical therapy
163. Advances in the studies of the link between diabetes and cancer
164. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes–focus on pancreatitis and pancreas cancer
165. Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
166. African American breast and endometrial cancer survivors with type 2 diabetes: Perceived barriers and preferred components for a physical activity program
167. Age-related differences in the consequences of obesity on cardiovascular disease, type 2 diabetes, osteoarthritis, cancer, physical function, osteoporosis, cognitive …
168. Age, gender and type 2 diabetes contribute to the risk of gastric cancer: a retrospective single institution analysis
169. AIDS, diabetes, and lung cancer mortality at the northern Mexican border: 1979-1997
170. Akt enzyme: new therapeutic target in cancer and diabetes?
171. Akt2 Redox-regulation in Breast cancer and diabetes
172. Alarmins in chronic noncommunicable diseases: atherosclerosis, diabetes and cancer
173. All-cause, cardiovascular, and cancer mortality rates in postmenopausal white, black, Hispanic, and Asian women with and without diabetes in the United States: the …
174. All‐cause cancer mortality over 15 years in multi‐ethnic Mauritius: The impact of diabetes and intermediate forms of glucose tolerance
175. Alpha-glucosidase inhibitors and risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
176. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes and cancer
177. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8)
178. Alternative splicing of insulin receptor mRNA in cancer and type 2 diabetes mellitus: a review
179. American diabetes Association 60th Scientific Sessions, 2000: glucose tolerance, diabetes and cancer, glycemic control, monitoring, and related topics
180. AMP-activated protein kinase: a target for old drugs against diabetes and cancer
181. AMPK activators as a drug for diabetes, cancer and cardiovascular disease
182. AMPK-a nutrient and energy sensor with roles in diabetes, cancer and viral infection
183. AMPK: a target for drugs and natural products with effects on both diabetes and cancer
184. AMPK: therapeutic target for diabetes and cancer prevention
185. An analysis of the impact of irrational beliefs and illness representation in predicting distress in cancer and type II diabetes patients
186. An assessment of the shared allelic architecture between type II diabetes and prostate cancer
187. An Australian man who stays he developed bladder cancer after using a diabetes drug is taking legal action against the drug’s manufacturer and distributor
188. An autopsy case of pulmonary tumor thrombotic microangiopathy due to rapidly progressing colon cancer in a patient with type 2 diabetes
189. An ecological association between the prevalence of diabetes Mellitus and the incidence of colorectal cancer
190. An elevated HbA1c level is associated with short-term adverse outcomes in patients with gastrointestinal cancer and type 2 diabetes mellitus
191. An epidemiology study of the relationship between pancreatic cancer and diabetes mellitus
192. An experimental model of diabetes and cancer in rats
193. An extended Myc network contributes to glucose homeostasis in cancer and diabetes
194. An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
195. An integrative hypothesis linking cancer, diabetes and atherosclerosis: the role of mutations and epigenetic changes
196. An optimization approach to improve classification performance in cancer and diabetes prediction
197. An uncommon case of T1b breast cancer with diabetic mastopathy in type II diabetes mellitus
198. An Unusual Case of Emphysematous Cystitis in Non diabetes Metastatic Lung cancer Patient Undergoing Chemotherapy
199. Anabolic and pro-metabolic functions of CREB-CRTC in skeletal muscle: advantages and obstacles for type 2 diabetes and cancer cachexia
200. Analysis and prediction of breast cancer and diabetes disease datasets using data mining classification techniques
201. Analysis of cardiovascular events or diabetes mellitus during androgen deprivation therapy in Korean prostate cancer patients
202. Analysis of clinical data in breast cancer patients with type 2 diabetes
203. Analysis of clinical features in colorectal cancer patients with Type 2 diabetes
204. ANALYSIS OF CLINICAL FEATURES OF COLORECTAL cancer PATIENTS COMBINED TYPE 2 diabetes MELLITUS
205. Analysis of Drug Use in Clinical Comprehensive Therapy for Advanced Lung cancer Patients with diabetes Mellitus
206. Analysis of functional genetic polymorphisms in prostate cancer and type 2 diabetes: Mucin 1 and growth hormone receptor
207. Analysis of gene expression patterns and metabolomics correlated to obesity, diabetes, and outcomes in patients with epithelial ovarian cancer
208. Analysis of microrna signatures as biomarker to investigate interlink between type 2 diabetes and breast cancer
209. Analysis of perioperative treatment on 43 cases of gastric cancer complicated with diabetes mellitus [J]
210. Analysis of Serum Growth Differentiation Factor-15 in Progression of Breast cancer in Type II diabetes Mellitus Patients
211. Analysis of the association of diabetes mellitus with cancer using autopsy records
212. Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors
213. Analysis of the efficacy of surgical treatment for 80 elderly laryngeal cancer patients with type 2 diabetes
214. Analysis on 57 cases of saving anus surgery for rectal cancer patients incorporated diabetes
215. Analyzing Targeted Nucleosome Position and Occupancy in cancer, Obesity, and diabetes
216. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors
217. Androgen Deprivation Therapy in Patients with Advanced Prostate cancer and Type 2 diabetes Impairs Glucose and Lipid Metabolism: 64
218. Androgen deprivation therapy increases the risk of diabetes and non-cancer mortality in prostate cancer patients: a meta-analysis
219. Androgen deprivation therapy, diabetes and poor physical performance status increase fracture risk in Chinese men treated for prostate cancer
220. Androgen receptor overexpression in prostate cancer in type 2 diabetes
221. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer
222. Androgens, diabetes and prostate cancer
223. Angiogenesis and inflammation at the crossroads between diabetes and cancer: PS226
224. Angiopoietin-like protein 2 is a useful biomarker for pancreatic cancer that is associated with type 2 diabetes mellitus and inflammation
225. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study
226. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-day Adventists
227. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung diabetes Study
228. Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai
229. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis
230. Anti-Diabetic Medications and Risk of Pancreatic cancer in Patients With diabetes Mellitus: A Systematic Review and Meta-Analysis
231. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
232. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis
233. Anti-diabetic treatment and cancer occurrence among patients with type II diabetes mellitus
234. Antidiabetic medication, statins and the risk and prognosis of non-endometrioid endometrial cancer in women with type 2 diabetes
235. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes
236. Antidiabetic medications and mortality risk in individuals with pancreatic cancer–related diabetes and postpancreatitis diabetes: a nationwide cohort study
237. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis
238. Antidiabetic medications use and cancer risk in type 2 diabetes
239. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer
240. Application of microbiological and immunological enteral nutrition in patients with gastrointestinal cancer complicated with diabetes mellitus
241. Applications of metabolomics for understanding the action of peroxisome proliferator-activated receptors (PPARs) in diabetes, obesity and cancer
242. Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
243. Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes
244. ARE diabetes MELLITUS AND CHROMOSOME 17Q12 GENETIC VARIANTS ASSOCIATED WITH PROSTATE cancer AGGRESSIVENESS?
245. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
246. Are the Different diabetes Subgroups Correlated With All-Cause, cancer-Related, and Cardiovascular-Related Mortality?
247. Are We doing a Better Job of Understanding Co-morbidity Conditions in Health Care (cancer, Tuberculosis, Hypertension, diabetes, etc.?
248. Aspects épidémiologiques de l’association diabète et cancer: Epidemiological features of the diabetes–cancer association
249. Assessing bladder cancer risk in type 2 diabetes clinical trials: the dapagliflozin drug development program as a ‘case study’
250. Assessing the relationship between institutional cancer and diabetes mortality rates using National Death Index data
251. Assessment of Blood Donation Safety by People Diagnosed with diabetes, Hypertension, Malaria and cancer
252. Assessment of classification algorithms in the diagnosis of diabetes and breast cancer
253. ASSESSMENT OF diabetes MELLITUS AS A MADHUMEHA AND cancer RISK–A REVIEW
254. Assessment of implementation of the national programme for the prevention and control of cancer, diabetes, cardiovascular diseases, and stroke at …
255. Assessment of quality of life in patients with cancer and diabetes 2 in Northern Greece
256. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer
257. Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort …
258. Association Between Breast cancer and diabetes
259. Association between cancer antigen 19‐9 and diabetes risk: A prospective and Mendelian randomization study
260. Association between cancer prevalence and use of thiazolidinediones: results from the Vermont diabetes Information System
261. Association between consumption of dairy products and incident type 2 diabetes—insights from the European Prospective Investigation into cancer study
262. Association between diabetes and cancer in Indian and US Populations using Longitudinal Study Design
263. Association between diabetes and colorectal cancer risk in a homogeneous canadian population
264. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population
265. Association between diabetes and oncological outcomes in patients undergoing neoadjuvant chemo-radiotherapy for rectal cancer
266. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
267. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature
268. Association between diabetes mellitus and kidney cancer
269. Association between diabetes mellitus and lung cancer: meta‐analysis
270. Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy
271. Association between diabetes mellitus and subsequent ovarian cancer in women: A systematic review and meta-analysis of cohort studies
272. Association between diabetes or antidiabetic therapy and lung cancer: A meta‐analysis
273. Association between diabetes, diabetes treatment and risk of developing endometrial cancer
274. Association between diagnosed diabetes and self-reported cancer among US adults: findings from the 2009 Behavioral Risk Factor Surveillance System
275. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
276. Association between exposure to desalinated sea water and ischemic heart disease, diabetes mellitus and colorectal cancer; A population-based study in Israel
277. Association between gestational diabetes mellitus and subsequent risk of cancer: a systematic review of epidemiological studies
278. Association between glucose‐lowering treatment and cancer metastasis among patients with preexisting type 2 diabetes and incident malignancy
279. Association between metabolic syndrome, diabetes mellitus and prostate cancer risk
280. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review
281. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies
282. Association between metformin use and mortality after cervical cancer in older women with diabetes
283. Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population …
284. Association between pancreatic cancer and metformin use in patients with type 2 diabetes
285. Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: a long-term historical cohort study …
286. Association between socioeconomic status and mortality, cardiovascular disease, and cancer in patients with type 2 diabetes
287. Association Between Statins and cancer Incidence in diabetes: a Cohort Study of Japanese Patients with Type 2 diabetes
288. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses
289. Association between type 2 diabetes and cancer incidence in China: data in hospitalized patients from 2006 to 2013
290. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study
291. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium
292. Association between type 2 diabetes mellitus (T2DM), diabetic therapies and clinical outcomes in patients (pts) with metastatic colorectal cancer (mCRC).
293. Association between type 2 diabetes mellitus risk factors with breast cancer in Mexican women
294. Association between type 2 diabetes, curative treatment and survival in men with intermediate‐and high‐risk localized prostate cancer
295. Association between type II diabetes and colon cancer among Japanese with reference to changes in food intake
296. Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
297. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective …
298. Association of Adipose Tissue Distribution With Type 2 diabetes in Breast cancer Patients
299. ASSOCIATION OF ANGIOTENSIN-RECEPTOR BLOCKERS WITH cancer RISK IN PATIENTS WITH TYPE 2 diabetes MELLITUS
300. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes
301. Association of arterial hypertension, diabetes mellitus and inflammation with cancer incidence and mortality
302. Association of breast cancer and diabetes mellitus in Korean postmenopausal women
303. Association of Comorbid diabetes With Clinical Outcomes and Healthcare Utilization in Colorectal cancer Survivors.
304. Association of Delta-6-Desaturase expression with aggressiveness of cancer, diabetes mellitus, and multiple sclerosis: a narrative review
305. Association of diabetes and cancer mortality in American Indians: the Strong Heart Study
306. Association of diabetes and cancer-diagnoses in primary care practices in Germany.
307. Association of diabetes and diabetes treatment with incidence of breast cancer
308. Association of diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast cancer Treatment for Breast cancer
309. Association of diabetes and perineural invasion in pancreatic cancer
310. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
311. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non‐muscle‐invasive bladder cancer
312. Association of diabetes mellitus with biological behaviors of colorectal cancer
313. Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer.
314. Association of diabetes mellitus with prostate cancer grade and prostate-specific antigen in Chinese biopsy population
315. Association of diabetes mellitus with prostate cancer: nested case–control study (Prostate testing for cancer and treatment study)
316. Association of diabetes mellitus with thyroid cancer risk: A meta-analysis of cohort studies
317. Association of diabetes Status With Survival After Immune Checkpoint Inhibitor Treatment for Advanced Lung cancer: a Retrospective Study in Japan
318. Association of diabetes Susceptibility Gene Calpain-10 with Pancreatic cancer Among Smokers
319. Association of diabetes with colorectal cancer treatment and outcomes.
320. Association of diabetes with colorectal cancer treatment and outcomes.
321. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study
322. Association of diabetes with oral cancer-an enigmatic correlation
323. Association of diabetes with perineural invasion and overall survival in surgically resected patients with pancreatic cancer.
324. Association of diabetes with prostate cancer risk in the multiethnic cohort
325. Association of diabetes with survival among cohorts of Indigenous and non-Indigenous Australians with cancer
326. Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer
327. Association of endometrial hyperplasia and cancer with a history of gestational diabetes
328. Association of endometrial hyperplasia or cancer with a history of gestational diabetes-results from a population-based study in Washington State, 1987-2013
329. association of Family history of Type 2 diabetes with Prostate cancer: a national cohort study
330. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry
331. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
332. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: a systematic review and meta-analysis
333. Association of metformin with breast cancer incidence and mortality in patients with type II diabetes: a GRADE-assessed systematic review and meta-analysis
334. Association of Metformin, Other Antidiabetic Medications, and Statins With Incidence of Colon cancer in Patients With Type 2 diabetes
335. Association of serum anti-gad antibody and hla haplotypes with type 1 diabetes mellitus triggered by nivolumab in patients with non–small cell lung cancer
336. Association of serum C-peptide concentrations with cancer mortality risk in pre-diabetes or undiagnosed diabetes
337. Association of serum paraoxonase 1 activities, polymorphisms and oxidative stress in breast cancer patients with type 2 diabetes mellitus
338. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer
339. Association of the consumption of common food groups and beverages with mortality from cancer, ischaemic heart disease and diabetes mellitus in Serbia, 1991 …
340. Association of the severity of diabetes-related complications with stage of breast cancer at diagnosis among elderly women with pre-existing diabetes
341. Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case–control study
342. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
343. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women
344. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
345. Association of type 2 diabetes mellitus and the risk of colorectal cancer: a meta-analysis and systematic review
346. Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate cancer Cohort Consortium
347. Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people
348. Association of type 2 diabetes with in-hospital complications among women undergoing breast cancer surgical procedures. A retrospective study using the …
349. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
350. Associations between diabetes and quality of life among breast cancer survivors
351. Associations between diabetes medication use and risk of second breast cancer events and mortality
352. Associations of change in television viewing time with biomarkers of postmenopausal breast cancer risk: the Australian diabetes, Obesity and Lifestyle Study
353. Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
354. Associations of hemoglobin A1c with risk of diabetes-related cancers in the cancer Prevention Study-II Nutrition Cohort (CPS-II NC)
355. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
356. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer
357. Associations of Telomere Length and diabetes with Pancreatic cancer
358. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
359. Asymptomatic acute pancreatitis due to tamoxifen-induced severe hypertriglyceridemia in a patient with diabetes mellitus and breast cancer
360. At the intersection of diabetes and cancer: the role of angiogenesis and inflammation
361. Atezolizumab-induced autoimmune diabetes in a patient with metastatic lung cancer
362. Atrial natriuretic peptide and type 2 diabetes development, evidence of causal association from the prospective Malmö diet and cancer study
363. Attitude toward death in healthy people and patients with diabetes and cancer
364. Attitudes, perceptions, and family coping in pediatric cancer and childhood diabetes
365. Atypical diabetes insipidus in small cell lung cancer: paraneoplastic syndrome or metastatic disease?
366. Atypical early onset of diabetes, deafness and lung cancer in a male patient with mitochondrial mutations in peripheral mononuclear cells
367. Author Correction: Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
368. Author Correction: Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, diabetes, Breast and Prostate cancer
369. Authors’ reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer
370. Autoimmune diabetes superimposed on type 2 diabetes in a patient initiated on immunotherapy for lung cancer
371. Automatic Extraction of Useful Information from Food-Health Articles related to diabetes, Cardiovascular Disease and cancer
372. Award of the Foundation for the State of Kuwait Prize for the Control of cancer, Cardiovascular Diseases and diabetes in the Eastern Mediterranean Region
373. Bamboo extract in the prevention of diabetes and breast cancer
374. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the ‘cerebral diabetes paradigm’
375. Benefits of screening for pancreatic cancer in new-onset diabetes mellitus
376. BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer
377. Beyond diabetes mellitus: role of metformin in non-muscle invasive bladder cancer
378. Biguanide therapy for diabetes and cancer & a novel methyltransferase that regulates energy expenditure and adiposity and is elevated in many cancers
379. Bio-Inspired and Nanotechnology-Enabled Drug Delivery for diabetes and Brain cancer
380. Bioactive Flavonoid Apigenin and Its Nanoformulations: A Promising Hope for diabetes and cancer
381. Biochemical mechanisms connecting diabetes and cancer. Effects of methormine
382. Biogenesis of silver nanoparticles to treat cancer, diabetes, and microbial infections: a mechanistic overview
383. Biologic evaluation of diabetes and local recurrence in non-small cell lung cancer
384. Biology of circulating nucleic acids and possible roles in diagnosis and treatment in diabetes and cancer.
385. Bitter melon as a therapy for diabetes, inflammation, and cancer: a panacea?
386. Bittergourd (Momordica charantia) scavenges free radicals by enhancing the expression of superoxide dismutase in in vitro models of diabetes and cancer
387. Blacks more likely to die of cancer and diabetes
388. Bladder cancer In Patients With Type 2 diabetes Treated With Pioglitazone, A Comparative Study
389. Blood glucose concentrations and breast cancer risk in women without diabetes: a meta-analysis
390. BMI and weight: their relation to diabetes, CVD, cancer and allcause mortality
391. Body fat distribution, diabetes, and prostate cancer in Afro-Caribbean men: the Tobago Prostate cancer Survey
392. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam study
393. Body mass index and cancer risk among Chinese patients with type 2 diabetes mellitus
394. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
395. Body mass index and cancer risk in patients with type 2 diabetes: a dose–response meta-analysis of cohort studies
396. Body mass index and diabetes are important prognostic signatures for bilateral breast cancer prognosis
397. Body mass index and obesity-and diabetes-associated genotypes and risk for pancreatic cancer
398. Body mass index and obesity-related cancer risk in men and women with type 2 diabetes (ZODIAC-56)
399. Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center diabetes Database
400. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into cancer and Nutrition (EPIC)–Potsdam Study–
401. Body mass index, diabetes and intrahepatic cholangiocarcinoma risk: the liver cancer pooling project and meta-analysis
402. Body mass index, diabetes and survival after diagnosis of endometrial cancer: a report from the HUNT-Survey
403. Body mass index, diabetes, and triple-negative breast cancer prognosis
404. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study …
405. Body mass index, type 2 diabetes, and insulin prescription in adolescents and young adults with cancer
406. Body mass index, waist circumference, diabetes, and risk of liver cancer for US adults
407. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study
408. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)
409. Breast and prostate cancer survivors in a diabetic cohort: results from the Living with diabetes Study
410. Breast cancer and diabetes mellitus
411. Breast cancer and diabetes mellitus: Complex interactions
412. Breast cancer and diabetes.
413. Breast cancer in women with diabetes mellitus type 2
414. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase
415. Breast cancer increases diabetes risk
416. Breast cancer patients with diabetes mellitus: Defining the population and assessing outcomes.
417. Breast cancer Radiotherapy Associated diabetes Mellitus Case Reports
418. Breast cancer resistance protein and diabetes
419. Breast cancer with diabetes insipidus
420. Breast cancer, diabetes mellitus and usefulness of immunonutrition
421. Breast cancer: Increased Risk of Cardiotoxicity Found with Trastuzumab for Elderly Patients with Heart Disease, diabetes
422. Breast, cervical and colorectal cancer screening in adults with diabetes: a systematic review and meta-analysis
423. Brief report: the risk of posttraumatic stress disorder in mothers of children diagnosed with pediatric cancer and type I diabetes
424. Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation
425. Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030
426. Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors
427. Burden of diabetes and oral cancer in India
428. Burden of diabetes in cancer inpatients
429. Burden of Health Disparities in Chronic Illnesses: A Report on Cardiovascular Disease, diabetes, and cancer in La Crosse County
430. Cadmium exposure and incidence of diabetes mellitus-results from the Malmö Diet and cancer study
431. Can a diabetes Drug Prevent cancer Death?
432. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort study
433. Can diabetes Change the Intrinsic Subtype Specificity of Breast cancer
434. Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models
435. Can luteolin be a therapeutic molecule for both colon cancer and diabetes?
436. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2
437. Can pancreatic cancer be detected by adrenomedullin in patients with new-onset diabetes? The PaCANOD cohort study protocol
438. cancer among patients with diabetes, obesity and abnormal blood lipids: a population-based register study in Sweden
439. cancer among patients with type 2 diabetes mellitus: a population-based cohort study in northeastern Italy
440. cancer and cholesterol: understanding the V-shaped association in patients with diabetes
441. cancer and diabetes
442. cancer and diabetes
443. cancer and diabetes
444. cancer and diabetes mellitus a review of the literature
445. cancer and diabetes mellitus based on autopsy data
446. cancer and diabetes‐a follow‐up study of two populationbased cohorts of diabetic patients
447. cancer and diabetes, an increasing common combination: Improving knowledge among oncology nurses.
448. cancer and diabetes: are there similarities?
449. cancer and diabetes: are we ready for prime time?
450. cancer and diabetes: new links and new challenges
451. cancer and diabetes: two pathological conditions in which adrenomedullin may be involved
452. cancer as a metabolic disease and diabetes as a cancer risk?
453. cancer biology and prevention in diabetes
454. cancer biology in diabetes
455. cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment,
456. cancer detection rates following enrolment in a disease management programme for type 2 diabetes
457. cancer has overtaken cardiovascular disease as the commonest cause of death in Scottish type 2 diabetes patients: A population‐based study (The Ayrshire diabetes …
458. cancer in diabetes patients: Basing a wrong conclusion on a wrong or on a correct analyses.
459. cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies
460. cancer in south Karnataka and its paradoxical relation to diabetes mellitus
461. cancer incidence among Finnish people with type 2 diabetes during 1989–2014
462. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
463. cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study
464. cancer incidence and mortality in patients with type 2 diabetes treated with human insulin: a cohort study in Shanghai
465. cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark
466. cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden
467. cancer incidence in patients with type 2 diabetes mellitus in Minhang District of Shanghai
468. cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai
469. cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
470. cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity.
471. cancer incidence in type 1 diabetes: A 5-country study of 9,000 cancers in type 1 diabetic individuals Electronic Supplementary Material
472. cancer incidence in type 2 diabetes patients-first results from a feasibility study of the D2C cohort
473. cancer morbidity in patients with diabetes mellitus
474. cancer of the breast, diabetes and pathological glucose tolerance
475. cancer of the organs of the reproductive system in women with type 2 diabetes. Effects of antidiabetic therapy
476. cancer of unknown primary is associated with diabetes
477. cancer Patients with Undiagnosed and Poorly Managed diabetes Mellitus
478. cancer patients with undiagnosed and poorly managed diabetes mellitus.
479. cancer prediction for type-2 diabetes using machine learning
480. cancer prevention with a diabetes pill?
481. cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data …
482. cancer recording in patients with type 2 diabetes in primary care and hospital admission data: IJPDS (2017) Issue 1, Vol 1: 314 Proceedings of the IPDLN …
483. cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population‐based cohort study in Sweden
484. cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China
485. cancer risk among patients with type 2 diabetes: A real‐world study in Shanghai, China
486. cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation
487. cancer risk associated with insulin glargine among adult type 2 diabetes patients–a nationwide cohort study
488. cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis
489. cancer risk due to type 2 diabetes
490. cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis
491. cancer risk in Chinese diabetes patients: a retrospective cohort study based on management data
492. cancer risk in dialyzed patients with and without diabetes
493. cancer risk in patients aged 30 years and above with type 2 diabetes receiving antidiabetic monotherapy: a cohort study using metformin as the comparator
494. cancer risk in patients with diabetes mellitus
495. cancer risk in patients with type 2 diabetes mellitus and their relatives
496. cancer Risk in Patients with Type 2 diabetes on Antidiabetic Monotherapy: A Population Based Cohort Study Using National Insurance Health Service Database
497. cancer risk in people with diabetes: does physical activity and adiposity modify the association? Prospective data from the HUNT Study, Norway
498. cancer risk in people with type 1 and type 2 diabetes in Australia
499. cancer risk in type 2 diabetes
500. cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations
501. cancer risk is higher in years before and shortly after type 2 diabetes diagnosis, study shows
502. cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan
503. cancer risks from diabetes therapies: evaluating the evidence
504. cancer risks of anti-hyperglycemic drugs for type 2 diabetes treatment–a clinical appraisal
505. cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
506. cancer Signaling Transcriptome Is Upregulated in Type 2 diabetes Mellitus
507. cancer specific mortality in insulin-treated type 2 diabetes patients
508. cancer stem cells generated by alcohol, diabetes, and hepatitis C virus
509. cancer susceptibility in two rat models of spontaneous diabetes
510. cancer treatment and cellular stress induced type 2 diabetes mellitus
511. cancer with diabetes: Prevalence, metabolic control, and survival in a general oncology practice.
512. cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice
513. cancer-related side effects and diabetes self-management.
514. cancer-suppressing enzyme adds a link to type 2 diabetes
515. cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer
516. cancer, diabetes, and angiotensin blockade: a question of hypohydration.
517. cancer, Heart Disease, and diabetes in Workers Exposed to 2,3,7,8-Tetrachlorodibenzo- p -dioxin
518. cancer, heart, and diabetes societies join to publicise uninsured Americans
519. cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis
520. cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
521. cancer, type 2 diabetes, and ageing: news from flies and worms
522. Candidate gene polymorphisms for diabetes mellitus, cardiovascular disease and cancer are associated with longevity in Koreans
523. Capnocytophaga sputigena pneumonia and bacteremia in a patient with diabetes and gastric cancer
524. Carbohydrate intake and incidence of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
525. Carbohydrate quantity and quality and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC-NL) study
526. Cardiorespiratory fitness as a predictor of cancer mortality among men with pre-diabetes and diabetes
527. Cardiovascular comorbidity and ovarian cancer patient survival: history of hypertension, heart disease, and diabetes, evidence from the Ovarian cancer Association …
528. Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission
529. Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory
530. Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity
531. Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre‐existing diabetes: A nationwide study
532. Cardiovascular, diabetes, and cancer strips: evidences, mechanisms, and classifications
533. Care of esophageal cancer patients with diabetes mellitus–preoperative management and treatment
534. Care Plan for Resuming the Physical Activity of Patients With Pancreatic cancer and diabetes After Surgery
535. CARING (cancer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants-a systematic review and a …
536. Case of small cell lung cancer complicated with diabetes insipidus and Cushing syndrome due to ectopic adrenocorticotropic hormone secretion
537. Case report of severe Cushing’s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception …
538. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan
539. Case–control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women
540. Causal Evaluation of Laboratory Markers in Type 2 diabetes on cancer and Vascular Diseases Using Various Mendelian Randomization Tools
541. Causative relationship between diabetes mellitus and breast cancer in various regions of Saudi Arabia: an overview
542. Cause of death for those with diabetes and/or cancer provides further support for an important role of vitamin D in reducing risk of many types of disease
543. Cause-specific mortality in endometrioid endometrial cancer patients with type 2 diabetes using metformin or other types of antidiabetic medication
544. Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000–2007)
545. Causes of death in men with prevalent diabetes and newly diagnosed high-versus favorable-risk prostate cancer
546. Central diabetes insipidus and Cushing’s syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report
547. Central diabetes insipidus caused by pituitary metastasis of lung cancer
548. Central diabetes insipidus caused by pituitary metastasis of lung cancer
549. Central diabetes insipidus caused by pituitary metastasis of lung cancer
550. Central diabetes Insipidus: An Unusual Initial Presentation of Lung cancer
551. Ceritinib aggravates glycemic control in insulin-treated patients with diabetes and metastatic ALK-positive lung cancer
552. Challenges and perspectives in the treatment of diabetes associated breast cancer
553. Challenges and Rewards of Pharmacotherapy Selection in Patients Newly Diagnosed with Lung cancer and diabetes Mellitus
554. Challenges in the management of people with diabetes and cancer
555. Challenges of imaging for cancer in patients with diabetes and obesity
556. Change in the incidence of diabetes mellitus in oral cancer patients based on a long-term comparative study
557. Changes in blood glucose of elderly patients with gastric cancer combined with type 2 diabetes mellitus after radical operation and the effect of mediation …
558. Changes in glucose-lowering drug use before and after cancer diagnosis in patients with diabetes
559. Changes in intake of dairy product subgroups and risk of type 2 diabetes: modelling specified food substitutions in the Danish Diet, cancer and Health cohort
560. Changes in medication management after a diagnosis of cancer among medicare beneficiaries with diabetes
561. Changes on blood glucose of different operation scheme after gastrectomy for gastric cancer in patients complicated with diabetes mellitus
562. Characteristics and prognosis of breast cancer patients with type-2 diabetes mellitus
563. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors
564. Characteristics of the clinical course of breast cancer in patients with diabetes mellitus
565. Characteristics of treatment of patients with breast cancer and diabetes mellitus
566. Characterizing hyperglycemia in cancer patients with diabetes in an Emergency Center
567. Chemical Investigations of diabetes Mellitus, Malaria, and Castrate-Resistant Prostate cancer
568. Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer
569. Chemotherapy and glycemic control in patients with type 2 diabetes and cancer: a comparative case analysis
570. Childhood cancer Survivors Have More diabetes
571. Childhood cancer, type 1 diabetes and other immune diseases: healthcare visits in the year before diagnosis in Taiwan
572. Chinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case–control study
573. Cholesterol drugs improve breast cancer prognosis in women with diabetes mellitus
574. Christian Religious Coping with HIV, cancer, and diabetes: African American Women and the Church’s Response
575. Chronic diseases and health care: new trends in diabetes, arthritis, osteoporosis, fibromyalgia, low back pain, cardiovascular disease, and cancer
576. Chronic Low‐grade Inflammation in Obesity and diabetes associated Colorectal cancer Development.
577. Chronic pancreatitis, type 3c diabetes, and pancreatic cancer risk
578. Circulating nucleic acids in plasma and serum: roles in diagnosis and prognosis in diabetes and cancer.
579. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
580. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
581. Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical …
582. Cisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients
583. Classification of cancer for Type 2 diabetes Using Machine Learning Algorithm
584. Clinical analysis of breast cancer patients with type 2 diabetes mellitus in Xinjiang
585. Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension
586. Clinical challenges in caring for patients with diabetes and cancer
587. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus
588. Clinical course of diabetes after gastrectomy according to type of reconstruction in patients with concurrent gastric cancer and type 2 diabetes
589. Clinical differences between patients with new-onset diabetes and those without it in a cohort of individuals with pancreatic cancer
590. Clinical effects of postoperative early enteral nutrition for the gastric cancer patients with diabetes [J]
591. Clinical epidemiological analysis of the relationship between pancreatic cancer and diabetes mellitus: data from a single institution in China
592. Clinical features and molecular phenotypes of breast cancer in patients with type-2 diabetes mellitus
593. Clinical improvement of diabetes mellitus type 1 by bD-mannuronic acid (M2000) in a breast cancer patient—as a case report
594. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor?
595. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
596. Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study
597. Clinical Research on the Relationship between Type 2 diabetes Mellitus and Colorectal cancer
598. Clinical review 63: diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy
599. Clinical significance of serum lncRNA cancer susceptibility candidate 2 (CASC2) for chronic renal failure in patients with type 2 diabetes
600. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer
601. Clinical study of cytidine deaminase in serum of cancer thalassemia and diabetes patients
602. Clinical Translational Research: cancer, diabetes, and Cardiovascular Disease
603. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study
604. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
605. Clinicopathologic characteristics and prognostic analysis of luminal B breast cancer patients with diabetes
606. Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China
607. Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus
608. Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus
609. Clinicopathological characteristics of colorectal cancer complicated with type 2 diabetes mellitus: analysis of clinicopathological data from 3, 202 colorectal cancer …
610. Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer
611. Clinicopathological features of pancreatic cancer-related diabetes.
612. Close Relationship between diabetes and cancer
613. Co-existing prostate cancer and diabetes mellitus: implications for patient outcomes and care
614. Co-Managing Patients with Type 1 diabetes and cancer
615. Co-morbilities and survival of patients initially diagnosed with extensive-stage small cell lung cancer: Impact of hypertension, diabetes and chronic hepatitis B …
616. Co-occurrence of diabetes and breast cancer among women by ethnicity
617. Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data
618. Codon 72 polymorphisms of p53 are associated with obesity, diabetes, and race in breast cancer
619. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer
620. Cohort profile: the Australian and New Zealand diabetes and cancer collaboration (ANZDCC)
621. Cohort study of cancer incidence in patients with type 2 diabetes: record linkage of encrypted data from an external cohort with data from the epidemiological cancer …
622. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes
623. Cohort study of pioglitazone and cancer incidence in patients with diabetes
624. Colon cancer Patients with diabetes Have Increased Risk of Recurrence
625. Colorectal and prostate cancer risk in diabetes: metformin, an actor behind the scene
626. Colorectal cancer and diabetes
627. Colorectal cancer associated with BMI, physical activity, diabetes, and blood glucose.
628. Colorectal cancer in patients with type 2 diabetes mellitus: A single-center experience
629. COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes MELLITUS: PRELIMINARY RESULTS FROM AN ONGOING CASE-CONTROL STUDY
630. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis
631. Colorectal cancer Risks According to Sex Differences in Patients With Type II diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
632. Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics
633. Colorectal cancer, diabetes and survival: epidemiological insights
634. Colorectal cancer: another complication of diabetes mellitus?
635. Colorectal cancer: Histopathologic differences in tumor characteristics between patients with and without diabetes
636. Combination of type 2 diabetes and smoking increases total cancer mortality in Japanese men using competing risk analysis: the Tanno-Sobetsu study
637. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
638. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study
639. Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
640. Comment A turning point for chronic kidney disease in diabetes Perioperative FLOT: new standard for gastric cancer?
641. Comment on “Personal History of diabetes as Important as Family History of Colorectal cancer for Risk of Colorectal cancer: A Nationwide Cohort Study”
642. Comment on Andersen et al, Pancreatitis–diabetes–Pancreatic cancer: Summary of an NIDDK-NCI Workshop
643. Comment on: Need for Differentiating diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding cancer Survival
644. Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124–129
645. Comment on: Suissa and Azoulay. Metformin and the risk of cancer: time-related biases in observational studies. diabetes Care 2012; 35: 2665–2673
646. Comment on: Suissa and Azoulay. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
647. Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35: 2500–2502
648. Commentary on “Toxicity after external beam radiotherapy for prostate cancer: An analysis of late morbidity in men with diabetes mellitus.” Kalakota K, Liauw SL …
649. Comments on” Use of metformin and risk of kidney cancer in patients with type 2 diabetes“, Chin-Hsiao Tseng, Eur J cancer, 2016, No. 52, pp. 19-25.
650. Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm
651. Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature
652. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study
653. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer
654. Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes
655. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study
656. Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes
657. Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus
658. Comparing Survival Functions with Doubly Interval-Censored Data: An Application to diabetes Surveyed by Korean cancer Prevention Study
659. Comparing the patterns of hypertension and type 2 diabetes mellitus in patients with colorectal cancer
660. Comparison of AIS and fuzzy c-means clustering methods on the classification of breast cancer and diabetes datasets
661. Comparison of Bee and BMI Based on Charted Versus Measured Height and Weight of diabetes Mellitus and cancer Patients
662. Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey
663. Comparison of Health Hardness and Life Expectancy in Patients with diabetes and Breast cancer
664. Competing interests in a lung cancer with metastasis to the pituitary gland: syndrome of inappropriate ADH secretion versus diabetes insipidus
665. Complete Healing from cancer diabetes Leukemia and Other Chronic Disorders
666. Computational analysis of single nucleotide polymorphisms (SNPs) in PPAR gamma associated with obesity, diabetes and cancer
667. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer
668. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.
669. Confounding Factors of the diabetes-Metformin-cancer Relationship
670. Connecting the Dots Between Obesity, diabetes and cancer
671. Considerations for developing chronic care system for traumatic brain injury based on comparisons of cancer survivorship and diabetes management care
672. Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: from concept to reality
673. Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
674. Contribution of biomarkers for pancreatic cancer-associated new-onset diabetes to pancreatic cancer screening
675. Contribution of diabetes to the incidence and prevalence of comorbid conditions (cancer, periodontal disease, fracture, impaired cognitive function, and depression): a …
676. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings …
677. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the …
678. Control of luminal type A intrinsic subtype enriched transcription factor network by insulin: implications of diabetes on breast cancer classification.
679. Controversies Related to diabetes and Risk of Bladder cancer.
680. Controversy regarding gastric cancer and diabetes
681. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis
682. Convergence and divergence of genetic and modular networks between diabetes and breast cancer
683. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and cancer Study cardiovascular cohort
684. Correction to: Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
685. Correction to: The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.
686. Correction: Sex-specific Association between Family History of diabetes and Risk of Colorectal cancer: Two Prospective Cohort Studies
687. Correction: Survival Benefits of Metformin for Colorectal cancer Patients with diabetes: A Systematic Review and Meta-Analysis
688. Correlates Between Colorectal cancer Screening and diabetes Mellitus Among Residents of Ohio Appalachia: 1455
689. Correlation between blood glucose level and the prognosis of postoperative pancreatic cancer patients with diabetes
690. Correlation between BMI, diabetes Mellitus, and Outcomes in Patients Treated with BCG Immunotherapy for Non-Muscle Invasive Bladder cancer
691. Correlation Between Body Mass Index, diabetes and Outcome in a Cohort of Egyptian Early Breast cancer Patients
692. Correlation between circadian rhythm related genes, type 2 diabetes, and cancer: insights from metanalysis of transcriptomics data
693. Correlation between diabetes prevalence and subsequent cancer mortality in North Carolina counties
694. Correlation between renin-angiotensin system (RAS) related genes, type 2 diabetes, and cancer: Insights from metanalysis of transcriptomics data
695. Correlation between treatment of diabetes mellitus and development cancer
696. Correlations of microRNA-124a and microRNA-30d with clinicopathological features of breast cancer patients with type 2 diabetes mellitus
697. Cost-effectiveness of adjuvant therapy for treatment of stage II colon cancer in patients with diabetes.
698. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
699. Critical role of Dipeptidyl Peptidase IV: A therapeutic target for cancer & diabetes
700. Critical role of dipeptidyl peptidase IV: a therapeutic target for diabetes and cancer
701. Cullin-1 promotes cell proliferation in human breast cancer and is related to diabetes
702. Cultural worldviews and perceived risk of colon cancer and diabetes
703. Current drug information: Pioglitazone associated with increased risk of bladder cancer among people with type 2 diabetes
704. Current drug information: Thiazolidinediones associated with increased risk of bladder cancer among adults with type 2 diabetes
705. Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
706. Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis
707. Cytokine synergism in apoptosis: its role in diabetes and cancer
708. Cytokines in the interface of metabolomics based cancer and type-2 diabetes
709. Cytolysis and karyopyknosis in postmenopausal vaginal smears as markers of endometrial cancer, diabetes and obesity. Studies based on a ten-year follow-up.
710. Cytoplasmic ATM protein kinase: an emerging therapeutic target for diabetes, cancer and neuronal degeneration
711. Dapagliflozin Protects Doxorubicin-induced Cardiotoxicity in Breast cancer Patients With diabetes via Suppressing ER Stress
712. Data mining applications to dermatological diseases, colorectal cancer, diabetes, cardiology and medical audit systems
713. Data mining Twitter for cancer, diabetes, and asthma insights
714. Data on BMI, diabetes mellitus and non-muscle invasive bladder cancer recurrence and progression from the Nijmegen Bladder cancer study conducted in The …
715. Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
716. Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
717. Death by lung cancer or by diabetes? The unintended consequences of quitting smoking
718. Debating cancer and diabetes in Vienna
719. Decavanadate salts of cytosine and metformin: a combined experimental-theoretical study of potential metallodrugs against diabetes and cancer
720. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
721. Deciphering the scalene association among type‐2 diabetes mellitus, prostate cancer, and chronic myeloid leukemia via enrichment analysis of disease‐gene …
722. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study
723. Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study
724. Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus
725. Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
726. Defective Lipolysis In diabetes And cancer
727. Defining the molecular nexus of cancer, type 2 diabetes and cardiovascular disease
728. Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
729. Delivery of small molecule and RNA for the treatment of type 1 diabetes and prostate cancer
730. Demodex species positivity among patients with cancer, on hemodialysis and with diabetes mellitus
731. Demographic changes in the burden of diabetes and cancer
732. Demographic Characteristics, Survival and Prognostic Factors of Early Breast cancer Patients with Type 2 diabetes Mellitus: A Hospital-Based Cohort Study
733. Detection bias and overestimation of bladder cancer risk in type 2 diabetes: a matched cohort study
734. Deterioration of Glycemic Control Contributes to the Prevalence of Proteinuria among Bevacizumab-Treated cancer Patients with Type 2 diabetes Mellitus
735. Determination of polymorphism of K-ras and DPC4 genes in pancreatic cancer in the background of diabetes mellitus
736. Determining the Impact of a cancer Diagnosis on diabetes Management: A Systematic Literature Review
737. Developing a clinical and genetic risk prediction model for diabetes mellitus among survivors of childhood cancer
738. Development and characterisation of a multifunctional hybrid nano-flora composite for the prevention and management of cancer, diabetes, blood pressure and …
739. Development of a prediction model for colorectal cancer among patients with type 2 diabetes mellitus using a deep neural network
740. Development of a prediction model for pancreatic cancer in patients with type 2 diabetes using logistic regression and artificial neural network models
741. Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network
742. Development of the national Expected Screening Rate for cardiovascular disease, type 2 diabetes, cervical cancer and colorectal cancer as a benchmark for …
743. Development of the RapidMist drug delivery system for the treatment of diabetes, cardiovascular diseases and breakthrough cancer pain
744. Development of type 1 diabetes after cancer immunotherapy
745. Dexrazoxane improves cardiac autonomic function in epirubicin-treated breast cancer patients with type 2 diabetes
746. Dexrazoxane protects breast cancer patients with diabetes from chemotherapy-induced cardiotoxicity
747. diabetes after hormone therapy in breast cancer survivors: a case-cohort study
748. diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
749. diabetes and adiposity: a heavy load for cancer
750. diabetes and altered carbohydrate metabolism in patients with cancer
751. diabetes and beta-adrenergic blockage are risk factors for metastatic prostate cancer
752. diabetes and body mass index are associated with neuropathy and prognosis in colon cancer patients treated with capecitabine and oxaliplatin adjuvant …
753. diabetes and breast cancer among women with BRCA1 and BRCA2 mutations
754. diabetes and breast cancer in T aiwanese women: a detection bias?
755. diabetes and breast cancer mortality in Black women
756. diabetes and breast cancer risk in a population-based case-control study of Hispanic and white, non-Hispanic women living in US Southwestern states
757. diabetes and breast cancer risk: a meta-analysis
758. diabetes and breast cancer subtypes
759. diabetes and breast cancer: the women’s healthy eating & living study
760. diabetes and cancer
761. diabetes and cancer
762. diabetes and cancer
763. diabetes and cancer
764. diabetes and cancer
765. diabetes and cancer
766. diabetes and cancer
767. diabetes and cancer
768. diabetes and cancer
769. diabetes and cancer
770. diabetes and cancer
771. diabetes and cancer
772. diabetes and cancer
773. diabetes and cancer
774. diabetes and cancer
775. diabetes and cancer
776. diabetes and cancer
777. diabetes AND cancer
778. diabetes and cancer
779. diabetes and cancer
780. diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
781. diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
782. diabetes AND cancer AMONG VETERANS
783. diabetes and cancer I: risk, survival, and implications for screening
784. diabetes and cancer II: role of diabetes medications and influence of shared risk factors
785. diabetes and cancer in veterans of Operation Ranch Hand after adjustment for calendar period, days of spraying, and time spent in Southeast Asia
786. diabetes and cancer mortality: a multifaceted association
787. diabetes and cancer risk for all and specific sites among Japanese men and women
788. diabetes and cancer risk in the REDUCE trial.
789. diabetes and cancer risk: A Mendelian randomization study
790. diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky
791. diabetes and cancer screening: a win-win situation or a zero game?
792. diabetes and cancer Screening: A Win-Win Situation or a Zero Game?—Reply
793. diabetes and cancer-a dangerous liaison?
794. diabetes and cancer-Related Mechanisms.
795. diabetes and cancer—an AACE/ACE consensus statement
796. diabetes and cancer, common threads and missing links
797. diabetes and cancer: 5 years into the recent controversy
798. diabetes and cancer: a 2013 synopsis
799. diabetes and cancer: A comprehensive review
800. diabetes and cancer: a consensus report
801. diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links
802. diabetes and cancer: a postulated relationship
803. diabetes and cancer: a review of current knowledge
804. diabetes and cancer: an injurious association
805. diabetes and cancer: Associations, mechanisms, and implications for medical practice
806. diabetes and cancer: cancer should be screened in routine diabetes assessment
807. diabetes and cancer: could vitamin D provide the link?
808. diabetes and cancer: Debating the link through Ca2+/cAMP signalling
809. diabetes and cancer: Epidemiologic and physiopathogenic links
810. diabetes and cancer: epidemiological and biological links
811. diabetes and cancer: Epidemiological evidence and molecular links
812. diabetes and cancer: Epidemiological Evidence and Molecular Links
813. diabetes and cancer: Epidemiological Evidence and Molecular Links Series [Book Review]
814. diabetes and cancer: epidemiological, clinical, and experimental perspectives
815. diabetes and cancer: Epidemiological, Clinical, and Experimental Perspectives
816. diabetes and cancer: epidemiology and potential mechanisms
817. diabetes and cancer: Evidence for Risk, Methodology and Implications
818. diabetes and cancer: findings from the REACTION study: REACTION.
819. diabetes and cancer: impact on health-related quality of life
820. diabetes and cancer: is diabetes causally related to cancer?
821. diabetes and cancer: Is there a Link?
822. diabetes and cancer: looking at the multiligand/RAGE axis
823. diabetes and cancer: pathophysiological fundamentals of a ‘dangerous affair’
824. diabetes and cancer: placing the association in perspective
825. diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong diabetes Registry
826. diabetes and cancer: The Problem of Reverse Causality and Missing Links
827. diabetes and cancer: The Road Ahead
828. diabetes and cancer: two diseases with obesity as a common risk factor
829. diabetes and cancer: Unraveling the Complexity
830. diabetes and cancer.
831. diabetes AND cancer.
832. diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
833. diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer
834. diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.
835. diabetes and cardiovascular disease mortality among a population-based cohort of women with and without breast cancer
836. diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance)
837. diabetes and colorectal cancer incidence in the cohort of Swedish men
838. diabetes and colorectal cancer prognosis: a meta-analysis
839. diabetes and colorectal cancer screening among men and women in the USA: National Health Interview Survey: 2008, 2010
840. diabetes And Colorectal cancer: Could Ampk Signaling Pathway Explains The Link?
841. diabetes and differences in detection of incident invasive breast cancer
842. diabetes and endometrial cancer
843. diabetes and endometrial cancer in the Iowa women’s health study
844. diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors
845. diabetes and endometrial cancer: An evaluation of the modifying effects of other known risk factors.
846. diabetes and endometrial cancer: an Italian case‐control study
847. diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension
848. diabetes and gastric cancer: the potential links
849. diabetes and hyper-insulinemia as predictors of colorectal cancer risk in a prospective cohort of women
850. diabetes and infarcted papillary thyroid cancer.
851. diabetes and insulin therapy, but not metformin, are related to hepatocellular cancer risk
852. diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime
853. diabetes and its relationship with pancreatic cancer
854. diabetes and kidney cancer outcomes: a propensity score analysis
855. diabetes and kidney cancer risk among post-menopausal women: The Iowa women’s health study
856. diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis
857. diabetes and kidney cancer: A direct or indirect association?
858. diabetes and liver cancer risk: A stronger effect in Whites than Blacks?
859. diabetes and lung cancer among postmenopausal women
860. diabetes and metabolic syndrome in survivors of childhood cancer
861. diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast cancer Patients
862. diabetes and mortality in men with locally advanced prostate cancer: analyses of RTOG 92–02
863. diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02
864. diabetes and mortality in patients with prostate cancer: a meta-analysis
865. diabetes and Obesity and Their Association with Increased Acute Urinary Symptoms in Prostate cancer Patients After Receiving Interstitial LDR Brachytherapy
866. diabetes AND OBESITY INDUCE TRANSCRIPTOMIC AND METABOLOMIC CHANGES ENHANCING PANCREATIC cancer AGGRESSIVENESS
867. diabetes and onset of natural menopause: results from the European Prospective Investigation into cancer and Nutrition
868. diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast cancer Survivorship Consortium (CBCSC)
869. diabetes AND OUTCOMES AFTER RADICAL PROSTATECTOMY-ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL …
870. diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database
871. diabetes and overall survival among breast cancer patients in the US military health system
872. diabetes and pancreatic cancer
873. diabetes and pancreatic cancer
874. diabetes and pancreatic cancer
875. diabetes and pancreatic cancer
876. diabetes and pancreatic cancer
877. diabetes and pancreatic cancer
878. diabetes and pancreatic cancer
879. diabetes and pancreatic cancer
880. diabetes and pancreatic cancer
881. diabetes and pancreatic cancer
882. diabetes and pancreatic cancer survival: a prospective cohort study
883. diabetes and pancreatic cancer survival: a prospective cohort-based study
884. diabetes and Pancreatic cancer—A Dangerous Liaison Relying on Carbonyl Stress
885. diabetes and Pancreatic cancer: A Bidirectional Relationship Perspective
886. diabetes and pancreatic cancer: both cause and effect
887. diabetes and pancreatic cancer: chicken or egg?
888. diabetes and Pancreatic cancer: Reply
889. diabetes and prognosis in a breast cancer cohort
890. diabetes and prognosis in older persons with colorectal cancer
891. diabetes and prostate cancer (CaP): Clinical characteristics and disparity in outcomes
892. diabetes and Prostate cancer Aggressiveness at Diagnosis and Progression in White Americans and Black Americans from the North Carolina-Louisiana Prostate …
893. diabetes and prostate cancer risk in the REDUCE trial
894. diabetes and prostate cancer screening in black and white men
895. diabetes and risk of bladder cancer among postmenopausal women in the Iowa Women’s Health Study
896. diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
897. diabetes and risk of bladder cancer: evidence from a case‐control study in New England
898. diabetes and risk of breast cancer in Asian-American women
899. diabetes and risk of cancer
900. diabetes and risk of cancer
901. diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy
902. diabetes and risk of early-onset colorectal cancer
903. diabetes and Risk of Endometrial cancer: a Meta-analysis [J]
904. diabetes and risk of endometrial cancer: a population-based prospective cohort study
905. diabetes and risk of incident cancer: a large population-based cohort study in Israel
906. diabetes and risk of incident colorectal cancer in a prospective cohort of women
907. diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium
908. diabetes and risk of pancreatic cancer: a pooled analysis of three large case–control studies
909. diabetes and risk of prostate cancer in a prospective cohort of US men
910. diabetes and risk of prostate cancer: a study using the National Health Insurance
911. diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan
912. diabetes and sex-specific colorectal cancer risks in Newfoundland and Labrador: a population-based retrospective cohort study
913. diabetes and smoking as predictors of cancer in Indigenous adults from rural and remote communities of North Queensland–A 15‐year follow up study
914. diabetes and the cancer Patient
915. diabetes and the Development of Pancreatic cancer [J]
916. diabetes and the risk for colorectal cancer
917. diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis
918. diabetes and the Risk of cancer Death: A Case-Cohort Study in Taiwanese Men
919. diabetes and the risk of death in men with favorable or high-risk prostate cancer following radiation therapy
920. diabetes and the risk of lung cancer
921. diabetes and the risk of non-Hodgkin’s lymphoma and multiple myeloma in the European Prospective Investigation into cancer and Nutrition.
922. diabetes and the risk of pancreatic cancer
923. diabetes and the risk of pancreatic cancer
924. diabetes and the risk of prostate cancer
925. diabetes and the risk of prostate cancer: the role of diabetes treatment and complications
926. diabetes and Thyroid cancer in Chinatown: Diversity and Acculturation
927. diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of Taiwanese
928. diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study
929. diabetes and thyroid cancer risk: literature review
930. diabetes and urothelial cancer risk: the Multiethnic Cohort study
931. diabetes as a predictor of colon cancer prognosis: A single institution based retrospective data analysis.
932. diabetes as a presenting feature of pancreatic cancer: A case report
933. diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy
934. diabetes as a Risk Factor for Breast cancer
935. diabetes as a risk factor for death following endometrial cancer
936. diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population
937. diabetes as a risk factor of pancreatic cancer
938. diabetes as a risk factor to cancer: Functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer
939. diabetes as Independent Risk Factor for cancer after Heart and Lung Transplantation
940. diabetes as risk factor for pancreatic cancer: Hyperglycemia promotes epithelial-mesenchymal-transition and stem cell properties in pancreatic ductal epithelial cells
941. diabetes associated with abnormal p53 immunohistochemical patterns in colorectal cancer
942. diabetes associated with short survival in pancreatic cancer
943. diabetes association of polyps and colon cancer.
944. diabetes but not insulin increases the risk of lung cancer: a Taiwanese population-based study
945. diabetes but not insulin is associated with higher colon cancer mortality
946. diabetes care after cancer diagnosis in patients with type 2 diabetes and colorectal-or breast cancer treated with curative intent
947. diabetes care management during cancer treatment.
948. diabetes Care Management in the cancer Center: Challenging Current Models of Care to Optimize Outcomes for a Complex Population
949. diabetes care management patterns before and after a cancer diagnosis: A SEER‐Medicare matched cohort study
950. diabetes Comorbidity and All-Cause, Cardiovascular, and cancer Mortality in US Adults
951. diabetes conveys a higher risk of gastric cancer mortality despite an age-standardised decreasing trend in the general population in Taiwan
952. diabetes Could Be a Warning Sign of Pancreatic cancer: A Case Report and Literature Review
953. diabetes decreases FDG accumulation in primary lung cancer
954. diabetes drug helps towards immunity against cancer
955. diabetes drug is linked with bladder cancer risk
956. diabetes drug may be associated with increase in risk of bladder cancer
957. diabetes Genes and Prostate cancer in the Atherosclerosis
958. diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study
959. diabetes has protective effect against metastasis in patients with non-small cell lung cancer
960. diabetes in cancer Patients: Risks, Goals and Management
961. diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)–Medicare …
962. diabetes in midlife and risk of cancer in late life: a nationwide Swedish twin study
963. diabetes in relation to biliary tract cancer and stones: a population-based study in Shanghai, China
964. diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis
965. diabetes increases risk of gastric cancer after Helicobacter pylori eradication: a territory-wide study with propensity score analysis
966. diabetes increases the risk of breast cancer: a meta-analysis
967. diabetes increases the risk of colorectal cancer in Puerto Rico
968. diabetes increases the risk of liver, pancreas, and gastric cancer among the Puerto Rican population
969. diabetes influences cancer risk in patients with increased carotid atherosclerosis burden
970. diabetes insipida por cancer de pulmon
971. diabetes insipidus and adrenal insufficiency in a patient with metastatic breast cancer
972. diabetes insipidus and anterior pituitary insufficiency due to breast cancer metastasis
973. diabetes insipidus and breast cancer
974. diabetes insipidus and breast cancer-planning radiotherapy by the use of MRT
975. diabetes insipidus and panhypopituitarism due to intrasellar metastasis from medullary thyroid cancer
976. diabetes insipidus as a main symptom of cancer
977. diabetes insipidus as the first symptom caused by lung cancer metastasis to the pituitary glands: clinical presentations, diagnosis, and management
978. diabetes insipidus as the initial symtom in a patient with lung cancer: Case report
979. diabetes insipidus caused by isolated intracranial metatstases in patient with breast cancer
980. diabetes insipidus caused by pituitary gland metastasis accompanied by iris metastasis of small cell lung cancer: case presentation and review of the literature
981. diabetes insipidus due to pituitary metastasis from bladder cancer
982. diabetes insipidus due to pituitary metastasis of breast cancer
983. diabetes insipidus in a patient with small-cell lung cancer: a paradox?
984. diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancer
985. diabetes is an important risk factor for metastasis in non-muscle-invasive bladder cancer
986. diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico
987. diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer
988. diabetes Is Associated With Socioeconomic Disparities and More Comorbidities in Colorectal cancer Surgery: A Nationwide Inpatient Sample Study: 2041
989. diabetes is not a predisposing factor for pancreatic cancer-new evidence
990. diabetes Is Not Associated With Longer Survival in Patients With Lung cancer—Reply
991. diabetes management and self-care education for hospitalized patients with cancer
992. diabetes Management and Self-Care Education for Hospitalized Patients With cancer
993. diabetes management before and after cancer diagnosis: missed opportunity
994. diabetes management in cancer patients
995. diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway
996. diabetes May Increase Women’s Risk Of Developing Colorectal cancer
997. diabetes medication use in association with survival among patients of breast, colorectal, lung, and gastric cancer
998. diabetes medication use in association with survival among patients of breast, colorectal, lung, or gastric cancer
999. diabetes medications and cancer risk: review of the literature
1000. diabetes medications and cancer: A way out of uncertainty
1001. diabetes Medications, Prostate-Specific Antigen Values, and the Chemoprevention of Prostate cancer
1002. diabetes mellitus (DM), serum glucose, and outcome in gastroesophageal (GE) cancer
1003. diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer
1004. diabetes mellitus among cancer survivors
1005. diabetes mellitus and age are risk factors of interval colon cancer: a case-control study
1006. diabetes mellitus and bladder cancer—an epidemiological relationship?
1007. diabetes mellitus and breast cancer
1008. diabetes mellitus and breast cancer
1009. diabetes mellitus and breast cancer
1010. diabetes MELLITUS AND BREAST cancer OUTCOMES
1011. diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis
1012. diabetes mellitus and breast cancer: a retrospective population-based cohort study
1013. diabetes mellitus and breast cancer. A retrospective follow-up study
1014. diabetes mellitus and cancer
1015. diabetes mellitus and cancer
1016. diabetes Mellitus and cancer
1017. diabetes mellitus and cancer in Werner syndrome
1018. diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study
1019. diabetes mellitus and cancer of the digestive organs: an Italian population-based cohort study
1020. diabetes mellitus and cancer risk in a network of case-control studies
1021. diabetes mellitus and cancer risk in a population‐based case–controlstudy among men from Montreal, Canada
1022. diabetes mellitus and cancer risk: a multisite case-control study
1023. diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan
1024. diabetes mellitus and cancer risk: review of the epidemiological evidence
1025. diabetes mellitus and cancer: the different expression of these diseases in Israeli Arabs and Jews
1026. diabetes mellitus and cancer.
1027. diabetes mellitus and carbohydrate metabolism in patients with cancer
1028. diabetes Mellitus and Colorectal cancer Risk
1029. diabetes mellitus and colorectal cancer risk.
1030. diabetes mellitus and colorectal cancer–a revealed connection
1031. diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study
1032. diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives
1033. diabetes mellitus and HbA1c levels associated with high grade prostate cancer
1034. diabetes mellitus and health‐related quality of life in prostate cancer: 5‐year results from the Prostate cancer Outcomes Study
1035. diabetes Mellitus and Hypertension are Risk Factor for Endometrial cancer
1036. diabetes mellitus and hypertension increase the risk of colorectal cancer mortality; a robust Bayesian adjustment analysis
1037. diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
1038. diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis
1039. diabetes mellitus and incidence and mortality of kidney cancer: a meta-analysis
1040. diabetes Mellitus and Incidence of Bladder and Kidney cancer: An Exposure-Control Matched Study
1041. diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies
1042. diabetes Mellitus and Incident Gastroenteric cancer
1043. diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis
1044. diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs
1045. diabetes mellitus and kidney cancer risk: the results of Japan Collaborative Cohort Study for Evaluation of cancer Risk (JACC Study)
1046. diabetes mellitus and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population
1047. diabetes mellitus and long‐term mortality of ovarian cancer patients. A systematic review and meta‐analysis of 12 cohort studies
1048. diabetes Mellitus and Metformin Are Not Associated With Breast cancer Pathologic Complete Response
1049. diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health …
1050. diabetes mellitus and obesity among participants receiving screening for cancer in the Republic of the Marshall Islands
1051. diabetes mellitus and obesity as risk factors for pancreatic cancer
1052. diabetes Mellitus and Oral cancer: Are They Connected?
1053. diabetes Mellitus and Oral cancer: Is There a Causal Association?
1054. diabetes mellitus and oral cancer/oral potentially malignant disorders: A systematic review and meta‐analysis
1055. diabetes mellitus and outcomes of colorectal cancer
1056. diabetes mellitus and ovarian cancer (Sweden)
1057. diabetes mellitus and ovarian cancer risk: a systematic review and meta-analysis of observational studies
1058. diabetes mellitus and ovarian cancer: More complex than increasing risk
1059. diabetes mellitus and ovarian cancer: more complex than just increasing risk
1060. diabetes mellitus and pancreas cancer
1061. diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California
1062. diabetes mellitus and pancreatic cancer-cause or result?
1063. diabetes mellitus and pancreatic cancer-cause or result?
1064. diabetes mellitus and pancreatic cancer: a case-control study in Greater Montreal, Quebec, Canada
1065. diabetes Mellitus and Pancreatic cancer: A Risk Assessment
1066. diabetes mellitus and pancreatic cancer: why the association matters?
1067. diabetes mellitus and primary liver cancer: risk factor or real cause?
1068. diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis
1069. diabetes mellitus and prostate cancer metabolism: Is there a relationship?
1070. diabetes mellitus and prostate cancer risk
1071. diabetes mellitus and prostate cancer risk
1072. diabetes mellitus and prostate cancer risk among older men: population-based case–control study
1073. diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis
1074. diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian cancer Screening Trial
1075. diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis
1076. diabetes mellitus and prostate cancer risk; a nationwide case–control study within PCBaSe Sweden
1077. diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
1078. diabetes mellitus and risk of bladder cancer: a meta-analysis
1079. diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
1080. diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies
1081. diabetes mellitus and risk of breast cancer: a meta‐analysis
1082. diabetes mellitus and risk of cancer in T akayama: A population‐based prospective cohort study in J apan
1083. diabetes mellitus and risk of cancer-specific mortality among patients with clear cell renal cell carcinoma undergoing nephrectomy.
1084. diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study
1085. diabetes mellitus and risk of colorectal cancer mortality in Japan: the Japan Collaborative Cohort Study
1086. diabetes mellitus and risk of colorectal cancer: a meta-analysis
1087. diabetes mellitus and risk of endometrial cancer: a meta-analysis
1088. diabetes mellitus and risk of gastric cancer: a systematic review and meta-analysis of observational studies
1089. diabetes mellitus and risk of kidney cancer: a meta-analysis
1090. diabetes mellitus and risk of large bowel cancer
1091. diabetes mellitus and risk of ovarian cancer. A systematic review and meta-analysis of 15 cohort studies
1092. diabetes mellitus and risk of pancreatic cancer in China: A meta-analysis based on 26 case-control studies
1093. diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies
1094. diabetes mellitus and risk of prostate cancer (United States)
1095. diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition
1096. diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into cancer and Nutrition.
1097. diabetes mellitus and risk of prostate cancer in the health professionals follow‐up study
1098. diabetes mellitus and risk of prostate cancer-A focus on shared risk factors and survivor bias
1099. diabetes mellitus and risk of prostate cancer: a meta-analysis
1100. diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case–control and 25 cohort studies
1101. diabetes mellitus and risk of thyroid cancer: a meta-analysis
1102. diabetes mellitus and site-specific colorectal cancer risk in Korea: a case-control study
1103. diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
1104. diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women’s Health Study
1105. diabetes mellitus and survival after a diagnosis of breast cancer: A meta-analysis
1106. diabetes mellitus and survival of esophageal cancer patients after esophagectomy: a systematic review and meta-analysis
1107. diabetes mellitus and survival of non‐small cell lung cancer patients after surgery: A comprehensive systematic review and meta‐analysis
1108. diabetes mellitus and the incidence and mortality of colorectal cancer: a meta‐analysis of 24 cohort studies
1109. diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis
1110. diabetes mellitus and the occurrence of colorectal cancer: an updated meta-analysis of cohort studies
1111. diabetes Mellitus and the Risk for Developing cancer
1112. diabetes mellitus and the risk of bladder cancer: a PRISMA-compliant meta-analysis of cohort studies
1113. diabetes mellitus and the risk of bladder cancer: an Italian case–control study
1114. diabetes mellitus and the risk of cancer formation: Possible link and review of literature
1115. diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan
1116. diabetes mellitus and the risk of cancer.
1117. diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies
1118. diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies
1119. diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
1120. diabetes mellitus and the risk of postmenopausal breast cancer: A retrospective population-based cohort study.
1121. diabetes mellitus and the risk of primary liver cancer
1122. diabetes mellitus and the risk of prostate cancer
1123. diabetes mellitus and the risk of prostate cancer in Italy
1124. diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis
1125. diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
1126. diabetes mellitus as a result of pancreatic cancer
1127. diabetes mellitus as a risk factor for cancer: stress or viral etiology?
1128. diabetes mellitus as a risk factor for gastrointestinal cancer among American veterans
1129. diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis
1130. diabetes mellitus as a risk factor for prostate cancer progression after radical prostatectomy in an Hispanic population
1131. diabetes Mellitus as a Risk Factor of Interval Colon cancer
1132. diabetes mellitus as a risk-factor for colorectal cancer literature review–current situation and future perspectives
1133. diabetes mellitus as an early symptom of pancreatic cancer diagnosed three years later
1134. diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies
1135. diabetes mellitus carries a risk of esophageal cancer: a meta-analysis
1136. diabetes mellitus carries a risk of gastric cancer: a meta-analysis
1137. diabetes mellitus correlates with increased risk of pancreatic cancer: a population‐based cohort study in Taiwan
1138. diabetes MELLITUS DOES NOT INCREASE THE RISK OF METASTATIC COLON cancer: A CASE CONTROL STUDY: 353
1139. diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
1140. diabetes mellitus following platinum-based chemotherapy in gynecologic cancer patients
1141. diabetes mellitus in cancer patients treated with combination interleukin 2 and α-interferon
1142. diabetes mellitus in childhood and young adult cancer survivors: A meta-analysis.
1143. diabetes mellitus in long-term survivors of childhood cancer: increased risk associated with radiation therapy: a report for the childhood cancer survivor study
1144. diabetes mellitus in major head and neck cancer surgery
1145. diabetes mellitus in major head and neck cancer surgery: Systematic review and meta‐analysis
1146. diabetes mellitus in pancreatic cancer and the need for diagnosis of asymptomatic disease
1147. diabetes mellitus in pancreatic cancer follow-up.
1148. diabetes mellitus in pancreatic cancer patients in the Czech Republic: sex differences
1149. diabetes mellitus in pancreatic cancer: is it a causal relationship?
1150. diabetes Mellitus in the Middle-Aged and Elderly Population (> 45 Years) and Its Association with Pancreatic cancer: An Updated Review
1151. diabetes mellitus increased mortality rates more in gender-specific than in nongender-specific cancer patients: a retrospective study of 149,491 patients
1152. diabetes mellitus increases postoperative mortality in non-small cell lung cancer
1153. diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis
1154. diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies
1155. diabetes mellitus increases the risk of early gastric cancer development
1156. diabetes mellitus is a predictive factor for radiation pneumonitis after thoracic radiotherapy in patients with lung cancer
1157. diabetes MELLITUS IS A RISK FACTOR FOR COLON cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 352
1158. diabetes MELLITUS IS A RISK FACTOR FOR PANCREATIC cancer: A CASE CONTROL STUDY IN HALF A MILLION VETERANS: 168
1159. diabetes mellitus is an independent risk factor for colorectal cancer
1160. diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study
1161. diabetes mellitus is associated with breast cancer: systematic review, meta-analysis, and in silico reproduction.
1162. diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta‐analysis of 11 cohort studies
1163. diabetes Mellitus is Associated with High Grade and High Stage in Urinary Bladder cancer
1164. diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma
1165. diabetes mellitus is associated with occult cancer in endometrial hyperplasia
1166. diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer
1167. diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
1168. diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases
1169. diabetes Mellitus raise the Risk for Interval Colorectal cancer and Advanced Colorectal Adenomas
1170. diabetes mellitus reduces prostate cancer risk-no function of age at diagnosis or duration of disease
1171. diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway
1172. diabetes Mellitus Type 2 and Prolonged Exposure to Estrogen as Risk Factors for Development of Breast cancer in Women of Age 35-70 in Yerevan: A Case-Control …
1173. diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer
1174. diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
1175. diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung …
1176. diabetes mellitus type 2–an independent risk factor for cancer?
1177. diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
1178. diabetes Mellitus–A Prognostic Factor in Breast cancer?
1179. diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
1180. diabetes mellitus, family history, and colorectal cancer
1181. diabetes mellitus, genetic variants in the insulin‐like growth factor pathway and colorectal cancer risk
1182. diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into …
1183. diabetes mellitus, hyperglycaemia and cancer
1184. diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
1185. diabetes mellitus, metformin and head and neck cancer
1186. diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer
1187. diabetes mellitus, other medical conditions and pancreatic cancer: a case‐control study
1188. diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy
1189. diabetes mellitus, race, and the odds of high-grade prostate cancer in men diagnosed with prostate cancer in the United States.
1190. diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal cancer Risk
1191. diabetes mellitus: a risk factor for pancreatic cancer?
1192. diabetes mellitus: A significant co‐morbidity in the setting of lung cancer?
1193. diabetes mellitus: influences on cancer risk
1194. diabetes outcomes in patients with a history of breast cancer.
1195. diabetes outcomes in patients with breast cancer.
1196. diabetes pharmacotherapies and bladder cancer: a medicare epidemiologic study
1197. diabetes Phenotypes in Transgenic Pancreatic cancer Mouse Models
1198. diabetes Plus Weight Loss Signals Increased Pancreatic cancer Risk
1199. diabetes promotes DMH-induced colorectal cancer by increasing the activity of glycolytic enzymes in rats
1200. diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+ mice
1201. diabetes Protects from Prostate cancer by Downregulating
1202. diabetes protects from prostate cancer by downregulating androgen receptor: new insights from LNCaP cells and PAC120 mouse model
1203. diabetes risk in childhood cancer survivors: a population-based study
1204. diabetes Self-Management among cancer Survivors: Differences by Diagnosis and Treatment
1205. diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
1206. diabetes therapies affect pancreatic cancer risk
1207. diabetes therapy and cancer risk: causal effects and other plausible explanations
1208. diabetes therapy and cancer risk: Where do we stand when treating patients?
1209. diabetes therapy and lung cancer
1210. diabetes Treatment and Risks of Adverse Breast cancer Outcomes Among Elderly Breast cancer Patients: A SEER-Medicare Analysis
1211. diabetes treatments and cancer risk: the importance of considering aspects of drug exposure
1212. diabetes treatments and risks of adverse breast cancer outcomes among early-stage breast cancer patients: a SEER-medicare analysis
1213. diabetes type 2 and pancreatic cancer: a history unfolding
1214. diabetes type II, other medical conditions and pancreatic cancer risk: a prospective study in The Netherlands
1215. diabetes-associated angiotensin activation enhances liver metastasis of colon cancer
1216. diabetes-related complications and pancreatic cancer incidence in the Multiethnic Cohort
1217. diabetes-Specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectal cancer
1218. diabetes–associated dysregulated cytokines and cancer
1219. diabetes, abnormal glucose, dyslipidemia, hypertension, and risk of inflammatory and other breast cancer
1220. diabetes, and Incident Colorectal cancer in Men and Women: A Prospective Analysis from the European Prospective Investigation into cancer–Norfolk Study
1221. diabetes, Antidiabetic Medications and cancer Risk in Type 2 diabetes: Focus on SGLT-2 Inhibitors
1222. diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
1223. diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic cancer Case-Control Consortium
1224. diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
1225. diabetes, blood glucose lowering drugs and cancer risk
1226. diabetes, body fatness, and insulin prescription among adolescents and young adults with cancer
1227. diabetes, body size, and risk of endometrial cancer
1228. diabetes, breast cancer and mammographic density in the Minnesota breast cancer family study
1229. diabetes, cancer and iron
1230. diabetes, cancer and obesity: unequivocal association
1231. diabetes, cancer and treatment–a mini-review
1232. diabetes, cancer and weight: a Metabolic Typing survey
1233. diabetes, cancer Link Is New Research Focus
1234. diabetes, cancer, and metformin: connections of metabolism and cell proliferation
1235. diabetes, chronic kidney disease and cancer risk
1236. diabetes, colon cancer and Wnt beta-catenin signaling pathways
1237. diabetes, colorectal cancer and cyclooxygenase 2 inhibition
1238. diabetes, diabetes risk factors and treatments, and breast cancer
1239. diabetes, diabetes therapies and cancer: what’s the link?
1240. diabetes, diabetes treatment and breast cancer prognosis
1241. diabetes, diabetes treatment, and mammographic density in Danish Diet, cancer, and Health cohort
1242. diabetes, diabetes treatment, and risk of thyroid cancer
1243. diabetes, gall stone disease, and pancreatic cancer.
1244. diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms
1245. diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
1246. diabetes, Glycated Hemoglobin, and Risk of cancer in the UK Biobank Study
1247. diabetes, hypoglycemic drugs and pancreatic cancer
1248. diabetes, insulin and cancer risk
1249. diabetes, insulin and cancer risk The molecular role of insulin signaling and hyperinsulinemia in cancer development and progression in diabetes patients
1250. diabetes, insulin and cancer risk: you and your patient
1251. diabetes, Insulin Resistance, and cancer: An Update
1252. diabetes, insulin therapy, and colorectal cancer
1253. diabetes, insulin treatment, and cancer risk: what is the evidence?
1254. diabetes, insulin use, and cancer risk: are observational studies part of the solution–or part of the problem?
1255. diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese
1256. diabetes, insulin use, smoking, and pancreatic cancer mortality in Taiwan
1257. diabetes, insulin-use and risk of colorectal cancer in a US cohort study
1258. diabetes, insulin, and risk of cancer
1259. diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
1260. diabetes, metformin and breast cancer: a tangled web
1261. diabetes, metformin and cancer risk in myotonic dystrophy type I
1262. diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: results from the women’s health initiative
1263. diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
1264. diabetes, metformin use, and colorectal cancer survival in postmenopausal women
1265. diabetes, metformin use, and colorectal cancer survival in women: A retrospective cohort study.
1266. diabetes, metformin, and breast cancer in postmenopausal women
1267. diabetes, Metformin, and Lung cancer: Retrospective Study of the Korean NHIS-HEALS Database
1268. diabetes, obesity and cancer: risk and anti-risk factors
1269. diabetes, obesity, and breast cancer
1270. diabetes, obesity, and cancer—pathophysiology and clinical implications
1271. diabetes, obesity, and subsequent risk of postmenopausal breast cancer among white and black women in the Southern Community Cohort Study
1272. diabetes, obesity, and survival in a large cohort of early-stage breast cancer patients.
1273. diabetes, obesity, and the metabolic syndrome as prognostic factors in stages I to III colorectal cancer patients
1274. diabetes, obesity, insulin resistance: different pathways to cancer?
1275. diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay
1276. diabetes, pancreatic cancer and vitamin D. Is there a link?
1277. diabetes, pancreatic cancer, and metformin therapy
1278. diabetes, pancreatogenic diabetes, and pancreatic cancer
1279. diabetes, physical activity and breast cancer among Hispanic women
1280. diabetes, physical activity and endometrial cancer
1281. diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people
1282. diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million C hinese adults and a meta‐analysis of 22 cohort studies
1283. diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: a prospective study of 0.5 million people
1284. diabetes, prediabetes and cancer mortality
1285. diabetes, prostate cancer screening and risk of low-and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million …
1286. diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
1287. diabetes, treatments for diabetes and their effect on cancer incidence and mortality: attempts to disentangle the web of associations
1288. diabetes, Weight Change, and Pancreatic cancer Risk
1289. diabetes: diabetes therapy and cancer risk
1290. diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease?
1291. Diabetic ketoacidosis caused by fulminant type 1 diabetes during adjuvant chemotherapy for colon cancer: A case report
1292. Diabetic Status after Radical Gastrectomy in Gastric cancer Patients with Type 2 diabetes Mellitus
1293. Diagnosing and monitoring endocrine dysfunction, diabetes, and obesity in a cohort of adult survivors of childhood cancer
1294. Diagnosis and survival of pancreatic cancer in relation to depression and diabetes history: A population-based study in Finland
1295. Diagnosis and treatment of 17 cases of pulmonary tuberculosis complicated by diabetes misdiagnosed lung cancer
1296. Diagnosis of Breast cancer and diabetes using Hybrid Feature Selection Method
1297. Diagnostic yield of the plasma free amino acid index for pancreatic cancer in patients with diabetes mellitus
1298. Diastatic activity of the blood in cancer, syphilis and diabetes
1299. Diet quality and risk of type 2 diabetes: a prospective study in the Malmo Diet and cancer cohort
1300. Diet, diabetes and cancer–How and Why?
1301. Dietary energy density predicts the risk of incident type 2 diabetes: the European Prospective Investigation of cancer (EPIC)-Norfolk Study
1302. Dietary fat and the risk of clinical type 2 diabetes: the European prospective investigation of cancer-Norfolk study
1303. Dietary intake of carbohydrates and risk of type 2 diabetes: The European Prospective Investigation into cancer-Norfolk study
1304. Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC)-NL study
1305. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition: the EPIC-InterAct study
1306. Differences in Biological Behavior of Colorectal cancer between Patients With and Without diabetes: 590
1307. Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER‐Medicare‐linked data resource
1308. Differences in Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen Levels between Pancreatic cancer Patients with or Without diabetes Mellitus
1309. Different domains of self-reported physical activity and risk of type 2 diabetes in a population-based Swedish cohort: the Malmö diet and cancer study
1310. Differential expression and signaling activation of insulin receptor isoforms A and B: a link between breast cancer and diabetes
1311. Differential impact of anti-diabetic treatments on pancreatic cancer cell growth in cell culture conditions mimicking different stages in the natural history of diabetes …
1312. Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases
1313. Differential relationship between colorectal cancer and diabetes in a nationally representative sample of adults
1314. Diminishing differences in treatment between colorectal cancer patients with and without diabetes: a population-based study
1315. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population‐based study
1316. Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
1317. Discriminant, identifiable plasma metabolites in pancreatic cancer-associated diabetes-candidate early-detection biomarkers
1318. Discriminant, identifiable plasma metabolites in pancreatic cancer–associated diabetes.
1319. Discussion on the surgical treatment of cancer of esophageal and cardiac with diabetes——Clinical report of 31 cases
1320. Disease Detection Analytics: A Simple Linear Convex Programming Algorithm for Breast cancer and diabetes Incidence Decisions
1321. Disease-Proof: Slash Your Risk of Heart Disease, cancer, diabetes, and More–by 80 Percent
1322. Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
1323. Disease-specific mortality and secondary primary cancer in well-differentiated thyroid cancer with type 2 diabetes mellitus
1324. Diseases of Civilization–cancer, diabetes, Obesity and Acne–the Implication of Milk, IGF-1 and mTORC1
1325. Diseases of malfunction of body mechanisms.(Heart disease, diabetes, cancer etc.) risk by occupation, and correlation, male and female, with vehicle travel
1326. Disparities in receipt of screening tests for cancer, diabetes and high cholesterol in Ontario, Canada: a population-based study using area-based methods
1327. Dissecting mechanisms involved in the aetiological overlap between Type 2 diabetes and cancer
1328. Distances over Incomplete diabetes and Breast cancer Data Based on Bhattacharyya Distance
1329. Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer
1330. DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer.
1331. Do colorectal cancer resections improve diabetes in long-term survivors? A case–control study
1332. Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A …
1333. Do variants associated with susceptibility to pancreatic cancer and type 2 diabetes reciprocally affect risk?
1334. Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
1335. Does a single nucleotide polymorphism in the FGFR explain the connection between diabetes and cancer?
1336. Does A1c predict surgical complications? A retrospective chart review of patients with Type II diabetes Mellitus and Endometrial cancer
1337. Does Aspirin Decrease Risk of Specific Breast cancer Subtype in Women with diabetes?
1338. Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer?
1339. Does body mass index and adult height influence cancer incidence among Chinese living with incident type 2 diabetes?
1340. Does body mass index and adult height influence cancer incidence among people living with incident type 2 diabetes
1341. Does cancer risk increase with HbA 1c, independent of diabetes?
1342. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort …
1343. Does comorbidity influence the risk of myocardial infarction or diabetes during androgen-deprivation therapy for prostate cancer?
1344. Does diabetes affect [18 F] FDG standardised uptake values in lung cancer?
1345. Does diabetes mellitus affect presentation, stage and survival in operable pancreatic cancer?
1346. Does diabetes mellitus as a comorbid condition affect the health-related quality of life in prostate cancer survivors? Results of a population-based observational study …
1347. Does diabetes mellitus as a comorbid condition affect the health‐related quality of life in prostate cancer survivors? Results of a population‐based observational study
1348. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
1349. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy?
1350. Does diabetes mellitus influence standardized uptake values of fluorodeoxyglucose positron emission tomography in colorectal cancer?
1351. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer?
1352. Does diabetes mellitus influence the prognosis of patients with lung cancer?
1353. Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
1354. Does diabetes mellitus play an independent prognostic role in kidney cancer?
1355. Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study
1356. Does diabetes really impact on postoperative survival in patients with colorectal cancer?
1357. Does diabetes therapy influence the risk of cancer?
1358. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama
1359. Does Hyperinsulinemia in Type-II diabetes Mellitus Influence Disease Presentation and Long-Term Treatment Outcomes of Localized Prostate cancer?
1360. Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?
1361. Does Metformin Protect the Bone Marrow of Patients with diabetes Treated with 131I for 
Thyroid cancer?
1362. Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
1363. Does the hospitalization after a cancer diagnosis modify adherence to process indicators of diabetes care quality?
1364. Does the use of incretin‐based medications increase the risk of cancer in patients with type‐2 diabetes mellitus?
1365. Does Type 2 diabetes increase the risk of developing cancer?
1366. Does use of metformin protect against cancer in Type 2 diabetes mellitus?
1367. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six‐year population‐based cohort study
1368. Dose-dependent relationship between metformin and colorectal cancer occurrence among patients with Type 2 diabetes—A nationwide cohort study
1369. Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients
1370. DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate …
1371. Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breast cancer being treated for hypertension and diabetes
1372. Drug–subphenotype interactions for cancer in type 2 diabetes mellitus
1373. Drugs, diabetes and cancer
1374. Duration of diabetes and pancreatic cancer in a case-control study in the Midwest and the Iowa Women’s Health Study (IWHS) cohort
1375. Dysregulated mitochondrial dynamics and metabolism in obesity, diabetes, and cancer
1376. Early Life: Epigenetic Effects on Obesity, diabetes, and cancer
1377. Editorial (Thematic Issue: Nutrition And Immunology In diabetes, cancer and Infectious Diseases)
1378. Effect of aspirin on cancer chemoprevention in Japanese patients with type 2 diabetes: 10-year observational follow-up of a randomized controlled trial
1379. Effect of Billroth Ⅱ Gastrectomy on Type 2 diabetes Mellitus in Patients with Gastric cancer
1380. Effect of blood glucose level on the prognosis of breast cancer patients with type 2 diabetes mellitus
1381. Effect of diabetes and Obesity on Disparities in Prostate cancer Outcomes
1382. Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
1383. Effect of diabetes Mellitus and Glycemic Control on the Prognosis of Non-muscle Invasive Bladder cancer: A Retrospective Study
1384. Effect of diabetes mellitus on high-grade prostate cancer detection among Japanese obese patients with prostate-specific antigen less than 10 ng/mL
1385. Effect of diabetes mellitus on outcomes of colorectal cancer
1386. Effect of diabetes Mellitus on Patients Receiving Robotic-Assisted Laparoscopic Radical Prostatectomy for Prostate cancer
1387. Effect of diabetes mellitus on survival in patients with gallbladder cancer: a systematic review and meta-analysis
1388. Effect of diabetes Mellitus on Survival in Patients with Gallbladder cancer: A Systematic Review and Meta-analysis
1389. Effect of diabetes mellitus on survival in patients with pancreatic cancer: a systematic review and meta-analysis
1390. Effect of diabetes mellitus on the development of radiation pneumonitis in patients with non-small cell lung cancer
1391. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer
1392. Effect of diabetes on endometrial cancer recurrence and survival
1393. Effect of diabetes on neurological adverse effects and chemotherapy induced peripheral neuropathy in advanced colorectal cancer patients treated with different …
1394. Effect of diabetes Treatment on Breast cancer Outcomes: A Systematic Review and Meta-analysis
1395. Effect of different chemotherapy combined with radiotherapy for the treatment of non small cell lung cancer complicated with type 2 diabetes
1396. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: an observational population-based study
1397. Effect of digestive tract reconstructions after distal gastrectomy on gastric cancer patients complicated with diabetes
1398. Effect of dipeptidyl peptidase-4 inhibitors on cisplatin-induced acute nephrotoxicity in cancer patients with diabetes mellitus: A retrospective study
1399. Effect of glitazones on cancer mortality in type 2 diabetes
1400. Effect of human insulin on breast cancer risk in Taiwanese women with type 2 diabetes.
1401. Effect of hypoglycemic agents on survival outcomes of lung cancer patients with diabetes mellitus: a meta-analysis
1402. Effect of hypoglycemic agents on survival outcomes of patients with lung cancer and diabetes mellitus: A systematic review and meta-analysis.
1403. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer
1404. Effect of metformin in the prognosis of patients with smallcell lung cancer combined with diabetes mellitus.
1405. Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors: a meta-analysis of observational studies
1406. Effect of multimodal information delivery for diabetes care on colorectal cancer screening uptake among individuals with type 2 diabetes
1407. Effect of nursing intervention on patients with breast cancer accompanied by diabetes during the perioperative period
1408. Effect of Nuts on Markers of cancer and Coronary Heart Disease Risk in Type 2 diabetes: A Dose Response Study
1409. Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer
1410. Effect of perioperative nursing on blood sugar and complication of patients with gastric cancer complicated with diabetes mellitus
1411. Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives
1412. Effect Of Secoisolariciresinol Diglucoside (Sdg) On Colon cancer Associated With diabetes Mellitus.
1413. Effect of Three Procedures of Digestive Tract Reconstructions after Distal Gastrectomy on Blood Sugar of Gastric cancer Patients Complicated with diabetes
1414. Effect of type 2 diabetes and antihyperglycemic drug therapy on signs of tumor invasion in papillary thyroid cancer
1415. Effect of type 2 diabetes mellitus on prognosis of nonmetastatic renal cell cancer
1416. Effect of type 2 diabetes predisposing genetic variants on colorectal cancer risk
1417. Effect of uncontrolled diabetes on outcomes after cystectomy in patients with bladder cancer: a population-based study
1418. Effect of yoga on chemo-radiotherapy induced diabetes and hypertension (CRID-H) among cervical cancer patients at a regional cancer institute in south India
1419. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes
1420. Effects of aspirin or clopidogrel on colorectal cancer chemoprevention in patients with type 2 diabetes mellitus
1421. Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
1422. Effects of Breast cancer and Type 2 diabetes Mellitus on Pulmonary Volumes and Pressures in Adult Women
1423. Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program)
1424. Effects of continuing nursing care on postoperative quality of life and blood glucose control in patients with bladder cancer and diabetes mellitus
1425. Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients
1426. Effects of diabetes on Ovarian cancer: Data Analysis and Modeling Study
1427. Effects of metformin dose on cancer risk reduction in patients with type 2 diabetes mellitus: a 6‐year follow‐up study
1428. Effects of metformin on breast cancer risk and mortality in patients with type 2 diabetes
1429. Effects of Metformin on Breast cancer Risk and Mortality in Type 2 diabetes Mellitus: A Systematic Review and Meta-analysis
1430. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
1431. Effects of metformin on survival outcomes of pancreatic cancer patients with diabetes: A meta-analysis
1432. Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: A systematic review and meta-analysis
1433. Effects of Newly Diagnosed cancer on Medication Management of Prevalent diabetes
1434. Effects of propofol and sevoflurane on blood glucose, hemodynamics, and inflammatory factors of patients with type 2 diabetes mellitus and gastric cancer
1435. Efficacy of metformin for locally advanced rectal cancer complicating diabetes mellitus.
1436. Elderly diabetes and the correlation of colorectal cancer research
1437. Electronic nose: A non-invasive technology for breath analysis of diabetes and lung cancer patients
1438. Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes
1439. Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
1440. Emerging link between diabetes and cancer
1441. Emerging roles of cadmium and heme oxygenase in type-2 diabetes and cancer susceptibility
1442. Emerging trends in pancreatic cancer and diabetes.
1443. Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer
1444. Empirically supported treatments of disease-related symptoms in pediatric psychology: asthma, diabetes, and cancer.
1445. Enabling the nation’s schools to help prevent heart disease, stroke, cancer, COPD, diabetes, and other serious health problems
1446. Endocrinopathy in Pancreatic cancer Is Characterized by Reduced Islet Size and Density with Preserved Endocrine Composition as Compared to Type 2 diabetes …
1447. Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer?
1448. Enhanced System to Achieve Better Classification Performance in Forecasting diabetes and Breast cancer
1449. Enhancement of O‑linked N‑acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus
1450. Enhancing ensemble prediction accuracy of breast cancer survivability and diabetes diagnostic using optimized EKF-RBFN trained prototypes
1451. Epidemiological bases and molecular mechanisms linking obesity, diabetes, and cancer
1452. Epidemiological dimensions of the association between type 2 diabetes and cancer: A review of observational studies
1453. Epidemiological evidence of a relationship between type‐1 diabetes mellitus and cancer: a review of the existing literature
1454. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer
1455. Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
1456. Epidemiology of diabetes and cancer
1457. Epidemiology of diabetes and cancer: Lessons learnt
1458. Epigenetic mechanisms of breast cancer prevention by the Type II diabetes mellitus agent metformin
1459. Epithelial Mesenchymal Transition and Progression of Breast cancer Promoted by diabetes Mellitus in Mice Are Associated with Increased Expression of Glycolytic …
1460. Epithelial-mesenchymal transition phenotype, metformin, and survival for colorectal cancer patients with diabetes mellitus II
1461. Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
1462. Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
1463. Essential roles for the non-canonical IκB kinases in linking inflammation to cancer, obesity, and diabetes
1464. Estimating the causal effect of BMI on mortality risk in people with heart disease, diabetes and cancer using Mendelian randomization
1465. Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast cancer Health Disparities Study
1466. Ethno-medicinal plants for treatment of diabetes, cancer and heart diseases: Evidence based documentation from dependent stakeholders
1467. European Association for the Study of diabetes Annual Conference Explores Links Between diabetes and cancer
1468. Evaluating the effect of diabetes on the prognosis of gastric cancer using a propensity score matching method
1469. Evaluating the prevalence of diabetes mellitus subtypes in childhood cancer survivors: a systematic review protocol
1470. EVALUATING THE ROLE OF diabetes AND THE diabetes RELATED GENE, TCF2, IN PROSTATE cancer RISK AMONG AFRICAN-AMERICAN, CAUCASIAN …
1471. Evaluation of a mixed meal test for diagnosis and characterization of pancrEaTogEniC diabetes secondary to pancreatic cancer and chronic pancreatitis …
1472. Evaluation of lipid peroxidation activity at intravenous administration of gold nanorods in rats with simulated diabetes and transplanted liver cancer
1473. Evaluation of National Programme for Prevention and Control of cancer, diabetes, Cardiovascular disease and Stroke (NPCDCS) in Gandhinagar district, Gujarat.
1474. Evaluation of siRNA mediated Silencing of IKKα in Prostate cancer and CD40 in Type-1 diabetes
1475. Evaluation of the association between gestational diabetes mellitus at first pregnancy and cancer within 10 years postpartum using National health insurance data in …
1476. Evaluation of the impact of diabetes mellitus on the biology of prostate cancer
1477. Evaluation the Rate of cancer Risk in Patients with diabetes: A Systematic Review
1478. Evidence for DNA damage as a biological link between diabetes and cancer
1479. Examination of cause-of-death data quality among New York City deaths due to cancer, pneumonia, or diabetes from 2010 to 2014
1480. Examination of the complex relationships among dietary components, type II diabetes, weight change, and breast cancer risk among Singaporean Chinese women
1481. Examining known diabetes risk variants for association with prostate cancer in a multiethnic population
1482. Examining patterns of multivariate, longitudinal symptom experiences among older adults with type 2 diabetes and cancer via cluster analysis
1483. Examining the association between statins and lung cancer incidence in patients with type 2 diabetes mellitus
1484. Examining the effects of metformin on survival outcome in stage II/III colorectal cancer patients with diabetes mellitus.
1485. Examining the Impact of First Nations Status on the Relationship Between diabetes and cancer
1486. Examining the multilevel influences on diabetes and hypertension clinical care management among breast cancer patients
1487. Examining the relationship between diabetes and prostate cancer through changes in screening guidelines
1488. Excess body weight and cancer risk in patients with type 2 diabetes who were registered in Swedish National diabetes Register–register-based cohort study …
1489. Excess body weight, diabetes and cancer: epidemiologic evidence implicating hormonal and metabolic mechanisms
1490. Excess risk of primary liver cancer in patients with diabetes mellitus
1491. Excess risk of thyroid cancer in individuals with type 1 diabetes compared to those without diabetes in Finland; nationwide study
1492. Excessive weight, inflammation, diabetes, and cancer: Relationships and differences by race
1493. Exercise and patient populations: A community-based exercise intervention on cancer and Type 2 diabetes
1494. Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes
1495. Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy
1496. Exosomes: Mediators and Therapeutic Targets of diabetes and Pancreatic cancer
1497. Expanding the therapeutic spectrum of metformin: from diabetes to cancer
1498. Experience on Treating Oesophagus Cardia cancer Combined with diabetes 52 Cases in Peri-operation Period
1499. Exploiting the cancer and diabetes metabolic connection for therapeutic purposes
1500. Exploratory study of impact of cancer‐related posttraumatic stress symptoms on diabetes self‐management among cancer survivors
1501. Exploring online support spaces: using cluster analysis to examine breast cancer, diabetes and fibromyalgia support groups
1502. Exploring opportunities for colorectal cancer screening and prevention in the context of diabetes self-management: an analysis of the 2010 National Health Interview …
1503. Exploring the association between diabetes and breast cancer morbidity: considerations for quality care improvements among Latinas
1504. Exploring the association between diabetes and breast cancer outcomes among Latinas.
1505. Exploring the bi-directional relationship between pancreatic cancer and diabetes mellitus: a retrospective study
1506. Exploring the complex and paradoxical relationships between Type 2 diabetes, obesity and cancer, as a framework for risk prediction models
1507. Exploring the impact of metformin on cancer risk in diabetes patients
1508. Exploring the link between diabetes and pancreatic cancer
1509. Exploring the therapeutic ability of fenugreek against type 2 diabetes and breast cancer employing molecular docking and molecular dynamics simulations
1510. Exposure to Electric and Magnetic Fields (EMF) Linked to Neuro-Endocrine Stress Syndrome: Increased Cardiovascular Disease, diabetes, & cancer
1511. Expression and significance of SIRT1 in breast cancer with diabetes meilitus
1512. Expression and significance of SIRT1 in breast cancer with diabetes mellitus
1513. Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus
1514. Expression of HIF-1α and correlation with angiogenesis in tissue of breast cancer complicated with diabetes
1515. Expression of long non-coding RNA H19 in colorectal cancer patients with type 2 diabetes
1516. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
1517. Expression of protein kinase p70S6K in leukocytes of patients with cancer and diabetes mellitus
1518. Extracellular matrix glycation and RAGE activation. A missing piece in the puzzle of the association between diabetes and cancer
1519. Factors associated with cancer-and non-cancer-related deaths among Taiwanese patients with diabetes after 17 years of follow-up
1520. Factors associated with local, distant, overall recurrence in surgically-resected non-small cell lung cancer and the role of diabetes in local recurrence
1521. Factors that may influence the risk of cancer in diabetes
1522. Familial diabetes frequency as a factor in diabetics suffering from cancer
1523. Familial diabetes is associated with reduced risk of cancer in diabetic patients: a possible role for metformin
1524. Family caregivers’ strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving
1525. Family diabetes and its consequences in cancer patients
1526. Family disease history and perceived risk for Type 2 diabetes, cardiovascular disease, cancer and depression
1527. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer
1528. Family history and perceived risk of diabetes, cardiovascular disease, cancer, and depression
1529. Family history of diabetes and pancreatic cancer
1530. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study
1531. Fasting Plasma Glucose Variability and Gastric cancer Risk in Individuals Without diabetes Mellitus: A Nationwide Population-Based Cohort Study
1532. Fasting‐Mimicking Diet and Risk Factors for Aging, diabetes, cancer and Cardiovascular Disease
1533. Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer
1534. Fear of progression in patients with cancer, diabetes mellitus and chronic arthritis
1535. Features immuno-genetic, clinical and morphological characteristics of breast cancer in patients with type 2 diabetes melliuts
1536. Fight against chronic diseases (high blood pressure, stroke, diabetes and cancer) in Pakistan; cost-effective interventions
1537. Financial Burden Over Time in Older Adults with cancer, Heart Disease, or diabetes
1538. Food patterns in relation to weight change and incidence of type 2 diabetes, coronary events and stroke in the Malmö Diet and cancer cohort
1539. For better or worse: FFAR1 and FFAR4 signaling in cancer and diabetes
1540. For colorectal cancer patients with type II diabetes, could metformin improve the survival rate? A meta-analysis
1541. Forecasting of breast cancer and diabetes using ensemble learning
1542. Formulation of a Multifunctional Flora Composite for the Prevention and Management of cancer, diabetes, Blood Pressure and Stroke
1543. Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean
1544. Foundation for the state of Kuwait prize for the control of cancer, cardiovascular diseases and diabetes in the Eastern Mediterranean Region
1545. Four lifestyle factors prevent cancer, diabetes, and CVD
1546. Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort
1547. Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
1548. Free radical scavenging ability of Aspalathus linearis in two in vitro models of diabetes and cancer
1549. Frequency of type 2 diabetes in family and it’s changes in diabetic patients affected or not affected with cancer
1550. From diabetes to cancer: Glucose makes the difference
1551. From diabetes to cancer: New applications for targeting AMPK in the clinical setting
1552. From obesity to diabetes and cancer: epidemiological links and role of therapies
1553. Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors
1554. Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for diabetes and cancer Therapy
1555. FUMARATE METABOLISM IN cancer AND TYPE 2 diabetes
1556. Functional informed genome‐wide interaction analysis of body mass index, diabetes and colorectal cancer risk
1557. Galectin-3 and S100A9: Novel Diabetogenic Factors Mediating Pancreatic cancer–Associated diabetes
1558. Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients
1559. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK
1560. Gastrointestinal cancer incidence in type 2 diabetes mellitus: results from a large retrospective population-based cohort study
1561. Gastrointestinal tract cancer and diabetes mellitus
1562. Gaussian graphical models identified food intake networks and risk of type 2 diabetes, CVD, and cancer in the EPIC-Potsdam study
1563. GCN2 and FGF21 are likely mediators of the protection from cancer, autoimmunity, obesity, and diabetes afforded by vegan diets
1564. GDF-15 is associated with cancer incidence in patients with type 2 diabetes
1565. Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus
1566. Gene polymorphisms and their association with diabetes and hypertension in African American and Latina breast cancer patients
1567. Gene signature for prognosis in comparison of pancreatic cancer patients with diabetes and non-diabetes
1568. Gene-and pathway-based genomics of breast cancer and type 2 diabetes in African American women
1569. Generation and biological characteristics of a mouse model of breast cancer that copresents with diabetes mellitus
1570. Genes and molecular mechanisms affecting the correlation between liver cancer and diabetes mellitus
1571. Genes Associated with cancer, Schizophrenia and Type 2 diabetes in the Circassian and Chechen Populations in Jordan
1572. Genes related to diabetes may be associated with pancreatic cancer in a population-based case-control study in Minnesota
1573. Genes–environment interactions in obesity-and diabetes-associated pancreatic cancer: a GWAS data analysis
1574. Genetic Architecture of diabetes Mellitus in Long-term Survivors of Childhood cancer
1575. Genetic Basis Linking Variants for diabetes and Obesity with Breast cancer
1576. Genetic polymorphisms of diabetes‐related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast cancer …
1577. Genetic susceptibility to type 2 diabetes and breast cancer risk in women of European and African ancestry
1578. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk
1579. Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer
1580. Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes
1581. Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes
1582. Genome-wide association studies in aging-related processes such as diabetes mellitus, atherosclerosis and cancer
1583. Genome-wide gene-diabetes and gene-obesity interaction scan in the pancreatic cancer case control consortium
1584. Genomewide gene-diabetes and gene-obesity interaction scan in 7095 cases and 10710 controls from Pancreatic cancer Cohort Consortium and Pancreatic cancer …
1585. Genomic Epidemiology of Human Papillomavirus (HPV), Prostate cancer, and diabetes
1586. Genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer
1587. Gestational diabetes and risk of breast cancer in African American women
1588. Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel
1589. Gestational diabetes and risk of incident primary cancer: A large population-based cohort study in Israel.
1590. Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study
1591. Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study
1592. Gestational diabetes may increase risk of endometrial cancer later in life: Results of a population-based study in Washington State, 1987–2012
1593. Gestational diabetes mellitus and maternal breast cancer risk: a meta-analysis of the literature
1594. Gestational diabetes mellitus and risk of incident primary cancer: A population-based retrospective cohort study.
1595. Gestational diabetes mellitus and subsequent cancer risk: shared risk factors, causality or confounding?
1596. Gestational diabetes mellitus may be associated with increased risk of breast cancer
1597. Gestational diabetes, type II diabetes, and mammographic breast density in a US racially diverse population screened for breast cancer
1598. GI hormonal changes in diabetes influence pancreatic cancer growth
1599. Glargine safety, diabetes and cancer
1600. Global and regional effects of bladder cancer risk associated with pioglitazone therapy in patients with diabetes
1601. GLP-1 based therapy for diabetes and potential of thyroid cancer
1602. GLP-1 receptor agonist as treatment for cancer as well as diabetes: beyond blood glucose control
1603. GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
1604. Glucagon-like peptide (GLP)-1 and the synthetic analogue exenatide: From novel therapy for diabetes to growth inhibition of breast cancer cells.
1605. Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice …
1606. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus
1607. Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes
1608. Glucose transporters: their abnormalities and significance in type 2 diabetes and cancer
1609. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
1610. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer
1611. Glucose-Regulated TET2 Activity Links cancer to diabetes
1612. Glucose‐lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all‐cause mortality, cardiovascular events and cancer
1613. Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis
1614. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of cancer and Nutrition (EPIC-Norfolk)
1615. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into cancer (EPIC)–Norfolk prospective …
1616. Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography
1617. Glycated hemoglobin, diabetes treatment and cancer risk in type 2 diabetes. A case-control study
1618. Glycemia control using A1C level in terminal cancer patients with preexisting type 2 diabetes
1619. Glycemic changes after gastrectomy in non-morbidly obese patients with gastric cancer and diabetes.
1620. Glycemic control and survival of patients with coexisting diabetes mellitus and gastric or esophageal cancer
1621. Glycemic equilibrium of cancer patients with diabetes
1622. Glycemic Status, Insulin Resistance, and Risk of Pancreatic cancer Mortality in Individuals With and Without diabetes
1623. Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
1624. GO-25: Dose diabetes medication reduce recurrence of endometrial cancer?
1625. Gonadotrophin-releasing hormone agonists, diabetes and cardiovascular disease in men with prostate cancer: which metabolic syndrome?
1626. Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer
1627. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus
1628. Greater development of 1, 2-dimethylhydrazine-induced colon cancer in a rat model of type 2 diabetes mellitus
1629. Growth defect blocks cancer and diabetes
1630. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and cancer–Cardiovascular Cohort
1631. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans
1632. GSK3 inhibitors in the therapeutic development of diabetes, cancer and neurodegeneration: past, present and future
1633. Guest editorial: are diabetes-related wounds and amputations worse than cancer
1634. GW28-e0695 High-Density Lipoprotein Cholesterol and cancer Risk Among Chinese with or without diabetes Mellitus in Kailuan Cohort
1635. H eterogeneity in risk of prostate cancer: AS wedish population‐based cohort study of competing risks and T ype 2 diabetes mellitus
1636. HbA1C and cancer risk in patients with type 2 diabetes–a nationwide population-based prospective cohort study in Sweden
1637. HDL cholesterol and cancer risk among patients with type 2 diabetes
1638. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis
1639. HE LINK BETWEEN diabetes, diabetes TREATMENT AND cancer
1640. Head and neck cancer patients: impact of diabetes mellitus on surgical outcomes
1641. Health literacy and behavior related to cancer and diabetes among higher secondary students
1642. Health professionals’ views of current treatment pathways for cancer patients with comorbid diabetes
1643. Health-related quality of life for men with prostate cancer and diabetes: a longitudinal analysis from CaPSURE
1644. Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus
1645. Healthy gardens/healthy lives: Navajo perceptions of growing food locally to prevent diabetes and cancer
1646. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: prospective cohort study
1647. Heart disease risk factors, diabetes, and prostatic cancer in an adult community
1648. Helicobacter pylori infection and Hyperglycemia/diabetes are associated with an increased risk of gastric cancer
1649. Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team
1650. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients
1651. Herbal Medicines for diabetes and cancer—A Global Perspective
1652. High glucose and diabetes increase cancer risk
1653. High Norepinephrine Status Induced Growth of Colorectal cancer With Type 2 diabetes Mellitus Benefited From ADP-Ribosyltransferase 1
1654. High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey
1655. High prevalence of diabetes mellitus and impaired glucose tolerance in liver cancer patients: a hospital based study of 4610 patients with benign tumors or …
1656. High processed meat consumption is a risk factor of type 2 diabetes in the Alpha-Tocopherol, Beta-Carotene cancer Prevention study
1657. High rates of endometrial cancer among Pacific women in New Zealand: the role of diabetes, physical inactivity, and obesity
1658. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 …
1659. High‐density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells
1660. Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes–The Adiponectin Paradox
1661. Higher Concentrations of Glucose or Insulin Increase the Risk of Various Types of cancer in Obesity or Type 2 diabetes by Decreasing the Expression of …
1662. Higher expression of proteins in IGF/IR axes in colorectal cancer is associated with type 2 diabetes mellitus
1663. Higher glucose and insulin levels are associated with risk of liver cancer and chronic liver disease mortality among men without a history of diabetes
1664. Higher prevalence of lymph node metastasis in prostate cancer in patients with diabetes
1665. Higher Prevalence of Prostate cancer among Veterans with Type 2 diabetes
1666. Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation
1667. Higher risk of mortality from lung cancer in Taiwanese people with diabetes
1668. Higher whole-grain intake is associated with lower risk of type 2 diabetes among middle-aged men and women: the Danish diet, cancer, and health cohort
1669. Hijacking of endocrine and metabolic regulation in cancer and diabetes
1670. Hijacking of Endocrine and Metabolic Regulation in cancer and diabetes
1671. Hints that Glitazones, diabetes Drugs, May Work Against Breast cancer
1672. Histone deactylase inhibitors as novel target for cancer, diabetes, and inflammation
1673. History of cancer and the use of ACE inhibitors: results from the Vermont diabetes information system.
1674. History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium
1675. History of diabetes and risk of head and neck cancer: a pooled analysis from the international head and neck cancer epidemiology consortium.
1676. History of diabetes mellitus and risk of breast cancer in asian women: A meta-epidemiological analysis of population-based cohort studies
1677. History of diabetes mellitus and risk of prostate cancer in physicians
1678. History of diabetes Mellitus and Risk of Prostate cancer: A Meta-Epidemiological Study of Population-Based Cohort Studies in East Asian Men
1679. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study
1680. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
1681. History of diabetes mellitus as a risk factor for pancreatic cancer: The Iowa Women’s Health study
1682. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE TM (United States)
1683. History of gestational diabetes mellitus and risk of incident invasive breast cancer among parous women in the Nurses’ Health Study II prospective cohort
1684. History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium
1685. History of lower-limb complications and risk of cancer death in people with type 2 diabetes
1686. History of treated hypertension and diabetes mellitus and risk of renal cell cancer
1687. HNF1B and JAZF1 genes, diabetes, and prostate cancer risk
1688. Homeostasis, diabetes and cancer
1689. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women
1690. Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
1691. Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes
1692. Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
1693. How do people interpret their family histories of diabetes, coronary disease, or cancer?
1694. How does diabetes Mellitus Influence Early Postoperative Results and Survival in Rectal cancer?
1695. How shift work and a destabilized circadian system may increase risk for development of cancer and type 2 diabetes
1696. Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research
1697. Human insulin to increase breast cancer risk in Taiwanese women with type 2 diabetes.
1698. Hybrid feature selection based weighted least squares twin support vector machine approach for diagnosing breast cancer, hepatitis, and diabetes
1699. Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes
1700. Hyperglycemia among hospitalized cancer patients with co-existing diabetes mellitus.
1701. Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast cancer Patients without diabetes
1702. Hyperglycemia, classified with multiple biomarkers simultaneously in men without diabetes, and risk of fatal prostate cancer
1703. Hyperinsulinemia and type 2 diabetes: impact on cancer
1704. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors
1705. Hypertension, diabetes, cognitive impairment, renal cancer, polymyalgia rheumatica and chronic hemodialysis treatment: so many diseases or just only one?
1706. Hypophysial disorder in mammary cancer and its relation to diabetes insipidus
1707. IDDF2019-ABS-0075 Serum metabonomic analysis and establishment of diagnostic model of pancreatic cancer associated diabetes
1708. IDDF2020-ABS-0051 Association between type-2 diabetes mellitus and platelet distribution width in patients with primary liver cancer
1709. Identification of key candidate genes and pathways for relationship between ovarian cancer and diabetes mellitus using bioinformatical analysis
1710. Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics
1711. Identification of Therapeutic Targets in diabetes induced Breast cancer Metastasis
1712. Identifying clinical factors associated with an increased risk of diabetes Mellitus among cancer survivors.
1713. Illuminating the diabetes–cancer link
1714. Immunologic predictors of diabetes mellitus in menopausal breast cancer patients
1715. Immunomodulatory perspectives of potential biological spices with special reference to cancer and diabetes
1716. Impact of cancer on adherence to glucose lowering drugs in individuals with diabetes
1717. Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes
1718. Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms
1719. Impact of cancer on use of glucose-lowering drug treatment in individuals with diabetes: potential mechanisms. Reply to Pouwer F
1720. Impact of cancer related stress on illness beliefs and glycemic control in breast cancer survivors with comorbid diabetes.
1721. Impact of clinical pharmacy recommendations and patient counselling program among patients with diabetes and cancer in outpatient oncology setting
1722. Impact of consumption of animal products on cardiovascular disease, diabetes, and cancer in developed countries
1723. Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus
1724. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy
1725. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy.
1726. Impact of diabetes and hyperglycemia on outcomes in advanced breast cancer patients.
1727. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients
1728. Impact of diabetes and Hyperglycemia on Survival in Advanced Breast cancer Patients
1729. Impact of diabetes and insulin use on prognosis in patients with resected pancreatic cancer: an ancillary analysis of NRG Oncology RTOG 9704
1730. Impact of diabetes and metformin use on prostate cancer outcome of patients treated with radiation therapy: results from a large institutional database.
1731. Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two …
1732. Impact of diabetes Complications on Breast cancer Screening, Diagnosis, and Prognosis among Elderly Women with Pre-existing diabetes Using the SEER …
1733. Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk
1734. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the cancer Prevention Study-II Nutrition Cohort
1735. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study
1736. Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis
1737. Impact of diabetes mellitus on clinical presentation and prognosis of pancreatic cancer
1738. Impact of diabetes mellitus on clinicopathological factors and prognosis of patients with colorectal cancer.
1739. Impact of diabetes mellitus on clinicopathological factors and relation with radiation pneumonitis in 332 patients with lung cancer
1740. Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer
1741. Impact of diabetes mellitus on complications of chemotherapy and outcomes in older patients with breast cancer
1742. Impact of diabetes mellitus on epithelial ovarian cancer survival
1743. impact of diabetes Mellitus on Head and neck cancer patients Undergoing concurrent chemoradiotherapy
1744. Impact of diabetes Mellitus on Head and Neck cancer Patients Undergoing Concurrent Chemoradiotherapy
1745. Impact of diabetes mellitus on head and neck cancer patients undergoing surgery
1746. Impact of diabetes mellitus on oncological outcomes after radical hysterectomy for early stage cervical cancer
1747. Impact of diabetes mellitus on outcomes in patients with colon cancer
1748. Impact of diabetes Mellitus on Outcomes in Patients With Stage II and III Colon cancer
1749. Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study
1750. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)‐core prostate biopsy
1751. Impact of diabetes mellitus on the outcome of colon cancer
1752. Impact of diabetes mellitus on the outcome of pancreatic cancer
1753. Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis
1754. Impact of diabetes Mellitus on the Treatment Outcomes of Chemotherapy in Women with Breast cancer—A Population-Based Prospective Cohort Study
1755. Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer
1756. Impact of diabetes on cancer chemotherapy outcome: A retrospective analysis.
1757. Impact of diabetes on clinicopathologic and genetic features of colorectal cancer formation.
1758. Impact of diabetes on Colorectal cancer Outcomes
1759. Impact of diabetes on Colorectal cancer Screening Rates in US Adults
1760. Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study
1761. Impact of diabetes on early complications after pancreaticoduodenectomy in patients with pancreatic cancer
1762. Impact of diabetes on oncologic outcome of colorectal cancer patients: colon vs. rectal cancer
1763. Impact of diabetes on outcome and toxicity of neoadjuvant (chemo) radiation for rectal cancer
1764. Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients
1765. Impact of diabetes on postoperative outcomes following colon cancer surgery
1766. Impact of diabetes on prognosis of gastric cancer patients performed with gastrectomy
1767. Impact of diabetes on site-specific oncologic outcome in stage I-III colorectal cancer.
1768. Impact of diabetes on the outcomes of patients with castration-resistant prostate cancer treated with docetaxel: a pooled analysis of three phase III studies
1769. Impact of diabetes status and medication on presentation, treatment, and outcome of stage II colon cancer patients
1770. Impact of diabetes Status on Long Term Oncological Outcome of Stage II Colorectal cancer
1771. Impact of diabetes type II and chronic inflammation on pancreatic cancer
1772. Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor 2–positive primary breast cancer …
1773. Impact of glycemic control and metformin use on the recurrence and progression of non-muscle invasive bladder cancer in patients with diabetes mellitus
1774. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study
1775. Impact of Gonadotropin-releasing Hormone Agonist on Cardiovascular Disease and diabetes Mellitus in Prostate cancer Patients: A Nationwide Population-based …
1776. Impact of improvement of diabetes on survival after radical pancreatic resection in patients with pancreatic cancer and diabetes
1777. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
1778. Impact of metformin on survival in patients with type II diabetes and metastatic colorectal cancer.
1779. Impact of Metformin Use on Survival in Patients with Gastric cancer and diabetes Mellitus Following Gastrectomy
1780. Impact of obesity during adulthood on chronic disease: diabetes, hypertension, metabolic syndrome, cardiovascular disease, and cancer.
1781. Impact of pre-existing type-2 diabetes on patient outcomes after radical resection for gastric cancer: a retrospective cohort study
1782. Impact of socio‐economic status on breast cancer screening in women with diabetes: a population‐based study
1783. Impact of stress on diabetes self-management in cancer survivors.
1784. Impact of the duration of diabetes mellitus (DM) on the outcomes of metastatic pancreatic cancer (mPC) treated with gemcitabine (G): A retrospective study
1785. Impact of the duration of diabetes mellitus on the outcome of metastatic pancreatic cancer treated with gemcitabine: a retrospective study
1786. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
1787. Impact of transcriptional and posttranscriptional regulation of HNF4A and its target genes on diabetes and cancer
1788. Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a …
1789. Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People’s Republic of China
1790. Impact on different type of gastrectomy reconstruction in patients with gastric cancer and diabetes
1791. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer
1792. Impacts of New-Onset and Longstanding diabetes on the Incidence and Mortality of Pancreatic cancer: Population Based Big-Cohort Study.
1793. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
1794. Implications of breast cancer with diabetes mellitus on patient outcomes and care
1795. Implications of pancreatic cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
1796. Implications of prostate cancer with diabetes mellitus on patient outcomes and care: A matched case-control study.
1797. Implications of the hyperinsulinaemia-diabetes–cancer link for preventive efforts.
1798. Implications of type1/2 diabetes mellitus in breast cancer development: a general female population-based cohort study
1799. Importance of diabetes in inhibition of pancreatic cancer by streptozotocin
1800. Importance of glycemic control in cancer patients with diabetes: treatment through end of life
1801. Improve the performance of cancer and diabetes detection using novel technique of machine learning
1802. Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent …
1803. Improvement of type 2 diabetes in a lung cancer patient treated with Erlotinib
1804. Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy
1805. Improving Coordination of Care Among Healthcare Professionals and Patients With diabetes and cancer.
1806. Improving health engagement and lifestyle management for breast cancer survivors with diabetes
1807. Improving lifestyle behaviors after breast cancer treatment among African American women with and without diabetes: Role of health care professionals
1808. Improving Māori access to cancer, diabetes and cardiovascular health care: Key informant interviews
1809. Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical …
1810. Improving prediction accuracy of breast cancer survivability and diabetes diagnosis via RBF networks trained with EKF models
1811. In-vitro analysis of glucose and quercetin effects on m-TOR and Nrf-2 expression in HepG2 cell line (diabetes and cancer connection)
1812. Incidence and mortality risks of cancer in patients with type 2 diabetes: a retrospective study in Shanghai, China
1813. Incidence and peculiarities of thyroid cancer in patients with type 2 diabetes mellitus
1814. Incidence and predictors of all-cause and site-specific cancer in type 2 diabetes: the Fremantle diabetes Study
1815. Incidence and Predictors of diabetes Mellitus after a Diagnosis of Early-Stage Breast cancer in the Elderly Using Real-World Data
1816. Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas
1817. Incidence of bladder cancer in type 2 diabetes mellitus patients: A population-based cohort study
1818. Incidence of breast cancer in women with type 2 diabetes
1819. Incidence of cancer in a population-based cohort of patients with type 2 diabetes
1820. Incidence of carbapenem-resistant Pseudomonas aeruginosa in diabetes and cancer patients
1821. Incidence of diabetes after cancer development: a Korean national cohort study
1822. Incidence of diabetes among patients with colorectal cancer.
1823. Incidence of diabetes among postmenopausal breast cancer survivors
1824. Incidence of diabetes and its predictive factors in cancer patients treated with phosphatidylinositol 3 kinase inhibitors
1825. Incidence of diabetes in colorectal cancer survivors
1826. Incidence of diabetes mellitus, cardiovascular diseases, and cancer in patients undergoing malabsorptive surgery (biliopancreatic diversion and biliointestinal bypass) …
1827. Incidence of human papillomavirus‐related anogenital precancer and cancer in women with diabetes: A nationwide registry‐based cohort study
1828. Incidence of medication-treated depression and anxiety associated with long-term cancer, cardiovascular disease, diabetes and osteoarthritis in community …
1829. Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients
1830. Incidence of Pancreatic cancer Associated Insulin Dependent diabetes at an Inner City Hospital
1831. Incidence of type 2 diabetes among oral cancer patients in Hungary
1832. Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the European Prospective Investigation of cancer–Norfolk cohort: implications for preventive …
1833. Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment
1834. Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
1835. Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts
1836. Increased 30-day Mortality in Patients with diabetes Mellitus Undergoing Surgery for Colorectal cancer
1837. Increased 30-Day Mortality Risk in Patients With diabetes Mellitus After Colon cancer Surgery: A Mediation Analysis
1838. Increased 30‐day mortality in patients with diabetes undergoing surgery for colorectal cancer
1839. Increased cancer incidence around the time of type 2 diabetes diagnosis (ZODIAC-49)
1840. Increased cancer incidence risk in type 2 diabetes mellitus: results from a cohort study in Tyrol/Austria
1841. Increased cancer mortality in type 2 diabetes (ZODIAC-3)
1842. Increased cancer risk with drug use among patients with diabetes: Are the biased methods the culprit?
1843. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin
1844. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.
1845. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Farooki and Schneider
1846. Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate cancer Tissues of Men with Type 2 diabetes
1847. Increased kidney cancer risk in diabetes mellitus patients: a population-based cohort study in Lithuania
1848. Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
1849. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer
1850. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
1851. Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis
1852. Increased risk of cancer death with type 2 diabetes, finds Asian study
1853. Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China
1854. Increased risk of colon cancer in men in the pre-diabetes phase
1855. Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality
1856. Increased risk of kidney cancer in a cohort of Lithuanian diabetes mellitus patients
1857. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer
1858. Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
1859. Increased risk of site-specific cancer in people with type 2 diabetes: a national cohort study
1860. Increased serum levels of betatrophin in pancreatic cancer-associated diabetes
1861. Increased survival in lung cancer patients with diabetes mellitus: A large cohort study
1862. Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer
1863. Incretin-based drugs and the incidence of colorectal cancer in patients with type 2 diabetes
1864. Incretin-based therapy and risk of pancreatic cancer in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
1865. Incretin-Based Therapy and Risk of Pancreatic cancer in Patients with Type 2 diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.: 20
1866. Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes
1867. Incretin‐based therapies and risk of pancreatic cancer in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
1868. Incretins and cancer of the bile duct in type 2 diabetes
1869. Incretins, diabetes, pancreatitis and pancreatic cancer: what the GI specialist needs to know
1870. Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based …
1871. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus
1872. Indispensability of Chemotherapy in Estrogen Receptor–Negative Early Breast cancer in Elderly Women with diabetes Mellitus
1873. Individuals with diabetes Have an Increased Risk of Colon cancer: A Cross-Sectional Analysis: 1073
1874. Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer
1875. Infection, antibiotic therapy and risk of colorectal cancer: A nationwide nested case–control study in patients with Type 2 diabetes mellitus
1876. Infectious and allergic diseases, cancer, and diabetes
1877. Infectious tenosynovitis of the long head of the biceps caused by methicillin-resistant Staphylococcus aureus in a patient with diabetes and small cell lung cancer
1878. Inflammation in Colorectal cancer Inflammatory Bowel Disease, and diabetes Mellitus: The Link
1879. Inflammation, Type 2 diabetes, and cancer: Identifying Biomarkers Associated with Colorectal cancer and Type 2 diabetes, and the Use of microRNA Molecules as a …
1880. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links
1881. Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)
1882. Influence of age on incident diabetes (DM) and cardiovascular disease (CVD) among prostate cancer survivors receiving androgen deprivation therapy (ADT).
1883. Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy
1884. Influence of alimentary tract reconstruction on gastric cancer patients complicated with type 2 diabetes mellitus (a report of 67 cases)
1885. Influence of Breast cancer and Metastases on Incidence of diabetes
1886. Influence of concurrent diabetes mellitus on clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer.
1887. Influence of diabetes Melitus, BMI, and HBA1C in High Grade Prostate cancer
1888. Influence of diabetes mellitus and nodal distribution in endometrial cancer and correlation to clinico-pathological prognostic factors.
1889. Influence of diabetes mellitus on changes in plasma osmotic pressure during bowel preparation in patients undergoing radical resection for colon cancer
1890. Influence of diabetes mellitus on mortality in breast cancer patients
1891. Influence of diabetes mellitus type 2 and prolonged estrogen exposure on risk of breast cancer among women in Armenia
1892. Influence of diabetes on susceptibility to experimental pancreatic cancer
1893. Influence of diabetes on the interpretation of PET scans in patients with esophageal cancer
1894. Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study
1895. INFLUENCE OF DIFFERENT GASTROINTESTINAL RECONSTRUCTIONS ON TYPE Ⅱ diabetes IN PATIENTS WITH DISTAL GASTRIC cancer
1896. Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m2
1897. Influence of Hypertension and diabetes on Postoperative Outcomes In cancer Patients Undergoing Moderate/High Risk Surgical Procedures
1898. Influence of Hypertension on the Survival of Non-Small Cell Lung cancer Patients with Type 2 diabetes Mellitus
1899. Influence of insulin therapy for type 2 diabetes mellitus on cancer incidence.
1900. Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
1901. Influence of pathogenetic factors of type 2 diabetes on activation of PI3K/AkT/mTOR pathway and on the development of endometrial and breast cancer
1902. Influence of Preexisting diabetes on Survival After a Breast cancer Diagnosis in First Nations Women in Ontario, Canada
1903. Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients
1904. INFLUENCE OF TYPE Ⅱ diabetes ON SHORT-TERM SURGICAL OUTCOMES OF PATIENTS WITH GASTRIC cancer
1905. Influence on blood sugar and nutrition indicators from EN or TPN for postoperative patients with gastric cancer and diabetes [J]
1906. Influences from the treatment of thyroid disease and diabetes mellitus on breast cancer prognosis
1907. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus
1908. Innovative approaches in oral, inhalational, and transdermal drug delivery for cancer and diabetes treatment.
1909. Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of β-catenin signaling
1910. Insights into the relationships between diabetes, prediabetes, and cancer
1911. Insulin glargine and cancer risk in patients with diabetes: a meta-analysis
1912. INSULIN RESISTANCE IN PATIENTS WITH PANCREATIC AND COLORECTAL cancer DIAGNOSED AGAINST THE BACKGROUND OF TYPE 2 diabetes …
1913. Insulin Resistance Is a Common Core Tethered to diabetes and Pancreatic cancer Risk
1914. Insulin Resistance, Metabolic Syndrome and diabetes in Women at High Risk for Breast cancer
1915. Insulin therapy and cancer in type 2 diabetes
1916. Insulin therapy and cancer risk in diabetes mellitus
1917. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
1918. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
1919. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta‐analysis of observational studies
1920. Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis
1921. Insulin therapy in diabetes and cancer risk: current understanding and implications for future study
1922. Insulin therapy, duration of diabetes linked to cancer risk
1923. Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies
1924. Insulin use and smoking jointly increase the risk of bladder cancer mortality in patients with type 2 diabetes
1925. Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
1926. Insulin-increasing diabetes therapies raise risk of death from cancer
1927. Insulin-like growth factor genetic variation, colorectal cancer and diabetes
1928. Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer
1929. Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes
1930. Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes
1931. Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
1932. Intake of 12 food groups and disability-adjusted life years from coronary heart disease, stroke, type 2 diabetes, and colorectal cancer in 16 European countries
1933. Intake of dietary saturated fatty acids and risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition-Netherlands cohort …
1934. Intensive glucose control and risk of cancer in patients with type 2 diabetes
1935. Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
1936. Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial
1937. Intensive weight loss intervention and cancer risk in adults with type 2 diabetes: analysis of the Look AHEAD randomized clinical trial
1938. Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients
1939. Interactions between diabetes and cancer
1940. Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer
1941. Interim Report-September 2011 Cohort Study of Pioglitazone and cancer Incidence in Patients with diabetes Mellitus Extended Follow-up (1997-2009)
1942. Interrelationship between oxidative stress, DNA damage and cancer risk in diabetes (Type 2) in Riyadh, KSA
1943. Intersections and clinical translations of diabetes mellitus with cancer promotion, progression and prognosis
1944. Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes
1945. Investigating the Mechanisms Underlying the Link Between diabetes and cancer
1946. Investigation of the biological function of fibroblast activation protein and its potential as a therapeutic target in cancer and diabetes
1947. Investigation of the presence of polymorphism in exons 2 and 3 of the DIRAS3 gene in women with breast cancer and diabetes
1948. Involvement of Adrenomedullin Expression in Tumor Cells and Stroma in the Development of diabetes in Pancreatic cancer Patients
1949. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer
1950. Is cancer incidence different between type 2 diabetes patients compared to non-diabetics in hemodialysis? A study from the REIN registry
1951. Is colorectal cancer associated with diabetes mellitus?
1952. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms
1953. Is diabetes a risk factor for colorectal cancer?
1954. Is diabetes Associated with Progression to Dysplasia or cancer in Barrett’s Esophagus?: 49
1955. Is diabetes mellitus (DM) associated with worse outcomes in pancreatic cancer (PC)?
1956. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
1957. Is diabetes mellitus a prognostic factor for survival in patients with small cell lung cancer?
1958. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States)
1959. Is diabetes mellitus a risk factor for pancreatic cancer?
1960. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?
1961. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort …
1962. Is diabetes mellitus associated with poorly differentiated prostate cancer (PCA)?
1963. Is diabetes mellitus associated with prostate cancer incidence and survival?
1964. Is there a link between BRCA1 and BRCA2 mutations and obesity, high blood pressure and diabetes mellitus in Romanian high-risk breast cancer cases?
1965. Is there any relation between diabetes therapy and cancer risk?
1966. Is there evidence for sex differences in the association between diabetes and cancer?
1967. Is there evidence for sex differences in the association between diabetes and cancer? Reply to Dankner R, Boker LK, Freedman LS
1968. Is type 2 diabetes a risk factor for pancreatic cancer
1969. Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study
1970. Is Type 2 diabetes Mellitus a Risk Factor for Pancreatic cancer and is Metformin Able to Prevent this Risk?
1971. Is Type 2 diabetes Mellitus Causally Associated with cancer Risk? Evidence from a Two-Sample Mendelian Randomisation Study
1972. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
1973. Islet hormone secretion in pancreatic cancer patients with diabetes.
1974. Islet inflammation: a causal link between diabetes and pancreatic cancer?
1975. Isoform-and Paralog-Switching in IR-Signaling: When diabetes Opens the Gates to cancer
1976. Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan
1977. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
1978. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
1979. Killing by lung cancer or by diabetes? The trade-off between smoking and obesity
1980. Knowledge, attitudes, and practices related to pet contact by immunocompromised children with cancer and immunocompetent children with diabetes
1981. KRAS-induced actin-interacting protein: a potent target for obesity, diabetes and cancer
1982. Lactate, a neglected factor for diabetes and cancer interaction
1983. Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood …
1984. Late-onset diabetes and the link with pancreatic cancer
1985. Latest insights into the risk of cancer in diabetes
1986. LEISURE-TIME PHYSICAL ACTIVITY AND THE ONSET OF TYPE 2 diabetes IN THE MALMÖ DIET AND cancer STUDY COHORT
1987. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
1988. Less advanced stages of colon cancer in patients with type 2 diabetes mellitus: an unexpected finding?
1989. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis
1990. Letter to the Editor-The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes
1991. Letter to the Editor: Comments on “Use of metformin and risk of kidney cancer in patients with type 2 diabetes”, Chin‐Hsiao Tseng, Eur J cancer 2016; 52: 19 …
1992. Lifestyle factors and mortality among adults with diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam study
1993. Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer
1994. Linking type 2 diabetes and gynecological cancer: an introductory overview
1995. Links among type 2 diabetes, cancer and metformin use: What have we learned?
1996. Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations
1997. LIVER cancer PREDICTION FOR TYPE-II diabetes USING CLASSIFICATION ALGORITHM.
1998. Liver cirrhosis with high IgG4 in a patient with, diabetes mellitus, ulcerative colitis with papillary thyroid cancer, is it all related? which one to blame& is it time to raise …
1999. Liver enzymes and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition (EPIC)-Potsdam Study
2000. Long non‐coding RNAE330013P06 promotes progression of breast cancer with type 2 diabetes
2001. Long-standing diabetes and its effects on outcomes in colon cancer.
2002. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis
2003. Long-term diabetes mellitus is associated with an increased risk of pancreatic cancer: a meta-analysis
2004. Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study
2005. Long-term diabetes risk among ovarian cancer survivors in a population-based cohort study
2006. Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort
2007. Long-term follow-up for type 2 diabetes mellitus after gastrectomy in non-morbidly obese patients with gastric cancer: the legitimacy of onco-metabolic surgery
2008. Long-term Mortality in cancer Patients With Preexisting diabetes
2009. Long-term Mortality in cancer Patients With Preexisting diabetes—Reply
2010. Long-term use of long-acting insulin analogs and breast cancer incidence in women with type 2 diabetes
2011. Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus
2012. Loss of microRNA expression is involved in the development and prognosis of breast cancer complicated by Type 2 diabetes mellitus
2013. Low cancer death rate in chronic dialysis patients with diabetes mellitus
2014. Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong diabetes Registry
2015. Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry
2016. Low National Breast and Cervical cancer Screening Rates in American Indian and Alaska Native Women with diabetes
2017. Low national breast and cervical cancer-screening rates in American Indian and Alaska Native women with diabetes
2018. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmö Diet and cancer study
2019. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong diabetes Registry
2020. Low-dose aspirin reduces breast cancer risk in women with diabetes: a nationwide retrospective cohort study in Taiwan
2021. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes
2022. Lung cancer and diabetes: A role for advanced glycation end‐products?
2023. Lung cancer presenting as Central diabetes Insipidus
2024. Lung cancer risk, diabetes, and diabetes treatments.
2025. MA06. 07 Impact of Type 2 diabetes Mellitus and Its Metabolic Control on Prognosis of Unresectable Non-Small Cell Lung cancer Patients
2026. Machine Learning in Healthcare: Breast cancer and diabetes Cases
2027. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer
2028. Mammary Adipose Tissue Control of Breast cancer Progression: Impact of Obesity and diabetes
2029. Management of colorectal cancer and diabetes
2030. Management of comorbid diabetes and cancer in the elderly
2031. Management of comorbid diabetes and cancer.
2032. Management of diabetes and pancreatic cancer.
2033. Management of diabetes in patients with cancer
2034. Management of diabetes mellitus in terminally ill cancer patients
2035. Managing diabetes in cancer patients
2036. Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines
2037. Managing people with diabetes during the cancer palliation in the era of simultaneous care
2038. Mandibular reconstruction using 2-step bone transport in an irradiated cancer patient with type 2 diabetes mellitus
2039. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension
2040. Mass spectrometry in the analysis of peptides involved in cancer, diabetes and long-term memory
2041. Maternal diabetes and incidence of childhood cancer–a nationwide cohort study and exploratory genetic analysis
2042. Maternal diabetes and risk of childhood cancer in the offspring
2043. Maternal perceptions of paediatric cancer and diabetes in Cameroon
2044. Maternal pre-pregnancy and gestational diabetes, obesity, gestational weight gain, and risk of cancer in young children: a population-based study in California
2045. Mathematical Medicine: Modeling Disease and Treatment Key words: Immune dynamics; cancer; diabetes; Ordinary differential equations
2046. Matricaria Chamomile Protective Effect Against Type-2 diabetes Mellitus and cancer Cell Linings
2047. Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus
2048. Measures of impact: diabetes and urothelial cancer
2049. Mechanism (s) of pancreatic cancer-induced diabetes
2050. Mechanism of protein kinase B activation by insulin IGF1 revealed by specific inhibitors of the phosphoinositide 3-kinase. Significance for diabetes and cancer
2051. Mediation of black/white disparities in triple negative breast cancer by socioeconomic position, reproductive factors and diabetes in the Nurses’ Health Study Cohorts I …
2052. Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer
2053. Mediterranean diet and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition (EPIC) study: the InterAct project
2054. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 diabetes and cancer
2055. Meta-analysis of androgen deprivation therapy for prostate cancer related with diabetes
2056. Meta-analysis of mitochondrial T16189C polymorphism for cancer and Type 2 diabetes risk
2057. Meta-analysis of the relationship between type 2 diabetes and the risk of kidney cancer
2058. Meta‐analysis of the association between sodium‐glucose co‐transporter‐2 inhibitors and risk of skin cancer among patients with type 2 diabetes
2059. Metabolic Adaptations in diabetes Mellitus and cancer
2060. Metabolic reprogramming in type 2 diabetes and the development of breast cancer
2061. Metabolic syndrome and diabetes mellitus in childhood cancer survivors.
2062. Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways
2063. Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition-Potsdam Study
2064. Metabolic syndrome, diabetes mellitus, and the subsequent development of prostate cancer
2065. Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms
2066. Metastatic breast cancer presenting with diabetes insipidus
2067. Metastatic breast cancer presenting with diabetes insipidus.
2068. Metformin (M), diabetes (DM), and colorectal cancer (CRC) survival among US veterans.
2069. Metformin ameliorates testicular damage in diabetes and prostate cancer model
2070. Metformin and biliary tract cancer in patients with type 2 diabetes
2071. Metformin and breast and gynecological cancer risk among women with diabetes
2072. Metformin and cancer in type 2 diabetes
2073. Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
2074. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan
2075. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus
2076. Metformin and Gastrointestinal cancer Development in Newly Diagnosed Type 2 diabetes: A Population-Based Study in Korea
2077. Metformin and lung cancer risk in patients with type 2 diabetes mellitus
2078. Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta‑analysis
2079. Metformin and pancreatic cancer risk in patients with type 2 diabetes
2080. Metformin and pancreatic cancer risk in Taiwanese patients with type 2 diabetes
2081. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal cancer and diabetes in Mice
2082. Metformin and reduced risk of cancer in the Hong Kong diabetes registry: real effect or immortal time bias?
2083. Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis
2084. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus
2085. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies
2086. Metformin and the incidence of cancer in patients with diabetes: a nested case-control study
2087. Metformin and the incidence of prostate cancer in patients with type 2 diabetes
2088. Metformin and the incidence of prostate cancer in patients with type 2 diabetes
2089. Metformin and the risk of cancer in type 2 diabetes: methodological challenges and perspectives
2090. Metformin as a risk factor of pathogenesis of colorectal cancer in type 2 diabetes patients: a Meta-analysis
2091. Metformin associated with increased survival in type 2 diabetes patients with pancreatic cancer and lymphoma
2092. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16
2093. Metformin Associates With Aggressive Features of Endometrial cancer in Women With Type 2 diabetes
2094. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis
2095. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
2096. Metformin depresses overactivated Notch1/Hes1 signaling in colorectal cancer patients with type 2 diabetes mellitus
2097. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes
2098. Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes
2099. Metformin effect on clinical course of non-small cell lung cancer (NSCLC) in patients (pts.) with concomitant diabetes mellitus (DM) after radical resection.
2100. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis
2101. Metformin for primary colorectal cancer prevention in patients with diabetes: A case‐control study in a US population
2102. Metformin for Reducing Racial/Ethnic Difference in Prostate cancer Incidence for Men with Type 2 diabetes Running title: Metformin for Reducing Prostate cancer …
2103. Metformin for reducing racial/ethnic difference in prostate cancer incidence for men with type II diabetes
2104. Metformin has a positive therapeutic effect on prostate cancer in patients with type 2 diabetes mellitus
2105. Metformin Impacts the Prognosis of cancer Patients with Type 2 diabetes
2106. Metformin improves overall survival of colorectal cancer patients with diabetes: a meta-analysis
2107. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer
2108. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis
2109. Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer
2110. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
2111. Metformin Inhibits Thyrocyte Growth and Increases Complete Responses in Differentiated Thyroid cancer in Patients with diabetes
2112. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: a retrospective cohort analysis
2113. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes
2114. Metformin is associated with reduced odds for colorectal cancer among persons with diabetes
2115. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
2116. Metformin is associated with slightly reduced risk of colorectal cancer and moderate survival benefits in diabetes mellitus: a meta-analysis
2117. Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis
2118. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
2119. Metformin May Cut Risk of cancer in Type 2 diabetes
2120. Metformin may reduce bladder cancer risk in patients with type 2 diabetes
2121. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes
2122. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes
2123. Metformin may reduce oral cancer risk in patients with type 2 diabetes
2124. Metformin Prevents cancer in Type 2 diabetes
2125. Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs
2126. Metformin protects against diabetes–induced heart injury and dunning prostate cancer model
2127. Metformin reduces colon cancer risk in patients with type 2 diabetes: a retrospective cohort analysis
2128. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus
2129. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus
2130. Metformin Reduces Radiation-Induced Cardiac Toxicity Risk in Patients Having diabetes and Breast cancer: Results from the Taiwan National Cohort and Basic …
2131. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National diabetes Program Cohort
2132. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes
2133. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus
2134. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
2135. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
2136. Metformin therapy associated with survival benefit in lung cancer patients with diabetes
2137. Metformin treatment and cancer risk: Cox regression analysis, with time-dependent covariates, of 320,000 persons with incident diabetes mellitus
2138. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
2139. Metformin use and cervical cancer risk in female patients with type 2 diabetes
2140. Metformin use and its effect on gastric cancer in patients with type 2 diabetes: a systematic review of observational studies
2141. Metformin use and kidney cancer outcomes in patients with diabetes: a propensity score analysis
2142. Metformin use and lung cancer risk in patients with diabetes
2143. Metformin use and pancreatic cancer survival among non-Hispanic White and African American US veterans with diabetes mellitus
2144. Metformin use and pancreatic cancer survival in US veterans with diabetes mellitus: Are there racial differences?
2145. Metformin use and renal cell cancer outcomes among patients with diabetes.
2146. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural …
2147. Metformin use and risk of lung cancer in patients with diabetes.
2148. Metformin Use and the Incidence of Colorectal and Lung cancer in Patients with Type 2 diabetes Mellitus
2149. Metformin use and the risk of cancer in patients with diabetes: A nationwide sample cohort study
2150. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
2151. Metformin Use for diabetes May Reduce cancer Risk in DM1
2152. Metformin use is associated with better survival of breast cancer patients with diabetes: a meta-analysis
2153. Metformin—mode of action and clinical implications for diabetes and cancer
2154. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells
2155. Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis
2156. Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells
2157. Metformin, diabetes, and survival among US veterans with colorectal cancer
2158. Metformin, diabetes, and Survival among US Veterans with Colorectal cancer
2159. Metformin, diabetes, and Survival among US Veterans with Colorectal cancer—Response
2160. METFORMIN, STATINS AND THE RISK AND PROGNOSIS OF ENDOMETRIAL cancer IN WOMEN WITH TYPE 2 diabetes
2161. Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
2162. Metformin: a bridge between diabetes and prostate cancer
2163. Metformin: a salutary candidate for colorectal cancer treatment in patients with diabetes
2164. Metformin: on ongoing journey across diabetes, cancer therapy and prevention
2165. Metformin: Possible Use of a diabetes Drug in Treatment of cancer
2166. Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer
2167. Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
2168. Metrics of diabetes risk are only minimally improved by exercise training in postmenopausal breast cancer survivors
2169. MicroRNA-30b is involved in the pathological process of diabetes mellitus induced by pancreatic cancer by regulating plasminogen activator inhibitor-1
2170. MicroRNA, diabetes Mellitus and Colorectal cancer
2171. MicroRNAs 103 and 107 link type 2 diabetes and post-menopausal breast cancer
2172. MicroRNAs 103 and 107: potential molecular links between diabetes and cancer
2173. Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer
2174. Microvascular reconstruction in elderly oral cancer patients: does diabetes status have a predictive role in free flap complications?
2175. Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
2176. Midlife cancer/diabetes and risk of dementia and mild cognitive impairment: A population-based prospective cohort study in Japan
2177. Milk intake and the risk of type 2 diabetes mellitus, hypertension and prostate cancer
2178. MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus
2179. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the ‘minute and miracle’molecule moving as a monitor in the ‘genomic galaxy’
2180. Mitochondrial dynamics in type 2 diabetes and cancer
2181. Modalities for assessing the nutritional status in patients with diabetes and cancer
2182. Model Checking a Synchronous diabetes–cancer Logical Network
2183. Model Checking of a diabetes‐cancer Model
2184. Model to determine risk of pancreatic cancer in patients with new-onset diabetes
2185. Model to Determine Risk of Pancreatic cancer in Patients with New-onset diabetes Running title: END-PAC Risk Stratification Score
2186. Model-based in silico analysis of the PI3K/Akt pathway: the elucidation of cross-talk between diabetes and breast cancer
2187. Modeling effects of diabetes and obesity co-morbidities in endometrial cancer development and progression
2188. Moderating effects of sleep duration on diabetes risk among cancer survivors: Analysis of the National Health Interview Survey in the USA
2189. Modern Eggs, Not Wild Type Eggs, Predispose Risk of Cardiovascular Disease, diabetes and cancer?
2190. Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients
2191. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival
2192. Modifications of fibronectin in age-related diseases: diabetes and cancer
2193. Molecular Correlations between Breast cancer and diabetes Mellitus Type 2 Examined by In Silico analyses and Drug Inhibitory Effects
2194. Molecular evidence of field cancerization initiated by diabetes in colon cancer patients
2195. Molecular mechanisms and therapeutic effects of (−)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration
2196. Molecular mechanisms of metformin for diabetes and cancer treatment
2197. Molecular mechanisms of the cross-impact of pathological processes in combined diabetes and cancer. Research and clinical aspects
2198. Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2 diabetes and cancer
2199. Molecular targets of functional foods and bioactive compounds in the prevention of type 2 diabetes and colon cancer
2200. MON-008 Use of National Death Index to Assess cancer Mortality and diabetes Relationship
2201. MON-116 Metabolic Parameters in cancer Patients with and Without diabetes Mellitus
2202. MON-678 Worsening diabetes Control in Breast cancer Patients Treated with Alpelisib
2203. MON-LB306 Association Between cancer Related Beliefs and diabetes Medication Adherence Among Breast cancer Survivors With Comorbid Type 2 diabetes
2204. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment
2205. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based …
2206. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment:(questionable) classification of diabetic patients based on …
2207. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
2208. Mortality and glycemic control among patients with diabetes mellitus and uterine or ovarian cancer
2209. Mortality and glycemic control among patients with gastric and esophageal cancer and diabetes mellitus.
2210. Mortality causes in cancer patients with type 2 diabetes mellitus
2211. Mortality trends of liver cancer among patients with type 2 diabetes at the global and national level
2212. MP-1.06: Is diabetes Mellitus Associated with Aggressive Characteristics in Prostate cancer?
2213. MP36-16 EFFECTS OF diabetes ON RENAL cancer PROGNOSIS
2214. MP37-08 THE ASSOCIATION BETWEEN diabetes AND PROSTATE cancer-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER …
2215. MP54-12 diabetes MELLITUS IS ASSOCIATED WITH AN INCREASED RISK OF cancer-SPECIFIC MORTALITY AMONG PATIENTS WITH CLEAR CELL RENAL …
2216. MP59-12 IS diabetes MELLITUS ASSOCIATED WITH cancer SPECIFIC AND OVERALL SURVIVAL IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA?
2217. MP72-13 OUTCOMES OF RADICAL CYSTECTOMY IN PATIENTS WITH BLADDER cancer AND UNCONTROLLED diabetes: A POPULATION-BASED STUDY
2218. MP77-03 diabetes MELLITUS INCREASES BLADDER cancer RECURRENCE RISK IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
2219. MP77-14 diabetes MELLITUS, METFORMIN AND PROSTATE cancer: RESULTS OF A PROSTATE cancer DATABASE ANALYSIS
2220. mTOR Complex1–S6K1 signaling: at the crossroads of obesity, diabetes and cancer
2221. mTOR: from growth signal integration to cancer, diabetes and ageing
2222. Multicenter results of long-limb bypass reconstruction after gastrectomy in patients with gastric cancer and type II diabetes
2223. Multiple autoimmunity, type 1 diabetes (T1DM), autoimmune thyroiditis and thyroid cancer: is there an association? A case report and literature review
2224. Multivariate analysis on the effects of diabetes and related clinical parameters on cervical cancer survival probability
2225. Mutant p53 and HbA1c in Type 2 diabetes Melitus Patients With and Without cancer
2226. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer
2227. Mycobacterium neoaurum Bloodstream Infection Associated with a Totally Implanted Subclavian Port in an Adult with diabetes and History of Colon cancer
2228. Myelotoxicity of cyclophosphamide, methotrexate and 5-fluorouracil regimen in the early stage breast cancer patients with diabetes mellitus
2229. Nanomedicine: cancer, diabetes, and cardiovascular, central nervous system, pulmonary and inflammatory diseases
2230. Nanoparticle-Based Delivery of Phytochemical Compounds Against Major Maladies: cancer, diabetes, and Cardiovascular Disease
2231. Nanowires for early cancer and diabetes diagnosis via micro-RNA detection in urine extracellular vesicles
2232. NATIONAL ESTIMATES OF UTILIZATION AND EXPENDITURES FOR PATIENTS WITH diabetes AND cancer
2233. Nationwide trends in pancreatitis and pancreatic cancer risk among patients with newly diagnosed type 2 diabetes receiving dipeptidyl peptidase 4 inhibitors
2234. NCOA5, a molecular link between type 2 diabetes and liver cancer
2235. Neither hormonal factors nor AGEs explain lower prostate cancer risk in older men with diabetes mellitus
2236. Nephrogenic diabetes insipidus. An unusual presentation of recurrent rectal cancer
2237. Nerve growth factor as an important possible component of novel therapy for cancer, diabetes and cardiovascular diseases
2238. Neurogenic diabetes insipidus: an unusual clinical presentation of small cell lung cancer.
2239. Neuronatin gene: imprinted and misfolded: studies in Lafora disease, diabetes and cancer may implicate NNAT-aggregates as a common downstream …
2240. New diabetes drug: Colon cancer friend or foe?
2241. New insight into metformin action: diabetes, prostate cancer, ion channels
2242. New insights in the molecular pathways linking obesity, type 2 diabetes and cancer
2243. New insights into pancreatic cancer-induced paraneoplastic diabetes
2244. New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review
2245. NEW ONSET TYPE 1 diabetes AFTER DOUBLE IMMUNOTHERAPY FOR NEUROENDOCRINE LUNG cancer
2246. New resveratrol analogues for potential use in diabetes and cancer
2247. New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes
2248. New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study
2249. New-onset diabetes and pancreatic cancer
2250. New-onset diabetes as an early sign of pancreatic cancer
2251. New-Onset diabetes Confers Increased Risk for Pancreatic cancer in a Large Cohort of US Veterans: 732
2252. New-onset diabetes in pancreatic cancer: a study in the primary care setting
2253. New-onset diabetes mellitus and risk of pancreatic cancer: A systematic review and meta analysis.
2254. New-onset diabetes patients need pancreatic cancer screening?
2255. New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer
2256. New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population
2257. New-onset diabetes: a clue to the early diagnosis of pancreatic cancer
2258. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
2259. New-onset diabetes: aclue to the early diagnosis of pancreatic cancer/Mechanism (s) of pancreatic cancer-induced diabetes
2260. New-Onset or Exacerbation of diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic cancer
2261. New-onset type 2 diabetes mellitus–a high-risk group suitable for the screening of pancreatic cancer?
2262. New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer
2263. Newly Diagnosed diabetes Mellitus With Pancreatic cancer Manifested as Hyperglycemic Hyperosmolar State
2264. Newly diagnosed type 2 diabetes may serve as a potential marker for pancreatic cancer
2265. News Briefs: Advances in Diagnosis/Treatment Options For diabetes, cancer, Incontinence, Peyronie’s Disease
2266. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer
2267. NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer
2268. No Association of Obesity and Type 2 diabetes Mellitus Related Genetic Variants With Colon cancer
2269. No association of risk variants for diabetes and obesity with breast cancer: the Multiethnic Cohort and PAGE studies
2270. No association of type 2 diabetes risk variants and prostate cancer risk: the multiethnic cohort and PAGE
2271. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
2272. No effect of season of birth on risk of type 1 diabetes, cancer, schizophrenia and ischemic heart disease, while some variations may be seen for pneumonia and …
2273. Non-coding RNAs in IGF-1R signaling regulation: the underlying pathophysiological link between diabetes and cancer
2274. Non-enzymatic glycation of proteins: from diabetes to cancer
2275. Non-enzymatic glycation of proteins: from diabetes to cancer
2276. Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
2277. Novel blood biomarkers of pancreatic cancer–associated diabetes mellitus identified by peripheral blood–based gene expression profiles
2278. Novel cancer therapies and their association with diabetes
2279. Novel strategies halt cardiovascular, diabetes, and cancer strips
2280. Nuclear factor kappa B (NF-κB): a novel cause for diabetes, coronary artery disease and cancer initiation and promotion?
2281. Number of amalgam fillings in relation to cardiovascular disease, diabetes, cancer and early death in Swedish women
2282. Nursing evaluation on early enteral nntrition after operation inpatients of careinoma of stomach cancer complicated with diabetes [J]
2283. Nursing for 49 Cases of Lung cancer Complicated with diabetes Mellitus at Chemotherapy [J]
2284. Nursing intervention on senile rectal cancer complicated with diabetes
2285. Nursing on cancer patients with diabetes treated by chemotherapy regimen including taxanes agents
2286. Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis
2287. Nutrient Regulation of Transcription & Signaling by O-GlcNAc: Fundamental Roles in diabetes, Neurodegeneration and cancer
2288. Nutrition and triple major risk of abdominal obesity: type 2 diabetes mellitus, cardiovascular diseases and cancer.
2289. Nutrition Interventions and Self-Management in Patients with Comorbid cancer and diabetes: A Narrative Review
2290. Nutrition Update: Pancreatic cancer and diabetes
2291. Nutrition, diabetes, and cancer
2292. Nutritional care with diabetes and ENT cancer
2293. Nutritional fats and the risk of type 2 diabetes and cancer
2294. Nutritional status and survival of 8247 cancer patients with or without diabetes mellitus—results from a prospective cohort study
2295. Nutritional therapy of cancer with diabetes mellitus [J]
2296. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
2297. Obesity and diabetes as prognostic factors in patients with colorectal cancer
2298. Obesity And diabetes Can Cause cancer
2299. Obesity and diabetes: the increased risk of cancer and cancer-related mortality
2300. Obesity and the risk of type 2 diabetes mellitus and certain types of cancer
2301. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence
2302. Obesity as a factor in the development of cancer in type 2 diabetes
2303. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus
2304. Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis
2305. Obesity, diabetes and Breast cancer: Defining Metabolic Oncogenesis
2306. Obesity, diabetes and cancer: a mechanistic perspective
2307. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency
2308. Obesity, diabetes and the risk of colorectal adenoma and cancer
2309. Obesity, diabetes and the Risk of Colorectal Adenoma and cancer
2310. Obesity, diabetes mellitus and vascular disease: a complex relationship with prostate cancer
2311. Obesity, diabetes mellitus, and cancer
2312. Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
2313. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis
2314. Obesity, diabetes, and risk of cancer
2315. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial
2316. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
2317. Obesity, diabetes, cancer and cardiovascular risk: a trans-generational network
2318. Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup study
2319. Obesity, diabetes, the cardiorenal syndrome, and risk for cancer
2320. OBESITY, HYPERINSULINEMIA, IGF-1, AND HYPERGLYCEMIA AS RISK FACTORS FOR COLORECTAL cancer IN PATIENTS WITH TYPE 2 diabetes …
2321. Obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer
2322. Obesity, type 2 diabetes and cancer
2323. Obesity, Type 2 diabetes and cancer Risk
2324. Obesity, type 2 diabetes and risk of digestive cancer
2325. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
2326. Obesity, Type 2 diabetes, and cancer: The Insulin and Insulin-Like Growth Factor Connection.
2327. Obesity, type-2 diabetes and cancer: mechanistic insights
2328. Obesity: Is it an Independent Risk Factor for diabetes and cancer
2329. Observation of application mode of insulin in perioperative colon cancer patients with diabetes mellitus
2330. Observation of different infusion methods of insulin in TPN in gastric cancer patients with diabetes after operation
2331. Occult colon cancer in a patient with diabetes and recurrent Klebsiella pneumoniae liver abscess
2332. Older adults with diabetes and cancer: Impact on diabetes self-management
2333. Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes …
2334. On the Correlation Between the” Corrected” cancer and diabetes Deathrates
2335. On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment
2336. Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer
2337. Oncogenic Function of a diabetes Target SHIP2 Presents Novel cancer Therapeutic and Preventive Opportunities
2338. Opioids and risk of type 2 diabetes in adults with non-cancer pain
2339. Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus
2340. Optimal glycemic target level for colon cancer patients with diabetes
2341. OPTIMIZING LIFESTYLE REDUCES THE RISK OF cancer IN diabetes
2342. Oral cancer in Taiwan: is diabetes a risk factor?
2343. ORAL CONDITIONS OF cancer PATIENTS ASSOCIATED WITH diabetes AND ARTERIAL HYPERTENSION: CASE REPORT
2344. Oral Glucose Lowering Agents and cancer in Type 2 diabetes Mellitus: Focus on Sulphonylurea Derivatives
2345. Oral Insulin Secretagogues and cancer Risk in Type 2 diabetes Mellitus: An Updated Review
2346. Oral insulin secretagogues, insulin, and cancer risk in type 2 diabetes mellitus
2347. Orbital Cellulitis Following Hordeolum in an Immunocompromised Patient with diabetes and Breast cancer-A Case Report
2348. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN
2349. Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
2350. Our experience with pancreatic cancer and its relation to diabetes mellitus
2351. Outcome after curative surgery for gastric cancer patients with type 2 diabetes
2352. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes
2353. Outcome effectiveness of therapeutic recreation camping program for adolescents living with cancer and diabetes
2354. Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer
2355. Ovarian cancer Increases the Risk of Stroke, but Not in Patients with Hypertension, diabetes or Both
2356. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts
2357. Overall Survival Found Worse in Study of Prostate cancer Patients with diabetes, but Applicability for Now Probably Limited
2358. Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle
2359. Oxidative Stress and its Clinical Consequences: Relationship between diabetes and cancer
2360. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer
2361. P-238 Metformin reduces biliary tract cancer in patients with type 2 diabetes
2362. P-268 diabetes and risk of pancreatic cancer
2363. P-glycoprotein associated with diabetes mellitus and survival of patients with pancreatic cancer: 8-year follow-up
2364. P0194 Association between abdominal obesity and type 2 diabetes and HSP70-2 (+ 1267) gene mutation in colorectal cancer
2365. P0293 PANDORA’S BOX–diabetes INSIPIDUS UNVEILS METASTATIC cancer
2366. P1-08-06: Breast cancer among Patients with diabetes, Obesity and Abnormal Blood Lipids–A Population-Based Register Study in Sweden.
2367. P5496 Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review …
2368. Painful neuropathy in a diabetic patient resulting from lung cancer and not diabetes: A case report
2369. Pan-PPAR Agonists as Potential Treatments for Type 2 diabetes, and the Effect of Adipocyte-derived Fatty Acids in Breast cancer Therapy
2370. Pancreatic cancer and diabetes
2371. Pancreatic cancer and diabetes
2372. Pancreatic cancer and diabetes
2373. Pancreatic cancer and diabetes mellitus
2374. Pancreatic cancer and diabetes mellitus
2375. Pancreatic cancer and diabetes mellitus
2376. Pancreatic cancer and diabetes mellitus: A retrospective cohort study.
2377. Pancreatic cancer and diabetes: a two-way relationship in the perspective of diabetologist
2378. Pancreatic cancer and diabetes: Is diabetes a risk factor or the outcome?
2379. Pancreatic cancer and diabetes: is there a relationship? A case‐controlled study
2380. Pancreatic cancer and its Relationship to New-onset Type 2 diabetes Mellitus
2381. Pancreatic cancer and sugar diabetes
2382. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
2383. Pancreatic cancer following incident diabetes in African Americans and Latinos: the multiethnic cohort
2384. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
2385. Pancreatic cancer manifesting as Sister Mary Joseph nodule during follow up of a patient with type 2 diabetes mellitus: A case report
2386. Pancreatic cancer presenting as new-onset diabetes
2387. Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells
2388. Pancreatic cancer–association with diabetes mellitus and smoking
2389. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications
2390. Pancreatic cancer-Associated diabetes: Is a Nihilistic Approach Justifiable
2391. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?
2392. Pancreatic cancer-induced diabetes: a call to action
2393. Pancreatic cancer–associated diabetes is an “exosomopathy”
2394. Pancreatic cancer–Associated diabetes is Clinically Distinguishable From Conventional diabetes
2395. Pancreatic cancer–associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer
2396. Pancreatic cancer, alcohol, diabetes mellitus and gall‐bladder disease
2397. Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes
2398. Pancreatic cancer: The importance of screening in atypical diabetes presentations.
2399. Pancreatic expression of immunoglobulin G in human pancreatic cancer and associated diabetes
2400. Pancreatic polypeptide response to a mixed meal is blunted in pancreatic head cancer associated with diabetes mellitus
2401. Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized …
2402. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop
2403. Pancreatitis, pancreatic cancer, and diabetes
2404. Partial cranial diabetes insipidus in breast cancer: invisible pituitary metastases or uncanny coincidence
2405. Pathogenegenetic mechanisms of oncogenesis in diabetes mel litus and analysis of cancer incidence in patients w ith diabetes mellitus in the Precarpathian region
2406. Pathogenesis of Pancreatic cancer-Related diabetes Mellitus: Quo Vadis?
2407. Pathogenic bacteria distribution and drug resistance of postoperative infection in elderly patients with gastric cancer complicated with diabetes mellitus
2408. Pathologic and molecular characteristics of colorectal cancer in patients with type 2 diabetes
2409. Pathophysiological link between diabetes and colorectal cancer: effect of diabetic microenvironment, metformin and 5-fluorouracil on AMPK activation, apoptosis and …
2410. Patient outcomes from lung cancer and diabetes mellitus: a matched case–control study
2411. Patient-centered prevention strategies for cardiovascular disease, cancer and diabetes
2412. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer
2413. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study
2414. Pay more attention to the study of the relationship between diabetes mellitus and cancer
2415. PCN173 EFFECT OF METFORMIN ON SURVIVAL AMONG OVARIAN cancer PATIENTS WITH COMORBID diabetes: A SYSTEMATIC REVIEW AND …
2416. PD12-4: THE IMPACT OF diabetes MELLITUS ON PATIENTS RECEIVING ROBOTIC ASSISTED RADICAL PROSTATECTOMY FOR PROSTATE cancer
2417. PD13-09 diabetes SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE …
2418. PD19-02 diabetes MELLITUS AND PROSTATE cancer RISK IN A SINGLE INSTITUTIONAL BIOPSY SERIES
2419. PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
2420. Peer Reviewed: A diabetes Pay-for-Performance Program and Risks of cancer Incidence and Death in Patients With Type 2 diabetes in Taiwan
2421. Peer Reviewed: Associations Between Colorectal cancer Screening and Glycemic Control in People With diabetes, Boston, Massachusetts, 2005-2010
2422. Peer reviewed: diabetes status and being up-to-date on colorectal cancer screening, 2012 behavioral risk factor surveillance system
2423. Pemetrexed-induced acute renal failure, nephrogenic diabetes insipidus, and renal tubular acidosis in a patient with non-small cell lung cancer
2424. Perceived Determinants of cancer Screenings in Women with diabetes
2425. Perceived experiences of discrimination in health care: a barrier for cancer screening among American Indian women with type 2 diabetes
2426. Perceived impact of cancer treatment on diabetes self-management
2427. Perceived impact of diabetes management in patients with cancer: the experience of a tertiary referral center
2428. Perceived medical discrimination in American Indian women: Effect on health care decisions, cancer screening, diabetes services and diabetes management
2429. Performance analysis of Machine learning classifiers for predicting diabetes and prostate cancer
2430. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
2431. Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease—is there cause for …
2432. PERIOPERATIONAL MANAGEMENT OF CARDIAC cancer & ITS CONCOMITANT diabetes MELLITUS
2433. Perioperative Management for Patients with Esophageal and Cardiac cancer Complicated with diabetes Mellitus [J]
2434. Perioperative Management of 288 Cases with Esophageal cancer or Cardiac cancer Complicated with diabetes Mellitus
2435. Perioperative management of colonrectal cancer patients with diabetes mellitus
2436. Perioperative management of esophageal cancer patients concomitent with diabetes
2437. Perioperative management of esophageal cancer patients concomitent with diabetes [J]
2438. Perioperative management of gastric cancer with diabetes [J]
2439. Perioperative management of large bowel cancer patients with diabetes mellitus
2440. Perioperative management of patients of colonorectal cancer with diabetes mellitus
2441. Perioperative Nursing for the Patients with Breast cancer Combined with diabetes Mellitus [J]
2442. Perioperative nursing in patients with rental cancer complicated with diabetes [J]
2443. Perioperative nursing of cervical cancer patients with diabetes mellitus
2444. Perioperative nutrition support for esophageal cancer complicated with diabetes mellitus
2445. Perioperative Treatment of Gastrointestinal cancer Combined with diabetes
2446. Perioperative treatment of patients with colorectal cancer and diabetes [J]
2447. Perioperative treatment of patients with gastric cancer complicated with diabetes
2448. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer
2449. Peroxisome proliferator-activated receptor gamma (PPARγ) as a target for concurrent management of diabetes and obesity-related cancer
2450. Personal history of diabetes as important as family history of colorectal cancer for risk of colorectal cancer: a nationwide cohort study
2451. Personalized diabetes and cancer medicine: A rationale for anti-diabetic nutrition (bitter melon) in a supportive setting
2452. Personalized indicator thrombocytosis shows connection to staging and indicates shorter survival in colorectal cancer patients with or without type 2 diabetes
2453. Pharmacogenomics-Personalized treatment of cancer, diabetes and cardiovascular diseases
2454. Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies
2455. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer
2456. Pharmacotherapy of diabetes and cancer risk
2457. Phosphate diabetes associated with bone metastases of oat cell lung cancer.
2458. Phosphorylation of PRAS40 in leukocytes of patients with cancer and diabetes
2459. Phosphorylation of Protein Kinase Akt by Mtorc2 in Peripheral Blood Mononuclear Cells of Patients with cancer and diabetes.
2460. Physical activity and mental distress among Veteran cancer survivors with heart disease and diabetes
2461. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response …
2462. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis
2463. Physical activity, diabetes, and thyroid cancer risk: a pooled analysis of five prospective studies
2464. Picture quiz: diabetes insipidus in a woman with breast cancer
2465. Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
2466. Pioglitazone and lung cancer risk in Taiwanese patients with type 2 diabetes
2467. Pioglitazone and oral cancer risk in patients with type 2 diabetes
2468. Pioglitazone and risk of bladder cancer in type 2 diabetes mellitus patients: A systematic literature review and meta-analysis of observational studies using real-world …
2469. Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes 2
2470. Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes
2471. Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study
2472. Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis
2473. Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes
2474. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
2475. Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis
2476. Pituitary metastasis from breast cancer presenting as diabetes insipidus
2477. Pituitary metastasis: lung cancer presenting as bitemporal hemianopsia with diabetes insipidus and anterior pituitary deficiency
2478. Pituitary stalk metastasis from lung cancer, preceding diabetes insipidus–case report and clinical review of the literature
2479. Plasma adropin as a potential marker predicting obesity and obesity-associated cancer in Korean patients with type 2 diabetes mellitus
2480. Plasma Lipidome and Prediction of Type 2 diabetes in the Population-Based Malmö Diet and cancer Cohort
2481. Plasma metals and cancer incidence in patients with type 2 diabetes
2482. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality
2483. Plasma-free amino acid profiles are predictors of cancer and diabetes development
2484. Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer
2485. Platelet Hyperactivity and Dysfunction in diabetes and cancer
2486. Pleiotropic effects of single nucleotide polymorphophisms of EDIL3 gene: Association with cancer, obesity, and type 2 diabetes
2487. Pleiotropy and pathway analyses of genetic variants associated with both type 2 diabetes and prostate cancer
2488. Pneumonia, diabetes and prostate cancer
2489. PO-240 WWOX suppressor gene regulate glucose metabolism and warburg effect in case of gestational diabetes mellitusas well as breast cancer
2490. POD-11.08: diabetes and risk of death from cancer of the prostate, kidney, and urinary bladder
2491. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study
2492. Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus
2493. Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population
2494. Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the …
2495. Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states
2496. Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
2497. Population-based estimation of mortality and occurrence of cancer in patients with and without diabetes in Pune
2498. Population‐based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women
2499. POS-03.118: Influence of diabetes mellitus on the prognosis of prostate cancer patients
2500. Positive association between diabetes mellitus and risk of colorectal cancer.
2501. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: National cohort study
2502. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes
2503. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men
2504. Poster# 0598–Type 2 diabetes Mellitus-A risk indicator for colorectal cancer
2505. Postmenopausal women with diabetes risk breast cancer
2506. Postmenopausal women with medically treated diabetes have increased risk of lung cancer
2507. Postoperative diabetes mellitus following resection of the body and tail of the pancreas for secondary invasion by gastric cancer
2508. Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis
2509. Postoperative serum carcinoembryonic antigen levels cannot predict survival in colorectal cancer patients with type II diabetes
2510. Postpancreatitis diabetes confers higher risk for pancreatic cancer than type 2 diabetes: Results from a nationwide cancer registry
2511. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer
2512. PP28 Exploring the Associations between diabetes and Site-Specific cancer Mortality: Evidence from the Health Survey for England and Scottish Health Survey linked …
2513. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer
2514. PPAR-γ: A multifaceted transcription factor important in diabetes, cardiovascular disease, and cancer
2515. Practical aspects of large register studies: Multiple states and multiple timescales: The diabetes and cancer study.
2516. Pre-and post-diagnosis diabetes as a risk factor for all-cause and cancer-specific mortality in breast, prostate, and colorectal cancer survivors: A prospective …
2517. Pre-diabetes and breast cancer outcomes: Abrogating the confounding effect of anti-diabetic therapy.
2518. Pre-existing diabetes and breast cancer prognosis among elderly women
2519. Pre-existing diabetes and lung cancer prognosis
2520. Pre-existing diabetes in early stage breast cancer patients is associated with lack of improvement in quality of life 2 years after diagnosis
2521. Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia
2522. Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis
2523. Pre-existing type 2 diabetes and risk of lung cancer: a report from two prospective cohort studies of 133 024 Chinese adults in urban Shanghai
2524. Pre-existing type 2 diabetes and survival among patients with colorectal cancer
2525. Prebiotics, Probiotics, Synbiotics and Functional Foods in Control and Treatment of Type II diabetes Mellitus and Colorectal cancer
2526. Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort.
2527. Prediabetes and type 2 diabetes mellitus and risk of thyroid cancer
2528. Prediabetes, diabetes, and risk of breast cancer: a case-control study
2529. Prediagnostic diabetes, body mass index, and survival of endometrial cancer: A prospective study.
2530. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes
2531. Predictive factors for differentiating pancreatic cancer-associated diabetes mellitus from common type 2 diabetes mellitus for the early detection of pancreatic cancer
2532. Predictive factors for the development of diabetes in cancer patients treated with phosphatidylinositol 3-kinase inhibitors
2533. Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus
2534. Predictors of the Onset of Type 1 diabetes Obtained from Real-World Data Analysis in cancer Patients Treated with Immune Checkpoint Inhibitors
2535. Preexisting diabetes and risks of morbidity and mortality after gastrectomy for gastric cancer: a nationwide database study
2536. Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer
2537. Preoperative mean platelet volume predicts survival in breast cancer patients with type 2 diabetes
2538. Prevalence and clinical profile of pancreatic cancer–associated diabetes mellitus
2539. Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes
2540. Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut
2541. Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes
2542. Prevalence of diabetes in a cancer population in a Malaga hospital
2543. Prevalence of diabetes in Japanese patients with cancer
2544. Prevalence of diabetes in patients admitted to a cancer hospital
2545. Prevalence of diabetes Mellitus and Metabolic Syndrome in Prostate cancer Patients given Androgen Deprivation Therapy
2546. Prevalence of diabetes mellitus in pancreatic cancer compared to common cancers
2547. Prevalence of diabetes mellitus in pancreatic cancer patients
2548. Prevalence of diabetes mellitus in patients with newly evaluated papillary thyroid cancer
2549. Prevalence of diagnosed cancer according to duration of diagnosed diabetes and current insulin use among US adults with diagnosed diabetes: findings from the …
2550. Prevalence of hypertension and type 2 diabetes mellitus in patients with colorectal cancer and their median survival time: A cohort study
2551. Prevalence, awareness, control, and treatment of hypertension and diabetes in korean cancer survivors: a cross-sectional analysis of the fourth and fifth Korea …
2552. PREVALENCE, METABOLIC CONTROL, AND SURVIVAL IN AN ACADEMIC ONCOLOGY PRACTICE: cancer WITH diabetes
2553. Preventable diabetic complications after a cancer diagnosis in patients with diabetes: a population-based cohort study
2554. Preventing cancer, cardiovascular disease, and diabetes
2555. Preventing cancer, Cardiovascular Disease, and diabetes: A Common Agenda
2556. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American cancer Society, the American diabetes Association, and the American …
2557. Prevention and treatment effects of edible berries for three deadly diseases: Cardiovascular disease, cancer and diabetes
2558. Prevention of diabetes-promoted colorectal cancer by (n-3) polyunsaturated fatty acids and (n-3) PUFA mimetic
2559. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone
2560. Previous cholecystectomy, gastrectomy, and diabetes mellitus are not crucial risk factors for pancreatic cancer in patients with chronic pancreatitis
2561. Primary care cancer and diabetes complications screening of black women with type 2 diabetes
2562. Primary study of the relationship between diabetes and pancreatic cancer
2563. Primate-specific long non-coding RNA (LncRNA) genes as regulators and drug target candidates in human cancer and diabetes
2564. Probability of pancreatic cancer following diabetes: a population-based study
2565. Prognosis of colorectal cancer patients with diabetes according to medication adherence: A population-based cohort study
2566. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study
2567. Prognosis of Patients with Colorectal cancer with diabetes According to Medication Adherence: A Population-Based Cohort Study
2568. Prognosis of small cell lung cancer patients with diabetes treated with metformin
2569. Prognostic factors for resected non‐small cell lung cancer in patients with type 2 diabetes mellitus
2570. Prognostic Impact of diabetes Mellitus on Colorectal cancer
2571. Prognostic Impact of diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic cancer
2572. Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
2573. Prognostic significance of diabetes mellitus and dyslipidemia in men receiving androgen-deprivation therapy for metastatic prostate cancer
2574. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
2575. Prognostic Significance of Obesity and diabetes Mellitus in Women With Brain Metastases From Breast cancer Should Be Revisited
2576. Prognostic significance of type 2 diabetes in patients treated with surgery and irradiation for gingival cancer
2577. Prognostic value of metformin for non-small cell lung cancer patients with diabetes
2578. Program/Abstract# 48 A fly approach to cancer and diabetes
2579. Progress in the relationship between diabetes and prognosis of colorectal cancer
2580. Progress in the study on the correlation between Type 2 diabetes mellitus and colorectal cancer
2581. Progress of relationship between diabetes and papillary thyroid cancer
2582. Prohibitin–At the crossroads of obesity-linked diabetes and cancer
2583. Prolonged survival in lung cancer patients with diabetes mellitus
2584. Prolonged survival in patients with lung cancer with diabetes mellitus
2585. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes
2586. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study
2587. Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women
2588. Prospective study of a diabetes risk reduction diet and the risk of breast cancer
2589. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women
2590. Prospective study of cancer in Japanese patients with type 2 diabetes: the Fukuoka diabetes Registry
2591. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis
2592. Prospective study of diabetes mellitus and liver cancer in Japan
2593. Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
2594. Prospective study reveals associations between colorectal cancer and type 2 diabetes mellitus or insulin use in men
2595. Prostate cancer patients with unmanaged diabetes or on insulin have worse outcomes and toxicities after treatment with radiation therapy
2596. Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapy
2597. Prostate cancer risk among men with diabetes mellitus (Spain)
2598. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review
2599. Prostate cancer, diabetes Link Points to Potential Treatment with Metformin
2600. Prostate cancer: diabetes and prostate cancer—an open debate
2601. Prostate cancer: Hormone Therapy Associated with diabetes, Cardiovascular Disease
2602. Protective effect of diabetes against metastasis in patients with non–small cell lung cancer
2603. Protein-bound glycosaminoglycans in serum of patients with lung cancer and patients with diabetes mellitus
2604. Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes
2605. Proteomic analysis of pancreatic cancer associated with diabetes mellitus
2606. Proteomics Analysis of Gastric cancer Patients with diabetes Mellitus
2607. Psychological distress, resilience, social support and help-seeking behaviors in patients with type ii diabetes, breast cancer and hypertension
2608. PTEN link between cancer and diabetes
2609. PUK4 COMPARISON OF POSTTRANSPLANT NEW-ONSET diabetes AND cancer BETWEEN PERITONEAL AND HEMODIALYSIS RECIPIENTS …
2610. PWE-159 diabetes and Pancreatic cancer–Cause or Association?
2611. pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer
2612. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer
2613. Quality and outcomes of diabetes care in patients diagnosed with cancer
2614. Quality of diabetes care among cancer survivors with diabetes
2615. Quality of diabetes care in breast, colorectal, and prostate cancer
2616. Quality of diabetes care in cancer: a systematic review
2617. Quantitative aspects of mitochondrial genome in cancer and diabetes
2618. Racial disparities and colorectal cancer survival in older adults with and without diabetes mellitus
2619. Racial disparities in breast cancer mortality among women with diabetes mellitus.
2620. Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status
2621. Racial Variation in the Relationship of diabetes with Pancreatic cancer Risk
2622. Racial/ethnic disparities in the risk of posttraumatic stress disorder symptoms among mothers of children diagnosed with cancer and Type-1 diabetes mellitus.
2623. Racial/Ethnicity Disparities In The Association Between diabetes And Pancreatic cancer In The Elderly Medicare Population
2624. Radiation Dose and Volume to the Pancreas and Subsequent Risk of diabetes Mellitus: A Report from the Childhood cancer Survivor Study
2625. Radiation dose and volume to the pancreas and subsequent risk of diabetes mellitus: A report from the Childhood cancer Survivor study.
2626. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
2627. Radical gastrectomy combined with modified gastric bypass surgery for gastric cancer patients with type 2 diabetes
2628. Raised glucose concentrations and diabetes are associated with cancer risk
2629. Rapid biochemical profiling of endothelial dysfunction in diabetes, hypertension and cancer metastasis by hierarchical cluster analysis of Raman spectra
2630. Rapid progression of breast cancer cell proliferation in diabetes: Role of polyamines
2631. Rare case of manifestation of erectile dysfunction soon after thyroidectomy because of thyroid cancer in 56-year-old man with diabetes mellitus type 2 and diabetic …
2632. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model
2633. Re: Androgen-Deprivation Therapy and diabetes Control among Diabetic Men with Prostate cancer
2634. Re: Excess Risk of Primary Liver cancer in Patients With diabetes Mellitus
2635. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
2636. Re: prospective study of adult onset diabetes mellitus (Type 2) and risk of colorectal cancer in women
2637. Real life cancer comorbidity in Greek patients with diabetes mellitus followed up at a single diabetes center: an unappreciated new diabetes complication
2638. Rebuild: Recover from Heart Disease, cancer, diabetes and Other Serious Illness and be Healthier Than Ever Before
2639. Recent Advances in Histone Glycation: Emerging role in diabetes and cancer
2640. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer
2641. Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15 …
2642. Recent advances in the use of metformin: can treating diabetes prevent breast cancer?
2643. Recent data on Mediterranean diet, cardiovascular disease, cancer, diabetes and life expectancy.
2644. Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients
2645. Redefining the role of obesity, race and diabetes in Type I and Type II endometrial cancers: Potential targets for treatment beyond cancer itself
2646. Redox alterations in inflammatory diseases: diabetes, kidney failure and cancer
2647. Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis
2648. Reduced risk of prostate cancer among patients with diabetes mellitus
2649. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients
2650. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
2651. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes patients
2652. Reducing cancer and cancer disparities: lessons from a youth-generated diabetes prevention campaign
2653. Reducing the gap by focusing the ethnicity and migration lenses: examples in cancer, heart disease and diabetes
2654. Reference frameworks for the health management of measles, breast cancer and diabetes (type II).
2655. Regarding measures of impact: diabetes and urothelial cancer
2656. Regional variations in cancer screening rates found in women with diabetes
2657. Registry-based analysis of cancer and diabetes combination: prevalence and features
2658. Related Factors and Risk Prediction of Type 2 diabetes Complicated with Liver cancer
2659. RELATION BETWEEN COMPLICATIONS OF TYPE II diabetes MELLITUS AND ANEMIA CAUSED BY CHEMOTHERAPY IN WOMEN WITH BREAST cancer
2660. Relation between dietary calcium and vitamin D and risk of diabetes and cancer: a review and perspective
2661. Relation of prediabetes and type 2 diabetes mellitus to thyroid cancer
2662. Relationship between diabetes and diabetes medications and risk of different molecular subtypes of breast cancer
2663. Relationship between diabetes and pancreatic cancer
2664. Relationship between diabetes and risk of second primary contralateral breast cancer
2665. Relationship between diabetes Mellitus and Clinicopathological Stages of Breast cancer at Diagnosis
2666. Relationship between diabetes Mellitus and Colorectal cancer as well as its Metastasis
2667. Relationship between diabetes Mellitus and Lymphatic Metastasis in Patients with Colorectal cancer
2668. Relationship between diabetes Mellitus and Risk of Colorectal cancer: A META-ANALYSIS
2669. Relationship between diabetes mellitus and the site of colorectal cancer
2670. Relationship between gestational diabetes and endometrial cancer
2671. Relationship between HbA1c and cancer in people with or without diabetes: a systematic review
2672. RELATIONSHIP BETWEEN HISTORY OF GESTATIONAL diabetes AND THE RISK OF BREAST cancer: A POPULATION BASED COHORT STUDY
2673. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis
2674. Relationship between obesity, diabetes and the risk of thyroid cancer
2675. Relationship between Obesity, diabetes, and the Risk of Thyroid cancer
2676. Relationship between pancreatic cancer and diabetes mellitus
2677. Relationship between pancreatic cancer‐associated diabetes and cachexia
2678. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
2679. Relationship between type 2 diabetes and pancreatic cancer
2680. Relationship between type 2 diabetes mellitus and risk of breast cancer: a case-control study
2681. Relationship of diabetes and obesity with cancer incidence; review article
2682. Relationship of metformin with the risk of pancreatic cancer in patients with type 2 diabetes: a meta-analysis
2683. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity
2684. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
2685. Relationships of obesity and diabetes mellitus to other primary cancers in surgically treated gastric cancer patients
2686. Remedial applications of exosomes in cancer, infections and diabetes
2687. Renal Impairment Increases Serum cancer Antigen 125 Levels in Patients with Type 2 diabetes Mellitus
2688. Renin angiotensin system inhibitors may attenuate low LDL cholesterol‐related cancer risk in type 2 diabetes
2689. Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer”
2690. Reply to the letter by Fujishiro et al. concerning “Controversy regarding gastric cancer and diabetes”
2691. Report Clarifies Scientists’ Understanding of Association Between diabetes and cancer
2692. Report of the J apan diabetes Society/J apanese cancer Association joint committee on diabetes and cancer
2693. Report of the Japan diabetes Society (JDS)/Japanese cancer Association (JCA) joint committee on diabetes and cancer, second report
2694. Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report
2695. Report of the JDS/JCA joint committee on diabetes and cancer
2696. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition
2697. Research advances on diabetes-associated pancreatic cancer
2698. Research on the relationship between RAGE and its ligand HMGB1, and prognosis and pathogenesis of gastric cancer with diabetes mellitus
2699. Research Progress in New-onset diabetes and Early Diagnosis of Pancreatic cancer
2700. Research Progress of 70 kDa Ribosomal Protein S6 Kinase (P70S6K) Inhibitors as Effective Therapeutic Tools for Obesity, Type II diabetes and cancer
2701. Research Progress of Correlation between Type 2 diabetes Mellitus And Digestive System cancer Based on Meta-analysis
2702. Research Progress of Relationship between diabetes and Colorectal cancer [J]
2703. Research progress on the association of diabetes with pancreatic cancer
2704. Resectability of pancreatic cancer and diabetes
2705. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to …
2706. Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study
2707. Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung cancer in Patients With Type 2 diabetes. diabetes Care 2013; 36: 124 …
2708. Response to Comment on: Torres-Mejía et al. Moderate-Intensity Physical Activity Ameliorates the Breast cancer Risk in Diabetic Women. diabetes Care 2012; 35 …
2709. Response to Letter to the Editor:” Higher Circulating Adiponectin Concentrations Predict Incident cancer in Type 2 diabetes-The Adiponectin Paradox”
2710. Response to Yang and Chan. Metformin and the Risk of cancer: Time-Related Biases in Observational Studies. diabetes Care 2012; 35: 2665–2673
2711. RESPONSE: Re: diabetes Mellitus and Risk of Colorectal cancer in the Singapore Chinese Health Study
2712. Response: The Association between Type 2 diabetes Mellitus and Colorectal cancer.
2713. Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
2714. Response: The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012;36:371-8)
2715. Results of a community survey to assess African American and Latino knowledge, perceptions, and life style practices related to diabetes and cancer
2716. Results of general internal medicine consultations for diabetes mellitus in 283 cancer patients
2717. Resveratrol’s potential in the adjunctive management of cardiovascular disease, obesity, diabetes, Alzheimer disease, and cancer
2718. Retinol binding protein 4: role in diabetes and cancer
2719. Retinol binding protein 4: role in diabetes and cancer
2720. Retracted: Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
2721. Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment
2722. Retraction Notice to: The cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of diabetes
2723. Retrospective analysis of the relation between diabetes mellitus and endometrial cancer
2724. Retrospective analysis of the relationship between type 2 diabetes mellitus and colorectal cancer
2725. Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
2726. Retrospective evaluation of Middle Eastern patients (pts) with type II diabetes mellitus (DM) and colorectal cancer (CRC): Validation of metformin effect on overall …
2727. Retrospective evaluation of patients with colorectal cancer (CRC) and type II non-insulin-dependent diabetes (NIDDM).
2728. Reversal of enhanced pancreatic cancer growth in diabetes by insulin
2729. Review of Associations Between Type 2 diabetes and cancer
2730. Risk analysis on diabetes mellitus patients complicating colorectal cancer
2731. Risk differences between prediabetes and diabetes according to breast cancer molecular subtypes
2732. Risk established between type II diabetes mellitus and cancer: a review
2733. Risk factor, early diagnosis and overall survival on outcome of association between pancreatic cancer and diabetes mellitus: Changes and advances, a …
2734. Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age
2735. Risk factors for cancer development in type 2 diabetes: a retrospective case-control study
2736. Risk factors for elevated serum colorectal cancer markers in patients with type 2 diabetes mellitus
2737. Risk factors for papillary thyroid cancer in obesity and diabetes mellitus
2738. Risk factors for radiation esophagitis and pneumonitis in esophageal cancer patients with diabetes or hypertension
2739. Risk factors of catheter-related bloodstream infections in cancer patients with diabetes
2740. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes
2741. Risk of bladder cancer among patients with diabetes treated with a 15 mg pioglitazone dose in Korea: a multi-center retrospective cohort study
2742. Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
2743. Risk of bladder cancer in patients with diabetes: a retrospective cohort study
2744. Risk of bladder cancer in patients with diabetes: a retrospective cohort study.
2745. Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women
2746. Risk of breast cancer among daughters of mothers with diabetes: a population-based cohort study
2747. Risk of Breast cancer in Patients diagnosed with Type 2 diabetes (T2DM)
2748. Risk of cancer following hospitalization for type 2 diabetes
2749. Risk of cancer in a large cohort of US veterans with diabetes
2750. Risk of cancer in diabetes: the effect of metformin
2751. Risk of cancer incidence and mortality associated with diabetes: A systematic review with trend analysis of 203 cohorts
2752. Risk of cardiovascular disease among Nordic childhood cancer survivors with diabetes mellitus: A report from adult life after childhood cancer in Scandinavia
2753. Risk of cause‐specific death in individuals with cancer—modifying role diabetes, statins and metformin
2754. Risk of colon cancer recurrence in relation to diabetes
2755. Risk of colorectal cancer in patients with diabetes mellitus: A Swedish nationwide cohort study
2756. Risk of diabetes after para-aortic radiation for testicular cancer
2757. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer
2758. Risk of diabetes Associated With cancer Development
2759. Risk of diabetes Associated With cancer Development—In Reply
2760. Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer
2761. Risk of diabetes, cancer, large vessel disease and mortality in young women with Polycystic Ovary Syndrome: a retrospective database analysis
2762. Risk of endometrial and breast cancer in patients with diabetes mellitus
2763. Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies
2764. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan
2765. Risk of head and neck cancer in patients with diabetes mellitus: a retrospective cohort study in Taiwan
2766. Risk of Myocardial Infarction or diabetes During Androgen Deprivation Therapy for Prostate cancer: Does Comorbidity Influence Risk?
2767. Risk of prostate cancer across different racial/ethnic groups in men with diabetes: A retrospective cohort study
2768. Risk of skin cancer in patients with diabetes mellitus: a nationwide retrospective cohort study in Taiwan
2769. Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: a retrospective population-based time-dependent cohort study
2770. Risks of breast and endometrial cancer in women with diabetes: a population-based cohort study
2771. Risks of Colorectal cancers Associated with diabetes Were Particularly Increased in Middle-aged Men Running title: Colorectal cancer in Diabetic Patients
2772. Role for diabetes in colorectal cancer risk
2773. Role of breast cancer inhibitors on diabetes mellitus–an in silico approach
2774. Role of gut microbiome in regulating the effectiveness of metformin in reducing colorectal cancer in type 2 diabetes
2775. Role of Heat Shock Protein 90 in diabetes and Pancreatic cancer Management
2776. Role of Mitochondria in Pancreatic Metabolism, diabetes, and cancer
2777. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011.
2778. Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002–2011
2779. Role of signal dynamics in the link between type 2 diabetes and cancer
2780. Role of the tumor suppressor IQGAP2 in metabolic homeostasis: Possible link between diabetes and cancer
2781. Roles of microRNA-124a and microRNA-30d in breast cancer patients with type 2 diabetes mellitus
2782. Rosemary leaf extract inhibits glycation, breast cancer proliferation, and diabetes risks
2783. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes
2784. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
2785. Rosiglitazone use and the risk of bladder cancer in patients with type 2 diabetes
2786. SAT-134 Association between Serum Branched-Chain Amino Acids and cancer Risk: The Hong Kong diabetes Register (HKDR)
2787. Screening for Pancreatic cancer in Individuals With New-onset diabetes Mellitus
2788. Screening Strategy of Pancreatic cancer in Patients with diabetes Mellitus
2789. Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort …
2790. Secondhand Smoke Exposure, diabetes, Elevated Glucose Level Are Risk Factors for Uterine Cervical cancer: A Cross-Sectional Study From the Korea …
2791. Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006
2792. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta …
2793. Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after
2794. Self reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population based, cross sectional study
2795. Self-rated health and type 2 diabetes risk in the European Prospective Investigation into cancer and Nutrition-InterAct study: a case-cohort study
2796. Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in …
2797. Self-reported memory problems in adult-onset cancer survivors in the United States with or without: Type 2 diabetes mellitus, hypertension and hyperlipidemia.
2798. Senile Colon cancer with diabetes Patients Perioperative Features and Nursing Intervention [J]
2799. Sera anti-p53 antibody provides new information which explains the link between diabetes and cancer
2800. Serious illness in childhood: the different threats of cancer and diabetes from a parent perspective
2801. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø …
2802. Serum HSP70 level in patients with endometrial cancer with and without diabetes
2803. Serum Levels of 8-Hydroxy-2′-Deoxyguanosine DNA in Patients with Breast cancer and Endometrial cancer with and without diabetes Mellitus
2804. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
2805. Serum proteomic analysis of pancreatic cancer associated diabetes
2806. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes
2807. Session 4: CVD, diabetes and cancer A dietary portfolio for management and prevention of heart disease: Symposium on ‘Dietary management of disease’
2808. Session 4: CVD, diabetes and cancer Diet, insulin resistance and diabetes: the right (pro) portions: Symposium on ‘Dietary management of disease’
2809. Session 4: CVD, diabetes and cancer Evidence for the use of the Mediterranean diet in patients with CHD: Symposium on ‘Dietary management of disease’
2810. SESSION IA| HEALTHCARE DISPARITIES: TYPE 2 diabetes & BREAST cancer
2811. Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry
2812. Severe Visceral Obesity, Fatty Liver and diabetes after Orchiectomy for Prostate cancer
2813. Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
2814. Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and …
2815. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic …
2816. Sex-and site-specific differences in colorectal cancer risk among people with type 2 diabetes
2817. Sex-specific association between family history of diabetes and risk of colorectal cancer: two prospective cohort studies
2818. SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
2819. Shaping environments for reductions in type 2 diabetes risk behaviors: A look at CVD and cancer interventions
2820. Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study
2821. Should healthcare be guaranteed for cancer but not diabetes?
2822. Significance of angiotensin targeting on treatment of liver metastasis in colorectal cancer patients with diabetes
2823. Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer
2824. Significantly increased risk of cancer in diabetes mellitus patients: a meta‐analysis of epidemiological evidence in Asians and non‐Asians
2825. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis
2826. Sitagliptin and oral cancer risk in type 2 diabetes patients
2827. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes
2828. Sitagliptin may reduce breast cancer risk in women with type 2 diabetes
2829. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes
2830. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes
2831. Sitagliptin use may reduce oral cancer risk in patients with type 2 diabetes
2832. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study
2833. Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
2834. Site-specific cancer risk in people with type 2 diabetes: Nationwide population-based cohort study in Korea
2835. Skeletal muscle microRNAs in human cancer cachexia and Type 2 diabetes
2836. Sleep apnea: a common mechanism for the deadly triad—cardiovascular disease, diabetes, and cancer?
2837. Small cell lung cancer expressing glutamate decarboxylase with latent autoimmune diabetes in adults
2838. Small cell lung cancer starting with diabetes mellitus: Two case reports and literature review
2839. Small-cell lung cancer presenting as diabetes insipidus and cushing’s syndrome
2840. Smoking Despite Lung cancer or diabetes: A Pressing Challenge to Smoking Abstinence
2841. Smoking, alcohol, diabetes, obesity, socioeconomic status, and the risk of colorectal cancer in a population-based case–control study
2842. Smoking, family history of cancer, and diabetes mellitus are associated with the age of onset of pancreatic cancer in Japanese patients
2843. Social Welfare Approaches for Patients with Concurrent diabetes and cancer.
2844. Socioeconomic characteristics, life style, diabetes, family history of cancer and risk of pancreatic cancer
2845. Sodium–glucose cotransporter 2 inhibitors and the short-term risk of breast cancer among women with type 2 diabetes
2846. SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes
2847. Speaking with one voice on worksite wellness: the American cancer Society, the American diabetes Association, and the American Heart Association
2848. Spontaneous remission of cranial diabetes insipidus due to concomitant development of ADH-producing lung cancer–an autopsied case
2849. Sporadic Pancreatic cancer: Glucose Homeostasis and Pancreatogenic Type 3 diabetes
2850. Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus
2851. Standard risk factors for lung cancer, cardiac infarct, apoplexy, diabetes mellitus and their changes in psychosocial context
2852. Statin use and cancer incidence in patients with type 2 diabetes mellitus: a network meta-analysis
2853. Statin Use and the Risk of Colorectal cancer in Patients with diabetes: 881
2854. Statins and finasteride use differentially modify the impact of metformin on prostate cancer incidence in men with type 2 diabetes
2855. Statins and the risk of gastric cancer in diabetes patients
2856. Statistical analysis of the effect of metformin use on endometrial cancer incidence in patients with type 2 diabetes
2857. Stem cell-based approach in diabetes and pancreatic cancer management
2858. Steroid-induced diabetes in cancer patients
2859. Storage of vitamin D in adipose tissue and associations between vitamin D related genetic variants and diabetes, myocardial infarction, cancer, death, and low bone …
2860. Stratification of cancer and diabetes based on circulating levels of formate and glucose
2861. Stratification of cancer and diabetes based on circulating levels of formate and glucose
2862. Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?
2863. Stroke, lung cancer, and diabetes health beliefs and lifestyle practices of Vietnamese elders: Implications for geriatric rehabilitation
2864. Structural and Biophysical Characterization of SPOP-Client Interactions Involved in diabetes and cancer
2865. Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
2866. Studies on the relationships between blood trace metal concentrations and the clinical status of patients with cerebrovascular disease, gastric cancer and diabetes …
2867. Study of correlation between pancreatic cancer and diabetes mellitus [J]
2868. Study of serum IGF-1, IGFBP-3 and insulin levels in patients with type 2 diabetes mellitus and their relationship with colorectal cancer
2869. Study of the Association Between Antihyperglycemic Therapy and cancer in Patients with Type 2 diabetes Mellitus
2870. Study of the Prevalence of Chronic Diseases (cancer, diabetes, Heart Disease) and Its Relationship with the Elderly’s Quality Of Life
2871. Study on the association between the different levels of C-peptide of type 2 diabetes and colorectal cancer risk
2872. Study on the effect of metformin in patients of metastatic renal cell cancer with diabetes receiving tyrosine kinase inhibitor therapy
2873. Study On The Prevalence Of Various Forms Of cancer In Diabetic Patients Hospitalized In The National Institute Of diabetes, Nutrition And Metabolic …
2874. STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
2875. STUDY ON THE RELATIONSHIP BETWEEN PANCREATIC cancer AND diabetes MELLITUS, OTHER MEDICAL CONDITIONS AND FAMILIAL HISTORY
2876. Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and …
2877. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus
2878. Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan
2879. Substitutions between dairy product subgroups and risk of type 2 diabetes: the Danish Diet, cancer and Health cohort
2880. Successful use of endoscopic argon plasma coagulation for patients with early gastric cancer and diabetes mellitus
2881. SUN-675 Breast cancer Treatment Causes diabetes
2882. SUN-688 Pancreatic cancer in Longstanding diabetes
2883. Superior Mesenteric Artery Syndrome Preceded by diabetes Insipidus in Advanced Lung cancer with Pituitary Metastasis–A Case Report
2884. Superoxide dismutases: significances in aging, diabetes, ischemia and cancer
2885. Supplemental Material The Association of Arsenic Metabolism with cancer, Cardiovascular Disease and diabetes: A Systematic Review of the Epidemiological …
2886. Surgical treatment of gastric cancer in elderly patients combinded with diabetes
2887. Surgical Treatment of Large Bowel cancer with diabetes Mellitus
2888. Survival advantage associated with metformin usage in patients with colorectal cancer (CRC) and type II noninsulin-dependent diabetes (NIDDM).
2889. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
2890. Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
2891. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus
2892. Survival and glycemic control in patients with colorectal cancer and diabetes mellitus
2893. Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus
2894. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
2895. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis
2896. Survival impact of diabetes and paraneoplastic thrombocytosis in women with breast cancer
2897. Survival of colorectal cancer patients with diabetes mellitus: A meta-analysis
2898. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
2899. Survival of non-small cell lung cancer (NSCLC) patients with and without diabetes mellitus (DM): Findings from the cancer Care Outcomes Research and Surveillance …
2900. Survival of patients with cervical cancer and diabetes: An exploratory study.
2901. Survival of patients with lung cancer and diabetes mellitus
2902. Survival of patients with stage IV lung cancer with diabetes treated with metformin
2903. Survival of resectable pancreatic cancer patients with diabetes
2904. Suva Residents’ Views on cancer, diabetes and HIV in The Fiji Times
2905. Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage
2906. SYMPOSIUMS: diabetes AND cancer: CAN RESVERATROL BE A GOOD CANDIDATE IN THIS TSUNAMI?
2907. Syndecan as a messenger to link diabetes and cancer
2908. Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong diabetes Registry
2909. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes
2910. Synthesis of Tin Oxide Nanofibers for Lung cancer, diabetes and Kidney Malfunction Detection
2911. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
2912. Systematic review and meta‐analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
2913. Systematic Survey of the Role of IGF in the Link Between diabetes and cancer
2914. Systemic cancer presenting as diabetes insipidus. Clinical and radiographic features of 11 patients with a review of metastatic‐induced diabetes insipidus
2915. Targeting acidity in cancer and diabetes
2916. Targeting dipeptidyl peptidase-4 (DPP-4) and fibroblast activation protein (FAP) for diabetes and cancer therapy
2917. Targeting receptors of advanced glycation end products (RAGE): preventing diabetes induced cancer and diabetic complications
2918. Targeting unfolded protein response in cancer and diabetes
2919. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study
2920. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer
2921. Technology-Enhanced consultations in diabetes, cancer, and heart failure: protocol for the qualitative analysis of remote consultations (QuARC) project
2922. Television watching and incident diabetes: findings from the European Prospective Investigation into cancer and Nutrition–Potsdam Study
2923. Test–retest reliability of self-reported diabetes diagnosis in the Norwegian Women and cancer Study: a population-based longitudinal study (n= 33,919)
2924. Testing Mice at Risk of Pancreatic cancer for Altered Protein Pathways Found in diabetes
2925. Texas Health Insurance Coverage for Prevention and Screening of cancer, Cardiovascular Disease, and diabetes
2926. TGFBIp mediated apoptosis: A role in cancer and diabetes mellitus type II
2927. TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
2928. The activation of ERK1/2 and JNK MAPK signaling by insulin/IGF-1 is responsible for the development of colon cancer with type 2 diabetes mellitus
2929. The advanced glycation end‐product Nϵ‐carboxymethyllysine promotes progression of pancreatic cancer: implications for diabetes‐associated risk and its …
2930. The American diabetes Association, the American cancer Society, and the American Heart Association
2931. The American diabetes Association, the American cancer Society, and the American Heart Association: A triumvirate of hope for the nation’s health
2932. The application of refined nursing in postoperative patients with breast cancer and diabetes
2933. The assessment of molecular markers of cell interaction and lipid peroxidation in rats with alloxan diabetes and trans-planted liver cancer after intravenous injection of …
2934. The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6-months post-chemotherapy
2935. The association between diabetes and breast cancer stage at diagnosis: a population-based study
2936. The association between diabetes and cancer incidence and mortality in the NIH-AARP study
2937. The association between diabetes and thyroid cancer risk: a hospital-based case-control study in China
2938. The Association between diabetes Mellitus and Colorectal cancer Stage at Presentation: Presidential Poster: 1559
2939. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer
2940. The association between diabetes, insulin use, and colorectal cancer among Whites and African Americans
2941. The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients: A systematic review and meta-analysis
2942. The association between fasting blood glucose trajectory and cancer risk in Chinese population without diabetes
2943. The association between gestational diabetes mellitus and cancer in women: a systematic review and meta-analysis of observational studies
2944. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
2945. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
2946. The association between paternal prostate cancer and type 2 diabetes
2947. The Association between Patient Characteristics and Use of Statin and Metformin among Elderly Women with Breast cancer and diabetes
2948. The association between self-reported diabetes and cancer incidence in the NIH-AARP Diet and Health Study
2949. The Association between thyroid cancer and type 2 diabetes mellitus
2950. The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women
2951. The Association between Type 2 diabetes Mellitus and Colorectal cancer.
2952. The Association between Type 2 diabetes Mellitus and Colorectal cancer.
2953. The association between type 2 diabetes mellitus and thyroid cancer
2954. The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms
2955. The association of arsenic metabolism patterns with cancer, cardiovascular disease and diabetes: A systematic review of the epidemiological evidence
2956. The association of arsenic metabolism with cancer, cardiovascular disease, and diabetes: a systematic review of the epidemiological evidence
2957. The Association of Arsenic Metabolism with cancer, Cardiovascular Disease, and diabetes: A Systematic Review of the Epidemiological Evidence
2958. The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study
2959. The association of diabetes and obesity with prostate cancer progression: HCaP‐NC
2960. The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series
2961. The Association of diabetes Mellitus with Colorectal cancer and Polyps in Asymptomatic Patients Undergoing Screening Colonoscopy: 447
2962. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
2963. The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients
2964. The association of diabetes with breast cancer incidence and mortality in the Long Island Breast cancer Study Project
2965. The association of diabetes with colorectal cancer risk: the Multiethnic Cohort
2966. The association of diabetes with risk of prostate cancer defined by clinical and molecular features
2967. The association of high-density lipoprotein cholesterol with cancer incidence in type II diabetes: a case of reverse causality?
2968. The association of hyperglycemia and diabetes mellitus and the risk of chemotherapy-induced neutropenia among cancer patients: a systematic review with meta …
2969. The association of hyperinsulinemia with cardiovascular risk and cancer poses new challenges in the treatment of the insulin resistance type 2 diabetes patient
2970. The association of recently-diagnosed diabetes and long-term diabetes with survival in pancreatic cancer patients: a pooled analysis
2971. The Baltimore Alliance for the Prevention and Control of Hypertension and diabetes: a model for developing a colorectal cancer community outreach program.
2972. The bidirectional interation between pancreatic cancer and diabetes
2973. The Biology of the Deadly Love Connection Between Obesity, diabetes, and Breast cancer
2974. The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes
2975. The clinical dependabilities between type 2 diabetes and lung cancer.
2976. The clinical effect of metformin on the survival of lung cancer patients with diabetes: a comprehensive systematic review and meta-analysis of retrospective …
2977. The Clinical Features of Patients with Type 2 diabetes and Colorectal cancer
2978. The Clinical Observation of diabetes Mellitus Following Cisplatin-based Chemotherapy on Head and Neck cancer [J]
2979. The Combined Impact of Chronic Kidney Disease and diabetes on the Risk of Colorectal cancer Depends on Sex: A Nationwide Population-Based Study
2980. The complex dual diagnosis of diabetes and cancer.
2981. The complex role of branched chain amino acids in diabetes and cancer
2982. The complexities of obesity and diabetes with the development and progression of pancreatic cancer
2983. The correlation analysis of primary liver cancer with Type 2 diabetes
2984. The Correlation Between Dairy Product Consumption and Gastrointestinal Bleed, Ovarian cancer, and diabetes in Infants: A Meta‐Analysis Approach
2985. The correlation between diabetes and pancreatic cancer and the imaging findings
2986. The correlation between type-2 diabetes and lung cancer
2987. The decline in cancer incidence in patients with long-duration type 1 diabetes: what really happens over time?
2988. The design, synthesis and evaluation of new chemical entities for the development of drugs against cancer, diabetes, autoimmune disorders and infectious …
2989. The development of fulminant type 1 diabetes during chemotherapy for rectal cancer
2990. The diabetes Drug Canagliflozin Enhances the Response of Prostate cancer to Radiotherapy
2991. The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration
2992. The diabetes–cancer link
2993. The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel
2994. The double trouble of metabolic diseases: the diabetes–cancer link
2995. The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and cancer
2996. The duration of obesity and the risk of type-2 diabetes, cardiovascular disease, cancer and mortality
2997. The dysfunction of NK cells in patients with type 2 diabetes and colon cancer
2998. The early diagnosis of pancreatic cancer and diabetes: what’s the relationship?
2999. The Effect of Aging Lung cancer Combined with Type Ⅱ diabetes Mellitus by Shenmai Injection
3000. The effect of Benign Thyroid Disease, diabetes Mellitus and Physical Activity on Breast cancer Risk
3001. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
3002. The effect of diabetes mellitus on lung cancer prognosis: a PRISMA-compliant meta-analysis of cohort studies
3003. The effect of diabetes mellitus on prognosis of patients with non-small-Cell lung cancer: a systematic review and meta-analysis
3004. The effect of diabetes on the perioperative outcomes of colorectal cancer surgery patients
3005. The effect of diabetes on the risk of endometrial cancer: an updated a systematic review and meta-analysis
3006. The effect of diabetes with pharmacotherapy for breast cancer on care resource use
3007. The effect of exposure to thiazolidinediones on the development of head-and-neck cancer in patients with diabetes mellitus
3008. The effect of incident cancer, depression and pulmonary disease exacerbations on type 2 diabetes control
3009. The Effect of intensive Glycemic Control on Postoperative Gastric cancer Patients Combined with diabetes
3010. The effect of long Roux-en-Y gastrojejunostomy in gastric cancer patients with type 2 diabetes and body mass index< 35 kg/m2: preliminary results
3011. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
3012. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis
3013. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis
3014. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta‐analysis
3015. The effect of metformin on mortality following cancer among patients with diabetes
3016. The effect of metformin on oncological outcomes in patients with cervical cancer with type 2 diabetes mellitus
3017. The effect of metformin on prognosis in patients with locally advanced gastric cancer associated with type 2 diabetes mellitus
3018. The effect of metformin on responses to chemotherapy and survival in stage IV colorectal cancer with diabetes
3019. The effect of metformin on the clinicopathological features of breast cancer with type 2 diabetes
3020. The effect of metformin on the progression of non-small cell lung cancer with diabetes mellitus: A review of studies between 2015 and 2017
3021. The effect of metformin use and the incidence of prostate cancer in type 2 diabetes mellitus patients: A nationwide population-based study
3022. The effect of neoadjuvant chemoradiation on pancreatic cancer-associated diabetes mellitus
3023. The Effect of Obesity and diabetes on Intermediate to High Grade Prostate cancer Patients Treated with Radical Prostatectomy
3024. The effect of obesity on the formation of cancer risk in patients with type 2 diabetes mellitus (literature review)
3025. The Effect of Pre-existing diabetes on the Incidence of Postradiation Retinopathy in Head and Neck cancer Patients
3026. The Effect of Prostate cancer Diagnosis on Adherence to Medications for Patients with Type 2 diabetes
3027. The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
3028. The effect of type 2 diabetes on selected clinical parameters and disease outcome in patients with colorectal cancer
3029. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy
3030. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
3031. The Elusive Link Between cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in diabetes
3032. The Emerging Link between Metformin Therapy for Type 2 diabetes Mellitus and Colorectal cancer
3033. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus
3034. The epidemiologic relationship between diabetes and cancer
3035. The epidemiologicalcharacteristics of 1205 cancer patients with previous type 2 diabetes mellitus
3036. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer
3037. The epidemiology of diabetes and cancer
3038. The Estimation of Thyroid cancer Risk based on Type 2 diabetes Mellitus and ABO Blood Group.
3039. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders
3040. The evaluation of Entamoeba gingivalis occurrence in samples from patients with cancer and diabetes
3041. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes—the 2001–2006 ENTRED cohort
3042. The experience of developing new-onset diabetes after cancer treatments in middle age and older adults
3043. The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus
3044. The expression of Transgelin in pancreatic cancer accompanied with diabetes and its effects on the migration and invasion of SW1990 cell line
3045. The frequency of cancer in diabetes mellitus
3046. THE GENETICAL ASSOCIATION BETWEEN PROSTATE cancer AND TYPE 2 diabetes
3047. The global implications of diabetes and cancer.
3048. The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer
3049. The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention
3050. The impact of cancer on diabetes outcomes
3051. The Impact of Comorbid diabetes on Short-Term Postoperative Outcomes in Stage I/II Colon cancer Patients Undergoing Open Colectomy
3052. The Impact of Comorbid diabetes Type 2 on Quality of Life in cancer Patients Undergoing Chemotherapy.
3053. The impact of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts
3054. The impact of diabetes and obesity on endometrial cancer outcomes.
3055. The impact of diabetes and other metabolic disorders on prostate cancer prognosis
3056. The impact of diabetes in head and neck cancer
3057. The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
3058. The impact of diabetes mellitus and metformin treatment on survival of patients with advanced pancreatic cancer undergoing chemotherapy
3059. The impact of diabetes mellitus and obesity on pathologic complete response rate of neoadjuvant chemoradation for gastroesophageal cancer: A retrospective review.
3060. The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study
3061. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis
3062. The impact of diabetes mellitus on early cervical cancer in Αsia: A population-based cohort study.
3063. The impact of diabetes mellitus on prognosis of early breast cancer in Asia
3064. The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
3065. The Impact of diabetes Mellitus on Survival in Men with Clinically Localized Prostate cancer Treated with Permanent Interstitial Brachytherapy
3066. The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy
3067. The Impact of diabetes Mellitus on the Second Primary Malignancies in Colorectal cancer Patients
3068. The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer
3069. The impact of diabetes on breast cancer treatments and outcomes: a population-based study
3070. The Impact of diabetes on Breast cancer Treatments and Outcomes: A Population-Based Study
3071. The Impact of diabetes on Colorectal cancer Stage at Diagnosis: A Population-Based Cohort Study
3072. The impact of diabetes on gynecologic cancer: Current status and future directions
3073. The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry
3074. The impact of diabetes on survival following breast cancer
3075. The impact of diabetes on survival in women with ovarian cancer
3076. The impact of diabetes on the risk of prostate cancer development according to body mass index: a 10-year nationwide cohort study
3077. The Impact of diabetes on the Symptoms of Breast cancer Survivors
3078. The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer
3079. The Impact of diabetes Treatment on Survival in a Breast cancer/diabetes Model
3080. The impact of gastrectomy on diabetes and related conditions, coronary heart disease, stroke, cancer, and survival: follow-up from the Honolulu heart program
3081. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits …
3082. The impact of having both cancer and diabetes on patient-reported outcomes: a systematic review and directions for future research
3083. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
3084. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
3085. The impact of physician communication on diabetes management in cancer survivors.
3086. The Impact of Race and diabetes on Mortality among Breast cancer Patients
3087. The Impact of Resolution of diabetes After Radical Pancreatic Resection on Long-term Survival of Patients With Pancreatic cancer
3088. The impact of thiazolidinediones on the risk for prostate cancer in patients with type 2 diabetes mellitus: A review and meta-analysis
3089. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth
3090. The impact of type 2 diabetes mellitus on cancer‐specific survival: a follow‐up study in Sweden
3091. The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in T aiwan
3092. The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer
3093. The implication of diabetes metabolomics in the early diagnosis and pathogenesis of pancreatic cancer.
3094. The incidence of cardiovascular disease, cancer and type 2 diabetes comorbidities in HIV infection: A systematic review
3095. The increased risk of cancer in obesity and type 2 diabetes: potential mechanisms
3096. The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry
3097. The individual and combined effects of obesity and type 2 diabetes on cancer predisposition and survival
3098. The influence of alloxan diabetes on experimental cancer.
3099. The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
3100. The influence of diabetes mellitus and metformin on distant metastases in oropharyngeal cancer: a multicenter study
3101. The Influence of diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal cancer: A Multicenter Study
3102. The influence of diabetes severity on guideline-concordant treatment for stage I-III breast cancer in the National Program of cancer Registries (NPCR) patterns of care …
3103. The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
3104. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
3105. The influence of psychological stress on the initiation and progression of diabetes and cancer
3106. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese
3107. The influence of type 2 diabetes on the risk of cancer
3108. The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression
3109. The interface of pancreatic cancer with diabetes, obesity, and inflammation: research gaps and opportunities: summary of a National Institute of diabetes and …
3110. The Interplay Between Type Two diabetes Mellitus and Prostate cancer
3111. The intricate relationship between diabetes, obesity and pancreatic cancer
3112. The levels of interleukin-2 and interleukin-10 in patients with type 2 diabetes and colon cancer
3113. The link between personality dimensions and pain perception in patients with diabetes mellitus or cancer
3114. The links between insulin resistance, diabetes, and cancer
3115. The management of diabetes in patients with advanced cancer
3116. The management of diabetes in terminal illness related to cancer
3117. The mechanisms of Fenretinide-mediated anti-cancer activity and prevention of obesity and type-2 diabetes
3118. The Mechanistic Link Between Type 2 diabetes and Colorectal cancer
3119. The metformin effect on survival in Middle Eastern patients (pts) with type II diabetes (DM) and colorectal cancer (CRC).
3120. The modern nutritional diseases: Heart disease, stroke, type-2 diabetes, obesity, cancer: and how to prevent them
3121. The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey
3122. The mutual aggravation syndrome in pancreatic cancer and diabetes mellitus
3123. The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
3124. The neglected insulin: IGF-II, a metabolic regulator with implications for diabetes, obesity, and cancer
3125. The nutritional value and health benefits of pulses in relation to obesity, diabetes, heart disease and cancer
3126. The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus …
3127. The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor
3128. The OMEGA-3 Miracle: The Icelandic Longevity Secret that Offers Super Protection Against Heart Disease, cancer, diabetes
3129. The orphan nuclear receptors in cancer and diabetes
3130. The pathway from diabetes and obesity to cancer, on the route to targeted therapy
3131. The performance of different artificial intelligence models in predicting breast cancer among individuals having type 2 diabetes mellitus
3132. The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases
3133. The possible role of diabetes in the etiology of laryngeal cancer
3134. The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes.
3135. The potential of glycemic control and body weight change as early markers for pancreatic cancer in patients with long-standing diabetes mellitus: a case-control study
3136. The potential of lupin as a functional food for the prevention of diabetes and pancreatic cancer
3137. The predictive effect of body mass index on type 2 diabetes in the Norwegian women and cancer study
3138. The present state of knowledge on the problem of the relation between diabetes mellitus and breast cancer
3139. The prevalence of disability among people with cancer, cardiovascular disease, chronic respiratory disease and/or diabetes: a systematic review
3140. The Prevention and Control of cancer by Metformin in Patients with Type 2 diabetes: A Systematic Mapping Review Protocol
3141. The Prime Cause of Type-2 (T2D), Type-1 diabetes (T1D) and the Relation Between diabetes and cancer
3142. The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia
3143. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis
3144. The protective effect of diabetes mellitus against prostate cancer: role of sex hormones
3145. The Protein Myth: Significantly Reducing the Risk of cancer, Heart Disease, Stoke and diabetes While Saving the Animals and the Planet
3146. The quality of diabetes care among cancer survivors: a retrospective cohort study
3147. The relation between the cancer and diabetes death-rates
3148. The Relation of diabetes Mellitus with Short-term Outcomes in Patients with Gastric cancer [J]
3149. The relation of type 2 diabetes and breast cancer incidence in Asian, Hispanic and African American Populations—a review
3150. The relation of type 2 diabetes and cancer
3151. The relationship between body mass index, diabetes, and triple-negative breast cancer prognosis.
3152. The relationship between diabetes and cancer
3153. The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies
3154. The relationship between diabetes and pancreatic cancer
3155. The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer
3156. The Relationship Between Insulin Therapy and cancer Incidences in Patients with diabetes: Follow up study in Korea
3157. The relationship between metformin and cancer in patients with type 2 diabetes
3158. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case–control study
3159. The relationship between obesity and cancer mortality in type 2 diabetes: a ten-year follow-up study (ZODIAC-21)
3160. The relationship between pancreatic cancer and type 2 diabetes: cause and consequence
3161. ThE RElATIONShIp BETwEEN TypE 2 diabetes AND cancer: AN INTEgRATIvE REvIEw
3162. The Relationship between Type 2 diabetes and cancer: An Integrative Review
3163. The relationship between type 2 diabetes mellitus and cancer-related mortality and survival using linked CPRD data
3164. The relationship between vitamin B6, diabetes and cancer
3165. The Relationship of Neutrophil-to-Lymphocyte Ratio or Platelet-to-Lymphocyte Ratio and Pancreatic cancer in Patients with Type 2 diabetes.
3166. The Relationship of Type 2 diabetes, Oral diabetes Medications, and Insulin Therapy to Risk for Breast cancer
3167. The Research Progress of Metformin in Type Ⅱ diabetes Mellitus with Liver cancer
3168. The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012; 36: 371-8)
3169. The Risk of Bladder cancer in Korean Diabetic Subjects Treated with Pioglitazone (diabetes Metab J 2012; 36: 371-8)
3170. The risk of breast cancer in women with diabetes
3171. The Risk of cancer in diabetes Patients: A Review
3172. The risk of cancer in people with diabetes and chronic kidney disease
3173. The risk of colorectal cancer in patients with type 2 diabetes mellitus: associations with treatment stage and obesity
3174. The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity
3175. The Risk of Onset of the Illnesses Based on Gender, Age, and Monthly Income; Focusing on cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders
3176. The role of adiposity in the association between type 2 diabetes and the risk of breast cancer.
3177. The role of diabetes and diabetes treatments in colorectal cancer mortality, incidence, and survival
3178. The role of diabetes and other co-morbidities on survival after esophageal cancer surgery in a population-based study
3179. The Role of diabetes in Molecular Pathogenesis of cancer
3180. The role of diabetes mellitus in the aetiology of renal cell cancer
3181. The Role of early-life psychological factors in the development of chronic disease: a longitudinal analysis applied to the onset of cancer, diabetes, and asthma in mid …
3182. The Role of Hypoxia Inducible Factor-1α in Pancreatic cancer and diabetes Mellitus
3183. The role of insulin and insulin-like growth factors in the increased risk of cancer in diabetes
3184. The Role of Insulin, IGF-1 and PRAS40 in the Processes of Oncogenesis in Women with Type 2 diabetes Mellitus and Endometrial cancer
3185. The Role of Islet Amyloid Polypeptide (IAPP) in the diabetes and Anorexia of Pancreatic cancer
3186. THE ROLE OF METFORMIN AND STATINS IN OVARIAN AND BREAST cancer IN WOMEN WITH TYPE 2 diabetes
3187. The role of metformin and statins in the incidence of epithelial ovarian cancer in type 2 diabetes: a cohort and nested case–control study
3188. The Role of Obesity-induced Inflammation During the Pathogenesis of Type 2 diabetes and cancer
3189. The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study
3190. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease
3191. The Role of Pi, Glutamine and the Essential Amino Acids in Modulating the Metabolism in diabetes and cancer
3192. The Role of Pre-Existing Type 2 diabetes Mellitus in Colorectal cancer Stage and Survival in Elderly Americans: A Seer-Medicare Population-Based Study 2002 …
3193. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies
3194. The Role of RNASE L in Type I diabetes and Development of Quantitative LC-MS/MS Methods for the Pharmacological Studies of Anti-cancer Drug Candidates
3195. The role of the adaptive stress response in the pathogenesis of neurodegenerative diseases, cancer and diabetes mellitus type 2
3196. The role of the pentose phosphate pathway in diabetes and cancer
3197. The role of type 2 diabetes mellitus in colorectal cancer patients
3198. The study of the etiology and pathogenesis of schizophrenia, the psychosomatic illnesses, diabetes mellitus and cancer.
3199. The study of the relationship between diabetes mellitus and pancreatic cancer [J]
3200. The survival advantage of milk and dairy consumption: an overview of evidence from cohort studies of vascular diseases, diabetes and cancer
3201. The temporal relationship between diabetes and cancer: A population‐based study
3202. The type 2 diabetes-associated Th17 cytokines IL-21 and IL-22 promote breast cancer cell survival.
3203. The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes
3204. The Use of Long-Acting Insulin Analogs and the Risk of Colorectal cancer Among Patients with Type 2 diabetes: A Population-Based Cohort Study
3205. The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus
3206. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes
3207. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
3208. Therapeutic Nanotechnology and Immunoengineering for Cellular Therapy in Autoimmune diabetes and cancer
3209. Therapeutic use of metformin in diabetes and survival outcomes in endometrial cancer patients with diabetes
3210. Therapeutic uses of epicatechin in diabetes and cancer
3211. Therapeutically and pharmacological virtues of god’s mushroom-Agaricus blazei Murill. inhibitory effects in infection, cancer and diabetes.
3212. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
3213. Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis
3214. Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis
3215. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
3216. Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus
3217. Thousands of cases of diseases such as cancer and diabetes could go on diagnosed if we put off visiting the doctor since the start of the covert crisis, GPS have …
3218. Thyroid hormones in diabetes, cancer, and aging
3219. Time perspective in healthy individuals and patients suffering from cancer and diabetes
3220. Time-dependent risk of cancer after a diabetes diagnosis in a cohort of 2.3 million adults
3221. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
3222. Time-varying risk for breast cancer following initiation of glucose-lowering therapy in women with type 2 diabetes: Exploring detection bias
3223. TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
3224. Total pancreatectomy for pancreatic head cancer–trading pancreatic fistulas for diabetes
3225. Total-Body Irradiation is a Major Risk Factor for Young Adult Onset diabetes Mellitus and Hyperlipidemia in Childhood cancer Survivors after Hematopoietic Stem …
3226. Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation
3227. Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus
3228. Trace element profile and incidence of type 2 diabetes, cardiovascular disease and colorectal cancer: results from the EPIC-Potsdam cohort study
3229. Traditional diabetes risk factors in pancreatic cancer associated diabetes (PacDM): A prospective study of 512 patients
3230. Traditional knowledge for modern ailments plants used for the treatment of diabetes and cancer in Northern Peru
3231. Trans fatty acids and lipid profile: a serious risk factor to cardiovascular disease, cancer and diabetes
3232. Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
3233. Transcriptomic Analyses and Potential Therapeutic Targets of Pancreatic cancer With Concomitant diabetes
3234. Transforming growth factor‐β signaling, a potential mechanism associated with diabetes mellitus and pancreatic cancer?
3235. Trastuzumab-related cardiotoxicity in patients with breast cancer with comorbidities of obesity, dyslipidemia, and diabetes.
3236. Treament-related diabetes and cardiovascular disease in prostate cancer survivors
3237. Treatment and outcome in non-Hodgkin’s lymphoma patients with and without prevalent diabetes mellitus in a population-based cancer registry
3238. Treatment outcomes in men with metastatic castration-resistant prostate cancer (mCRPC) and cardiovascular disorders or diabetes: The Prostate cancer Registry.
3239. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes
3240. Treatment with insulin (analogues) and breast cancer risk in women with diabetes; a systematic review and meta-analysis of in vitro, animal and human …
3241. Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells
3242. Trends in breast cancer incidence among women with type-2 diabetes in British general practice
3243. Trends in cancer mortality among people with vs without diabetes in the USA, 1988–2015
3244. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between …
3245. trouble, deafness, spider bite, diabetes, cancer and other con¬
3246. Tuesday, November 14, 2000-3: 00 PM Abstract# 8961 Enabling the nation’s schools to prevent cardiovascular disease, cancer, and diabetes: A CDC initiative
3247. Two diseases with one hit: inhibiting a potential diabetes target to reduce cancer risk and to improve anti-cancer therapy
3248. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
3249. Two-year Changes of Adiponectin after Bariatric Surgery and Their Association with Incident Type 2 diabetes, Cardiovascular Disease, cancer and Mortality: Results …
3250. Type 1 and type 2 diabetes and cancer mortality in the 2002-2009 cohort of 39 811 French dialyzed patients
3251. Type 1 diabetes mellitus and risk of cancer: a meta-analysis of observational studies
3252. Type 1 diabetes, ACTH Deficiency, and Hypothyroidism Simultaneously Induced by Nivolumab Therapy in a Patient with Gastric cancer: A Case Report
3253. Type 2 diabetes and Breast cancer Survivorship: A Case Report
3254. Type 2 diabetes and breast cancer-the role of hyperinsulinaemia in breast cancer development and mortality
3255. Type 2 diabetes and breast cancer: the interplay between impaired glucose metabolism and oxidant stress
3256. Type 2 diabetes and cancer
3257. Type 2 diabetes and cancer as redox diseases?
3258. Type 2 diabetes and cancer–cancer incidence and mortality among 457,473 persons with type 2 diabetes compared to 2,287,365 matched controls in Sweden: an …
3259. Type 2 diabetes and cancer: an overview of epidemiological evidence and potential mechanisms
3260. Type 2 diabetes and cancer: Should we prefer antihyperglycaemic treatments without unnecessarily increasing insulin levels?
3261. Type 2 diabetes and cancer: The Nitric Oxide Connection
3262. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
3263. Type 2 diabetes and cancer: what is the connection?
3264. Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing
3265. Type 2 diabetes and colorectal cancer survival: The multiethnic cohort
3266. Type 2 diabetes and gender differences in liver cancer by considering different confounding factors: a meta-analysis of cohort studies
3267. Type 2 diabetes and glycemic traits in relation to colorectal cancer risk: a Mendelian randomization study
3268. Type 2 diabetes and increased risk of estrogen receptor-negative breast cancer in African American women
3269. Type 2 diabetes and obesity in midlife and breast cancer risk in the Reykjavik cohort
3270. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy
3271. Type 2 diabetes and Pancreatic cancer–A Possible Reason
3272. Type 2 diabetes and prostate cancer risk in Korean men with low PSA
3273. Type 2 diabetes and risk of cancer
3274. Type 2 diabetes and risk of colorectal cancer in two large US prospective cohorts
3275. Type 2 diabetes and risk of incident cancer in China: a prospective study among 0.5 million Chinese adults
3276. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
3277. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses’ Health Study
3278. Type 2 diabetes and the risk of mortality among patients with prostate cancer
3279. Type 2 diabetes and the risk of renal cell cancer in women
3280. Type 2 diabetes as a potential risk marker for early onset colorectal cancer.
3281. Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort
3282. Type 2 diabetes associated with abnormal p53 immunohistochemical patterns in colorectal cancer
3283. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population …
3284. Type 2 diabetes may increase breast cancer risk
3285. Type 2 diabetes May Increase Breast cancer Risk in African-American Women
3286. Type 2 diabetes mellitus accompanied by isolated adrenocorticotropic hormone deficiency and gastric cancer
3287. Type 2 diabetes mellitus and cancer: the role of pharmacotherapy
3288. Type 2 diabetes mellitus and characteristics of breast cancer in China
3289. Type 2 diabetes Mellitus and Colorectal cancer Risk and Survival in Oman
3290. Type 2 diabetes mellitus and colorectal cancer risk: is homocysteine the missing link?
3291. Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences
3292. Type 2 diabetes mellitus and gastrointestinal cancer: Disease, drugs, or distortion?
3293. Type 2 diabetes mellitus and habits lifestyle increases the risk of cervical cancer: a cross-sectional population-based study
3294. Type 2 diabetes mellitus and kidney cancer risk: a retrospective cohort analysis of the National Health Insurance
3295. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort
3296. Type 2 diabetes mellitus and pancreatic cancer
3297. Type 2 diabetes mellitus and pancreatic cancer in related family
3298. Type 2 diabetes mellitus and prognosis in early stage breast cancer women
3299. Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta‐analysis of observational studies
3300. Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies
3301. Type 2 diabetes mellitus and risk of oral cancer and precancerous lesions: a meta-analysis of observational studies
3302. Type 2 diabetes mellitus and the risk of colorectal cancer
3303. Type 2 diabetes mellitus as a risk factor for female breast cancer in the population of Northern Pakistan
3304. Type 2 diabetes mellitus as risk factor for colorectal cancer
3305. Type 2 diabetes mellitus associated with increased risk for colorectal cancer: evidence from an international ecological study and population-based risk analysis in …
3306. Type 2 diabetes mellitus does not increase the risk of lung cancer among never-smokers: a nationwide cohort study
3307. Type 2 diabetes Mellitus Increases Economic Burden of Colorectal cancer Surgery: 2252
3308. Type 2 diabetes Mellitus Induced Paracrine Effects on Breast cancer Metastasis Through Extracellular Vesicles Derived from Human Mesenchymal Stem Cells
3309. Type 2 diabetes Mellitus Is Associated With Increased Mortality in Chinese Asian Patients Receiving Curative Surgery for Colon cancer
3310. Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer
3311. Type 2 diabetes mellitus is associated with increased risk of pancreatic cancer: a veteran administration registry study
3312. Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the …
3313. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome
3314. Type 2 diabetes mellitus, glycemic control, and cancer risk
3315. Type 2 diabetes mellitus, insulin‐use and risk of bladder cancer in a large cohort study
3316. Type 2 diabetes mellitus, oral diabetic medications, insulin therapy, and overall breast cancer risk
3317. Type 2 diabetes mellitus, smoking, and colorectal cancer
3318. Type 2 diabetes mellitus: a marker or a risk factor for pancreatic cancer?
3319. Type 2 diabetes mellitus: a risk indicator for colorectal cancer
3320. Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies
3321. Type 2 diabetes, adiposity and cancer morbidity and mortality risk taking into account competing risk of noncancer deaths in a prospective cohort setting
3322. Type 2 diabetes, antidiabetic medications, and colorectal cancer risk: two case–control studies from Italy and Spain
3323. Type 2 diabetes, Body Mass Index and cancer Mortality: A Population-Based Matched Cohort Study of 1.0 Million Adults in England
3324. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor …
3325. Type 2 diabetes, but not insulin (analog) treatment, is associated with more advanced stages of breast cancer: a national linkage of cancer and pharmacy registries
3326. Type 2 diabetes, insulin treatment and prognosis of breast cancer
3327. Type 2 diabetes, metformin, and the risk of mortality in patients with prostate cancer
3328. Type 2 diabetes, obesity, and breast cancer risk among Japanese women of the atomic bomb survivor cohort
3329. Type 2 diabetes, Obesity, and cancer Share Some Common and Critical Pathways
3330. Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001–2007
3331. Type 2 diabetes: a protective factor for prostate cancer? An overview of proposed mechanisms
3332. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer
3333. Type 3c diabetes and Pancreatic cancer
3334. Type II diabetes and breast cancer.
3335. Type II diabetes and incidence of estrogen receptor negative breast cancer in African American women
3336. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort
3337. Type II diabetes, obesity, and breast cancer risk: the Multiethnic Cohort
3338. Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer
3339. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
3340. UCP 2 gene polymorphisms in obesity and diabetes, and the role of UCP 2 in cancer
3341. UNDERSTANDING ROLE OF 9P21 GENE DESERT SNPS IN cancer, AGING, diabetes, AND CARDIO-VASCULAR DISEASES
3342. Understanding the association of type 2 diabetes mellitus in breast cancer among African American and European American populations in South Carolina
3343. Understanding the Relationship Between Type 2 diabetes and Bladder cancer
3344. Undiagnosed diabetes in breast, colorectal, lung, and prostate cancer: incidence and risk factors
3345. Unfolding link between diabetes and cancer
3346. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer
3347. Unravelling the link between diabetes, insulin treatment and breast cancer
3348. Upregulation of REG Ia accelerates tumor progression in pancreatic cancer with diabetes
3349. Upregulation of REG Iα accelerates tumor progression in pancreatic cancer with diabetes
3350. Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes
3351. Use of an α-glucosidase inhibitor and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based cohort study
3352. Use of Anti-Diabetic Medication is Not Associated with cancer Risk in Chinese Patients with Type 2 diabetes
3353. Use of family history in clinical guidelines for diabetes and colorectal cancer
3354. Use of insulin and mortality from breast cancer among Taiwanese women with diabetes
3355. Use of Insulin and Risk of cancer among Patients with diabetes Mellitus: A Nonconcurrent Prospective Study
3356. Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish diabetes Research Network Epidemiology Group
3357. Use of metformin and risk of kidney cancer in patients with type 2 diabetes
3358. Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes
3359. Use of sulphonylurea and cancer in type 2 diabetes—the Hong Kong diabetes Registry
3360. Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry
3361. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis
3362. Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case-control study
3363. Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes
3364. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
3365. Using genetics to decipher the link between type 2 diabetes and cancer: shared aetiology or downstream consequence?
3366. Using mouse and Drosophila models to investigate the mechanistic links between diet, obesity, type II diabetes, and cancer
3367. Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 diabetes in the Etiology of Colon cancer
3368. Vacuolar H+-ATPase in cancer and diabetes
3369. Validation of Breast cancer and Bladder cancer Among Patients With Type 2 diabetes Mellitus in US Medicare: A Pilot Study
3370. Validation of the enriching new-onset diabetes for pancreatic cancer model in a diverse and integrated healthcare setting
3371. Validation of the survival benefit from metformin use in patients with type 2 diabetes and colorectal cancer.
3372. Validation of the survival benefits of metformin in middle Eastern patients with type II diabetes mellitus and colorectal cancer
3373. Value of adipokines in the diagnosis and prognosis of pancreatic cancer complicated with diabetes
3374. Value of glycated hemoglobin in the diagnosis of diabetes and prediabetes in cancer patients
3375. Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse
3376. Venous thromboembolism and risk of cancer in patients with diabetes mellitus
3377. Ventures with venoms: several toxin-based products are in the running as treatments for cancer, stroke, and diabetes
3378. Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer
3379. Video consultations between patients and clinicians in diabetes, cancer, and heart failure services: Linguistic ethnographic study of video-mediated interaction
3380. VIewpoInt sectIon reference fraMeworks for the health ManaGeMent of Measles, Breast cancer and diabetes (type II)
3381. Visit-to-visit hemoglobin A1c variability is associated with later cancer development in patients with diabetes mellitus
3382. Vitamin D and pancreas: the role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer
3383. VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress
3384. Waist circumference, body mass index, and colorectal cancer risk according to diabetes status: A Korean nationwide population‐based cohort study
3385. Weight change and blood glucose concentration as markers for pancreatic cancer in subjects with new-onset diabetes mellitus: A matched case-control study
3386. Weight cycling, diabetes and risk of postmenopausal breast cancer.
3387. Weight loss precedes cancer specific symptoms in pancreatic cancer associated diabetes mellitus
3388. Weight loss, diabetes, fatigue, and depression preceding pancreatic cancer
3389. Weight Status and All-Cause Mortality in Older Adults: A Study of Patients With Type 2 diabetes Undergoing Subtotal Gastrectomy for cancer
3390. Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes
3391. Werner syndrome and diabetes mellitus accompanied by adrenal cortex cancer
3392. What do cancer, diabetes, and cardiovascular disease have in common?
3393. What every dentist should know about metformin, diabetes, and cancer
3394. White blood cell count and renin–angiotensin system inhibitors for the risk of cancer in type 2 diabetes
3395. Why are diabetes, stomach cancer and circulatory diseases more common in Northern Sweden?
3396. Why diabetes patients are more prone to the development of colon cancer?
3397. Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications
3398. Why should you care about free radicals? Because these molecules appear to play a role in the development of heart disease, cancer, diabetes, and other diseases …
3399. WITHDRAWN: Association of Type 2 diabetes Mellitus with the Histopathological Features of Early-Stage Breast cancer Patients: A Retrospective Cross-Sectional …
3400. Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55)–a study protocol
3401. Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes
3402. US-JAPAN CONFERENCE: INFLAMMATION, diabetes AND cancer held at the Beckman Research Institute of City of Hope, Duarte, CA, USA
3403. … -6-phenylimidazo (4, 5-b) pyridine (PhIP) induces gene expression changes in JAK/STAT and MAPK pathways related to inflammation, diabetes and cancer
3404. … -control study of the association between metabolic syndrome and colorectal cancer: a comparison of International diabetes Federation, National Cholesterol …
3405. … -free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer
3406. … -persistent environmental pollutants and risk of type 2 diabetes in a Spanish sub-cohort from the European Prospective Investigation into cancer and Nutrition study
3407. … -Spectrum Biomarkers for Atherosclerosis, Acute Ischemic Stroke, Cardiovascular Disease, diabetes Mellitus, Chronic Kidney Disease, and Digestive Organ cancer
3408. … -term effects of gestational diabetes on bone mineral density and fracture risk: Analysis of the Norfolk cohort of the European Prospective Investigation into cancer …
3409. … ‐Binding Globulin (SHBG) gene, related to both serum testosterone and SHBG levels and the risk of myocardial infarction, type 2 diabetes, cancer and mortality in …
3410. … , adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer
3411. … , and Practices Related to Noncommunicable Diseases Among Korean Adults Residing in Urban and Rural Areas-Focusing on Hypertension, diabetes, and cancer
3412. … , but What About Pancreatic cancer?: Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 diabetes …
3413. … , gonadotrophins and SHBG by type 2 diabetes in postmenopausal women: Clinical implications for the incidence of breast cancer, and cardiovascular risk in diabetic …
3414. … , Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF‐I‐like mitogenic and anti‐apoptotic activity in cultured cancer cells. diabetes Metab Res Rev …
3415. … , such as obesity and malnutrition, respectively (Rodríguez-Arauz et al., 2016). In western countries hypertension, cancer, diabetes and cardiovascular diseases …
3416. … , Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into cancer and Nutrition–Potsdam …
3417. … ; Hematology: Metachronous Double cancer Included B-Cell Chronic Lymphocytic Leukemia and Pancreatic cancer That Diagnosed After Progression of diabetes
3418. … : Ethnic differences in the relationship between diabetes, early age adiposity, and mortality among breast cancer survivors: The Breast cancer Health Disparities Study
3419. … : glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer …
3420. … : TP-65; diabetes Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lung cancer …
3421. … : WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNG cancer: The Impact Of Hba1c Levels On Survival Of Lung cancer Patients With diabetes …
3422. … . 02c-019 The Use of Metformin and the Incidence of Metastases at the Time of Diagnosis in Patients with Lung cancer and Type 2 diabetes: Topic: Targeted Therapy
3423. … (BMA) has increased over the last decade due to its association with, and potential role, in a range of diseases (osteoporosis, diabetes, anorexia, cancer) as well as …
3424. … (Curcuma longa): from a variety of traditional medicinal applications to its novel roles as active antioxidant, anti-inflammatory, anti-cancer, and anti-diabetes
3425. … (f) chromen-3-one as a potential inhibitor of NF-κB: A key regulatory molecule in inflammationmediated pathogenesis of diabetes, Alzheimer’s, and cancer
3426. … (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes …
3427. … (to RAR); a fellowship from a NIH diabetes, Endocrinology and Metabolism Training Grant (NIH DK07217)(to GT); an American diabetes Association mentor Based …
3428. … 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into cancer (EPIC)-Norfolk cohort and …
3429. … 2SI “VP Komisarenko Institute of Endocrinology and Metabolism of NAMS of Ukraine”, Kyiv BREAST cancer IN WOMEN WITH diabetes MELLITUS TYPE 2
3430. … 7 and its closest paralog tetraspanin 6: membrane organizers with key functions in brain development, viral infection, innate immunity, diabetes and cancer
3431. … a high index of suspicion for endometrial malignancy or hyperplasia with atypia in Hispanic patients who have hypertension, diabetes, history of hormone …
3432. … A. ferox leaf gel may show promise in alleviating symptoms associated with/or prevention of cardiovascular diseases, cancer, neurodegeneration, and diabetes …
3433. … activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer–a narrative review
3434. … acute recurrent and chronic pancreatitis: Protocol of a multicenter randomized controlled trial from the study of chronic pancreatitis, diabetes and pancreatic cancer …
3435. … al.(2010) Associations of Hyperglycemia and Insulin Usage With the Risk of cancer in Type 2 diabetes: The Hong Kong diabetes Registry. diabetes; 59: 1254–1260
3436. … And Assessment of Small Molecules as Free Radical Scavengers and Potential Multi-Target Therapeutic Agents against Alzheimer’s Disease, diabetes and cancer
3437. … and evaluation of the curriculum for BOLD (Bronx Oncology Living Daily) Healthy Living: a diabetes prevention and control program for underserved cancer survivors
3438. … and harmonized International diabetes Federation criteria tools to assess impact on cardiovascular risk assessmentRole of primary care management in cancer …
3439. … and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes …
3440. … and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer
3441. … and Mechanisms of diabetes Resolution According to the Range of Gastric Resection and the Length of Anastomosis in Animal Models: Implication for Gastric cancer …
3442. … and Mortality Risk in Individuals With Pancreatic cancer–Related diabetes and Postpancreatitis diabetes: A Nationwide Cohort Study. diabetes Care 2019; 42: 1675 …
3443. … and Mortality Risk in Individuals With Pancreatic cancer–Related diabetes and Postpancreatitis diabetes: A Nationwide Cohort Study. diabetes Care 2019; 42: 1675 …
3444. … and Risks Associated With Use of Social Media by People With Health Issues: Focusing on Mental Illness, HIV/AIDS, cancer, Intellectual Disability, and diabetes
3445. … and Yoga in prediabetic and type 2 diabetes under the National Programme for Prevention and Control of cancer, diabetes, Cardiovascular Diseases and …
3446. … antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125I seed brachytherapy for prostate cancer
3447. … as simulated patientsCaring and communicating in critical casesImplementation of the expanded chronic care model for the management of diabetes in a community …
3448. … assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
3449. … association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont diabetes Information System Study
3450. … Atlas of Major Disease Mortalities for Cities, Towns and Villages in Japan: All Causes of Death, cancer, Cardiovascular Diseases, diabetes Mellitus, Liver Cirrhosis …
3451. … Beneficial Effect of this Adipokine? Commentary to: Higher circulating adiponectin concentrations predict incident cancer in type 2 diabetes–the adiponectin paradox
3452. … Beneficial Effect on Breast cancer by Study Design Re:“Low-Dose Aspirin Reduces Breast cancer Risk in Women with diabetes: A Nationwide Retrospective Cohort …
3453. … between non-permanent migration and non-communicable chronic disease outcomes for cancer, heart disease and diabetes–a systematic review
3454. … between type of dietary fish and seafood intake and the risk of incident type 2 diabetes: the European prospective investigation of cancer (EPIC)-Norfolk cohort study
3455. … blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 …
3456. … by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into cancer and Nutrition (EPIC) …
3457. … cancer in diabetics and clinical characteristics of diabetes-associated with pancreatic cancer–comparison between diabetes with and without pancreatic cancer
3458. … cancer resistance protein expression and function at the blood–brain barrier and blood–cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes …
3459. … cancer Society, American diabetes Association, and American Heart Association joint statement on preventing cancer, cardiovascular disease, and diabetes: where …
3460. … cascade in the mononuclear cells of peripheral blood: association with insulin and insulin-like growth factor levels in the blood of patients with cancer and diabetes
3461. … cause and cause-specific mortality among Medicaid-insured women with preexisting type 2 diabetes diagnosed with breast cancer: A cancer registry-Medicaid linkage
3462. … circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes
3463. … concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, cancer and Health cohort
3464. … cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into cancer and Nutrition (EPIC) …
3465. … D levels are associated with greater all-cause and cancer-related mortality among Australian adults: findings from the Australian diabetes, Obesity and Lifestyle Study …
3466. … D, Wilde J, Schubert P: Mu-tations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005; 51 …
3467. … dependent insulinotropic polypeptide receptor modifies the association between carbohydrate and fat intake and risk of type 2 diabetes in the Malmö Diet and cancer …
3468. … diabetes as risk factor for pancreatic cancer: miRNA expression profiling in plasma uncovers a role for miR-20b-5p, miR-29a, and miR-18a-5p in diabetes of …
3469. … diabetes mellitus induced by immune checkpoint inhibitor therapy in an insulinoma-associated antigen-2 autoantibody-positive patient with advanced gastric cancer
3470. … diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer …
3471. … diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer
3472. … diabetes mellitus, glycated haemoglobin and incidence of and mortality from cancer: analysis of longitudinal data from England and Scotland linked to cancer …
3473. … diabetic retinopathy and diabetic kidney disease on all‐cause, cancer, vascular and non‐cancer non‐vascular mortality in patients with type 2 diabetes: A real‐world …
3474. … diagnosis of endometrial precancer and cancer by combined use of progesterone test and transvaginal ultrasonography in high risk groups of patients with diabetes …
3475. … DIE ANOTHER DAY: WHAT WE ARE LEARNING ABOUT HOW TO TREAT AND BEAT LUNG cancer: The Impact Of diabetes And Its Treatment On Lung cancer …
3476. … dietary intake, lifestyle and incident symptomatic peripheral arterial disease among individuals with diabetes mellitus: insights from the Malmö Diet and cancer study
3477. … disease, arthritis, cerebralstroke, diabetes, cardiovasculardisease, cancer, andotherconditions. The consequencesformanyarenumerousexpensivemedications …
3478. … drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary …
3479. … education programmes for patients with type 1 and 2 diabetes, asthma and COPD, coronary heart disease, hypertension, congestive heart failure, and breast cancer …
3480. … et al.(2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes Registry. diabetes; 59: 1254–1260
3481. … Exploration of the Relationship Between Insulin Glargine and Incident cancer: A Retrospective Cohort Study of Older Medicare Patients. diabetes Care 2011; 34 …
3482. … Exploration of the Relationship Between Insulin Glargine and Incident cancer: A Retrospective Cohort Study of Older Medicare Patients. diabetes Care 2011; 34 …
3483. … fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into cancer and Nutrition (EPIC) …
3484. … for a CuRE (INSPPIRE 2) Cohort Study: Design and Rationale From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
3485. … for chronic pancreatitis by using CT, MRI, and MR cholangiopancreatography: the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
3486. … for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
3487. … for vitamin D. Many observational and some interventional studies have linked vitamin D to car-diovascular disease, cancer, and diabetes. In addition, reduced levels …
3488. … Furthermore, it is well documented that obesity is a risk factor for certain chronic diseases, especially heart diseases, hypertension, diabetes and some forms of cancer …
3489. … gastrointestinal reconstruction methods after distal subtotal gastrectomy on nutritional status and blood glucose in patients with type 2 diabetes and gastric cancer
3490. … genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into cancer (EPIC) …
3491. … has identified numerous functional compounds in peanuts that promote health and may reduce the risk of cardiovascular disease, cancer, and diabetes.
3492. … Heart Attack, Stroke, cancer, Ovarian cancer, Lung cancer, diabetes, Dementia, Colon cancer, Pneumonia, Pancreatic cancer, Emphysema and More
3493. … impact of newly diagnosed diabetes mellitus on cancer-free survival in patients without colorectal polyps: A secondary analysis of Korean multicenter cancer …
3494. … importance of Cannabis sativa L. in regulation of insulin and IL-6R/MAO-A in cancer cell progression and migration of breast cancer patients with diabetes
3495. … important regulatory system with multiple options in the treatment of diabetes mellitus, inflammatory bowel disease and in the chemoprevention of colon cancer?
3496. … in glioma and acute myeloid leukemia 398 Circulating tumour cells in cancer patients: challenges and perspectives 407 The emerging genetics of type 2 diabetes
3497. … in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1beta gene and prostate cancer: a systematic review and …
3498. … in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population …
3499. … in Type 2 diabetes, Coronary Heart Disease and cancer Subgroups in the UK Biobank, and Their Modification by Smoking. diabetes Care,[dc172508]. https …
3500. … insulin-using diabetes mellitus patients, non-insulin-using diabetes mellitus patients and patients without diabetes mellitus after partial gastrectomy for gastric cancer
3501. … Learning from Genetically Modified Animals Guest Editor: Junichi FujiiThioredoxin binding protein (TBP)-2/Txnip and. ALPHA.-arrestin proteins in cancer and diabetes …
3502. … level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer–Norfolk prospective study
3503. … levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible …
3504. … Lifestyle and Metabolic Health Status With New-Onset diabetes and Major Cardiovascular Events: The China Cardiometabolic Disease and cancer Cohort (4C) Study
3505. … Lipoic Acid Breakthrough: The Superb Antioxidant that May Slow Aging, Repair Liver Damage, and Reduce the Risk of cancer, Heart Disease, and diabetes
3506. … LONG-TERM OUTCOMES IN LIVE KIDNEY DONORS: PREVALENCE OF ISCHEMIC HEART DISEASE, diabetes, cancer AND CEREBROVASCULAR DISEASE …
3507. … Lung cancer: diabetes Mellitus Predicts Poor Responses to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase inhibitor (TKI) in Non-Small Cell Lung cancer …
3508. … matrix glycation and receptor for advanced glycation end-products activation: a missing piece in the puzzle of the association between diabetes and cancer
3509. … measured lifestyle factors and BMI explain differences in health-related quality of life between colorectal cancer patients with and without comorbid diabetes
3510. … medicinal property of sage (Salvia) to prevent and cure illnesses such as obesity, diabetes, depression, dementia, lupus, autism, heart disease, and cancer
3511. … metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose …
3512. … metformin use and cancer stage at diagnosis among elderly medicare beneficiaries with preexisting type 2 diabetes mellitus and incident prostate cancer
3513. … morphometric studies on pancreatic endocrine cells, including IAPP in the normal pancreas and in pancreatic tissues from type 2 diabetes and pancreatic cancer
3514. … Natural products for diabetes and its complication as nephropathyA study to assess the effectiveness of informative booklet regarding knowledge of breast cancer …
3515. … new‐onset diabetes mellitus and worsening glycaemic variables for established diabetes in men undergoing androgen‐deprivation therapy for prostate cancer
3516. … nutrition and total parenteral nutrition on the nutritional status and blood glucose in patients with gastric cancer complicated with diabetes mellitus after radical …
3517. … O’Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014; 65 …
3518. … of artificial sweetener in packets or tablets and type 2 diabetes risk: evidence from the E3N-European prospective investigation into cancer and nutrition study
3519. … of common comorbidities, such as hypertension, dyslipidemia, diabetes mellitus, cardiovascular disease, cerebrovascular disease and cancer, in older Japanese …
3520. … of diabetes mellitus in pancreatic cancer population. Comparative study between new onset and long standing diabetes mellitus on 76 patients with pancreatic cancer …
3521. … of dietary and lifestyle interventions in elderly or people diagnosed with diabetes, metabolic disorders, cardiovascular disease, cancer and micronutrient deficiency on …
3522. … of genetic association of Thyroid cancer with Parkinsons disease, Osteoporosis, chronic heart failure, Chronic kidney disease, Type 1 diabetes and Type 2 diabetes
3523. … of Hospitalization for Pancreatic cancer in the First 8 Years after a Gestational diabetes Mellitus regardless of Subsequent Type 2 diabetes: A Nationwide Population …
3524. … of mammalian target of rapamycin signaling downregulates insulin receptor substrates 1 and 2 and AKT activation: a crossroad between cancer and diabetes?
3525. … of preexisting type 2 diabetes mellitus and antidiabetic drugs on all-cause and cause-specific mortality among Medicaid-insured women diagnosed with breast cancer
3526. … of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase—significance for diabetes and cancer
3527. … of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer …
3528. … of serum markers of oxidative stress with incident major cardiovascular events, cancer incidence, and all-cause mortality in type 2 diabetes patients: pooled results …
3529. … of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic review
3530. … of the Mammalian Target of Rapamycin, Protein Tyrosine Phosphatase 1b and Dipeptidase 4 Signaling Pathways in cancer and diabetes: A Narrative Review.
3531. … of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease, cancer, and diabetes among postmenopausal women
3532. … on Chronic Diseases: Cardiovascular Diseases, Oxidative Stress, Dyslipidemia, diabetes Mellitus, Blood Pressure, cancer, Neurodegenerative Disease and …
3533. … patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer
3534. … PEPTIDASE-4 INHIBITORS ON CISPLATIN-INDUCED ACUTE NEPHROTOXICITY IN cancer PATIENTS WITH diabetes MELLITUS: A RETROSPECTIVE …
3535. … pneumonitis in patients with NSCLC treated with concomitant chemoradiotherapy––Are we underestimating diabetes?––Turkish oncology group (TOG)/Lung cancer …
3536. … polyunsaturated fatty acids intake and risk of all-cause mortality, cardiovascular disease, breast cancer, mental health, and type 2 diabetes: a systematic review …
3537. … preferred components for physical activity interventions in African-American survivors of breast or endometrial cancer with type 2 diabetes: the SUCCESS framework
3538. … primary androgen deprivation therapy: validation of Japan cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes …
3539. … procedures for biospecimen collection, processing, and storage: from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer
3540. … review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes
3541. … RHEUMATOID ARTHRITIS37 PATTERNS OF CARDIOVASCULAR RISK AND DISEASE AMONG PEOPLE WITH TYPE 2 diabetes STARTING INSULIN: BASELINE …
3542. … RNA cancer susceptibility candidate 2 (CASC2) alleviates the high glucose-induced injury of CIHP-1 cells via regulating miR-9-5p/PPARγ axis in diabetes …
3543. … Roux-en-Y Construction Really Bring Benefit of Type 2 diabetes Mellitus Remission After Gastrectomy in Patients with Gastric cancer? A Systematic Review …
3544. … Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder cancer in Older US Adults with Type 2 diabetes
3545. … self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer
3546. … senescence-evasion mechanism involving Grap2 and Cyclin D interacting protein inactivation by Ras associated with diabetes in cancer cells under doxorubicin …
3547. … Society of Gastroenterology& SLDDS 2035: Slide Session; K-BP-25: Pancreatobiliary; Is diabetes a Useful Diagnostic Clue to Detect Early Stage of Pancreatic cancer …
3548. … Stat3 pathways respectively promotes and inhibits diabetes‐associated centrosome amplification by targeting at the ROCK1/14‐3‐3σ complex in human colon cancer …
3549. … strategies for addressing high levels of ‘I don’t know’responding to risk perception questions for colorectal cancer and diabetes: an experimental investigation
3550. … Stress, Blood Sugar, Blood Lipid, Body Mass Index, Fat Mass, and Body Weight in Patients with Type 2 diabetes. Journal of diabetes Nursing and Midwifery …
3551. … Study to Establish a New-Onset diabetes (NOD) Cohort: From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
3552. … that shed new light on the possible pathogenesis of a disease or an adverse effect: Atypical early onset of diabetes, deafness and lung cancer in a male …
3553. … the novel effect in relief, prevention, and treatment of a number of serious illnesses such as diabetes, cardiovascular disease, Alzheimer’s disease, and cancer
3554. … the synergistic interaction of diabetes, tobacco smoking, alcohol consumption, and hypercholesterolemia on the risk of pancreatic cancer: a case-control …
3555. … the Ten-Step Action Plan Scientifically Proven to Prevent or Reverse Obesity, Memory Loss, Alzheimer’s, diabetes, Autoimmunity, cancer, and Heart Disease
3556. … the validity and reliability of the health literacy questionnaire in Iran: Recognizing the risk factors for cardiovascular diseases, diabetes, and cancer
3557. … theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer
3558. … time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
3559. … to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis possible …
3560. … to incidence of type 2 diabetes: results from the Greek cohort of the population-based European Prospective Investigation into cancer and Nutrition (EPIC)
3561. … to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J cancer, 2016, No. 52, pp …
3562. … to prevent hospital admission and delay chemotherapy treatment in patient with a small cell lung cancer. Kamal Abouglila diabetes centre, University Hospital of …
3563. … Translational StuDies (PROCEED): Rationale and Study Design From the Consortium for the Study of Chronic Pancreatitis, diabetes, and Pancreatic cancer
3564. … vitamin D deficiency, part 2: deficiency and its association with autoimmune disease, cancer, infection, asthma, dermopathies, insulin resistance, and type 2 diabetes.
3565. … With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung cancer: Analysis of Safety and Efficacy in Patients With diabetes
3566. … with Incidence of Type 2 diabetes after Adjustment for Overall Dietary Quality in the European Prospective Investigation into cancer and Nutrition–Netherlands (EPIC …
3567. … women with preexisting type 2 diabetes mellitus diagnosed with breast cancer: An epidemiological analysis of linked New York State Medicaid and cancer …
3568. … workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer
3569. [Obesity, hypertension and diabetes mellitus in patients with endometrial cancer]
3570. [PP. 37.06] A GENETIC RISK SCORE FOR TYPE 2 diabetes IS INDEPENDENTLY ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIET cancer …
3571. 07 Surgery for Upper Gastrointestinal cancer in a Morbidly Obese Patient with diabetes and Renal Impairment
3572. 09 Incontinence Developing During Chemotherapy in a Patient with Advanced Ovarian cancer and diabetes
3573. 1045 Higher Pancreatic cancer Risk Following New Onset of diabetes Mellitus in Non-Obese Patients With Chronic Pancreatitis
3574. 1095-P: Exendin 4 Decreases Tumor Volume through Attenuation of psma-Induced Activation of NfκB Pathway in HPV-Induced diabetes/cancer Model
3575. 1110–1082 and TNFa-863 gene polymorphisms may favor the onset of chronic pancreatic diseases and of the associated diabetes, but not pancreatic cancer …
3576. 120P Breast cancer and diabetes: Retrospective Study
3577. 128: Androgen Deprivation Therapy and Risk of diabetes Mellitus in Men Undergoing Androgen Deprivation Therapy for Prostate cancer
3578. 1297-P: Mortality and Glycemic Control among Patients with Endometrial cancer and diabetes Mellitus: A Case-Control Study
3579. 1347 diabetes MELLITUS PREDICTS POOR RESPONSE TO INDUCTION BCG IN NON-MUSCLE INVASIVE BLADDER cancer
3580. 137-Quality of diabetes Care Among cancer Survivors
3581. 14 Obesity, diabetes, and Risk of cancer
3582. 14.4 A POSITIVE FAMILY HISTORY OF diabetes IS ASSOCIATED WITH ARTERIAL STIFFNESS: THE MALMO DIET cancer STUDY
3583. 1475-P: CA19-9, miR-200, and GIP in Patients with diabetes Mellitus and Pancreatic cancer
3584. 1506-P: Breast cancer as a Risk Factor for New diabetes
3585. 152: The Association between Androgen-Deprivation Therapy and the Incidence of diabetes Among Males with Prostate cancer
3586. 1550-P: Trends in cancer Mortality among US Adults With and Without diabetes, 1988-2015
3587. 158 Assessing the impact of diabetes mellitus and end stage renal disease on cervical cancer prognosis in an urban population
3588. 1597-P: Increased Pancreatic cancer Risk Associated with Dietary Iron in Whites, but Not Blacks with diabetes
3589. 160-OR: Pretreatment diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in cancer Patients with Immune-Check Point Inhibitor
3590. 1609-P: diabetes and Risk of All-Cause and cancer-Specific Mortality in Breast, Prostate, and Colorectal cancer Survivors
3591. 1646-P: Role Of Microbiota In diabetes-Associated Colorectal cancer
3592. 167 SERUM GLUCOSE IS ASSOCIATED WITH BIOCHEMICAL RECURRENCE IN MEN WITHOUT diabetes TREATED FOR LOCALIZED PROSTATE cancer
3593. 1685-P: Type 1 diabetes Mellitus and Incident Bladder cancer: A Systematic Review and Meta-analysis
3594. 1749 IMPACT OF diabetes MELLITUS ON THE RECURRENCE AND PROGRESSION OF PATIENTS WITH NON MUSCLE INVASIVE BLADDER cancer: A …
3595. 179 INDIVIDUALS WITH diabetes HAVE AN INCREASED RISK OF COLORECTAL cancer.
3596. 18. Does diabetes have an effect on FDG PET standardized uptake values in lung cancer?
3597. 191-LB: Comorbid diabetes and cancer: Differences by Patient Characteristics and Symptom Outcomes
3598. 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
3599. 2157 THE ASSOCIATION OF diabetes MELLITUS AND HIGH-GRADE PROSTATE cancer IN A MULTIETHNIC BIOPSY SERIES
3600. 216-LB: Risk Factors of Pancreatic cancer in Persons with Advancing diabetes
3601. 2280-PUB: Cluster of Metabolic Disorders Increases Risk of cancer in Chinese Patients with Type 2 diabetes
3602. 2283-PUB: Metformin Treatment and Prostate cancer Risk: Cox Regression Analysis with Time-Dependent Covariates of 150,000 Men with Incident diabetes Mellitus
3603. 25-Hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies
3604. 259 THE IMPACT OF diabetes AND METFORMIN USE IN CLINICALLY LOCALIZED PROSTATE cancer TREATED BY RADICAL PROSTATECTOMY
3605. 32nd National Medicinal Chemistry Symposium–medicinal chemistry developments for neurodegeneration, diabetes and cancer.
3606. 335 diabetes MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE cancer: RESULTS FROM THE DUKE PROSTATE CENTER
3607. 4 The influence of glucose-lowering therapies on cancer risk 5 in type 2 diabetes
3608. 434-P: diabetes in Patients with Pancreatic cancer: Relationship of Tumor Grade with Glycemic Control
3609. 487-P: The Activation of mTORC1 in Leukocytes of Patients with cancer and diabetes
3610. 8-Hydroxydeoxyguanosine: A valuable predictor of oxidative DNA damage in cancer and diabetes mellitus
3611. 8. Application Of Pharmacogenetics In Dose Individualization In diabetes, Psychiatry, cancer And Cardiology
3612. 856 Preliminary review of diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy–Roswell Park Comprehensive cancer Center …